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The N-acyliminium ion has long been an important tool in the synthesis of nitrogen 
containing heterocycles, capable of forming both carbon-carbon and carbon-heteroatom 
bonds. Recent advances in the chemistry of N-acyliminium ions has seen the development 
of α,β-unsaturated N-acyliminium ions, capable of reacting through sequential 1,4- and 
1,2-addition reactions to yield optically active heterocyclic spirocycles, generating high 
molecular complexity in a one-pot reaction. The α-cyclopropyl N-acyliminium ion under 
the right conditions reacts in an analogous way, capable of sequential 
homoconjugate-addition and 1,2-addition reactions, resulting in ring opening of the 
cyclopropyl group and its incorporation into a spirocyclic heterocycle. To the authors 
knowledge, only one report of an α-cyclopropyl N-acyliminium ion is in the literature 
where the chemistry was briefly mentioned in 1975, but the reactivity of α-cyclopropyl 
N-acyliminium ions had not been properly explored until this Thesis.  
In this thesis (Chapter 2), the synthesis of several α-cyclopropyl N-acyliminium ion 
precursors is described, from which an α-cyclopropyl N-acyliminium ion is generated in 
situ with BF3·Et2O and reacted with 1,2-dimethoxybenezne to furnish the desired 
spirocycle. Optimisation studies were carried out for the reaction of an α-cyclopropyl 
N-acyliminium ion precursor and 1,2-dimethoxybenzene, where complications arose due 
to the BF3OH
- anion ring opening the cyclopropyl group through homoconjugate 
addition, which led to an undesired spirocyclic furan.  
The reaction scope is then expanded to include other aromatic nucleophiles and 
allyltrimethylsilanes, which give a variety of novel homoconjugate addition products and 
1,2-addition products, as well as the undesired spirocyclic furan.  
From these reactions, indole proves to be the most promising, and so a range of substituted 
indoles were reacted with the α-cyclopropyl N-acyliminium ion precursors synthesised 
earlier. These results are reported in Chapter 4. The reaction product outcomes appear to 
be dependent on the electron richness (nucleophilicity) of the indole nucleophile, where 
highly electron rich nucleophiles result in 1,2-addition reactions to the α-cyclopropyl 
N-acyliminium ions, and electron poor nucleophiles result in the undesired spirocyclic 
furan, that is they do not react with the α-cyclopropyl N-acyliminium ion. Homoconjugate 
addition occurs somewhere between these two afore mentioned levels of nucleophilicity. 
It was discovered however, that steric effects from the substituents close to the iminium 
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carbon during the addition transition state favoured homoconjugate addition over 
1,2-addition products.  
Finally, a high throughput biological assay was carried out by Eli Lily on a subset of the 
products made in this thesis, with promising results in PCSK9 inhibition and in the 
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1.1 The α-Cyclopropyl N-Acyliminium Ion 
This thesis reports on our development of α-cyclopropyl N-acyliminium ion chemistry 
towards the synthesis of novel spirocyclic heterocycles. While the chemistry of 
N-acyliminium ions has been extensively studied and reviewed,1–4 the chemistry of 
α-cyclopropyl N-acyliminium ions is only inferred in the literature (intermediate 2 shown 
in Scheme 1.1 was not disclosed in the original publication).5 A caveat to this, is that 
α-cyclopropyliminium ions are utilised in the Cloke-Stevens-Beckman rearrangement, as 
discussed in Section 1.19, for the synthesis of 5-membered nitrogenated rings.6 
 
Scheme 1.1 Homoconjugate addition of X- to an α-cyclopropyl N-acyliminium ion 2. 
In this Chapter an outline of N-acyliminium ion chemistry will be provided with a focus 
on the synthesis of spirocyclic heterocycles, the synthetic targets of this thesis.  
1.2 Medicinally Useful Spirocyclic Alkaloids 
From the vast amount of medicinally interesting alkaloids that are found in Nature, those 
that are of particular interest to this thesis are spirocyclic. A spirocyclic compound is a 
compound composed of two rings bridged through a quaternary atom. An example of a 
spirocyclic heterocycle is compound 4, a 1-azaspiro[4,5]decane. There are many 
examples of medicinally interesting spirocyclic alkaloids having this core structure, 
Figure 1. These include; the acetylcholinesterase inhibitor sessilistemonamine D 5,7 the 
anticancer alkaloid cylindricine A 6,8 the antimuscarinic TAN1251A 7,9 and the 
immunosuppresent FR901483 8.10 The physical feature of particular importance in a 
spirocyclic compound is its structural rigidity, increasing the chance of specificity when 




Figure 1.1 Representative examples of bioactive spirocyclic alkaloids. 
1.3 Total Syntheses of Spirocyclic Alkaloids 
Although significant advances have been made in the field, the total synthesis of 
structurally complicated natural products poses intricate challenges to organic chemists. 
The total synthesis of the alkaloids above, as well as related alkaloids, are important for 
a variety of reasons. First, harvesting and extracting the alkaloids may not be 
commercially viable, and collection and extraction may be environmentally or ethically 
unsound. Secondly, analogues that are synthesised from the chemistry that has been 
developed could have greater medicinal applicability than the natural product. In addition 
to these two broad reasons, the human search for more knowledge would be furthered as 
our knowledge of organic chemistry and related sciences becomes greater through 
experimentation towards the synthesis of complex natural products. 
1.4 Importance of N-Acyliminium Ions and Their Generation 
An important method for preparing alkaloids, including spirocyclic alkaloids, is via the 
intramolecular and intermolecular reactions of N-acyliminium ions. An N-acyliminium 
ion has the general structure R1R2C=N+(COR4)R3, where a carbonyl group is attached to 
the nitrogen of the iminium ion, as demonstrated in compound 9 (Scheme 1.2).  
 
Scheme 1.2 An N-acyliminium ion 9 undergoing nucleophilic addition. 
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N-Acyliminium ions are important synthetic reactive intermediates and are readily 
attacked by nucleophiles (Scheme 1.2), allowing the intermolecular and intramolecular 
formation of carbon-carbon bonds as well as carbon-heteroatom bonds. Because of the 
electron withdrawing effect of the N-acyl group these intermediates are typically more 
susceptible to nucleophilic attack than iminium ions. 
The N-acyliminium ion moiety was first utilised in synthesis in the 1950s, with a range 
of papers published mostly focused on the synthesis of isoquinoline and indole 
alkaloids.11–16 An early paper on the use of an N-acyliminium ion in synthesis compared 
the reactivity of the N-acyliminium ion 15 to its iminium ion analogue 12, Scheme 1.3.11 
The aforementioned paper suggested that the Mannich and related Pictet-Spengler 
reactions of 11 are limited in scope compared to those that proceed via the reaction of 
N-acyliminium ion 15. This is due to the increased reactivity of the N-acyliminium ion 
imparted by the decreased electron density at the iminium carbon.11 
 
Scheme 1.3 Ring closing reactivities of iminium ion 12 and its N-acylated analogue 15.11  
 There are four common and six general methods that are used to generate N-acyliminium 
ions in the literature: a) enamide protonation (Scheme 1.4a);17 b) photooxidation 
(Scheme 1.4b);18,19 c) leaving group elimination (Scheme 1.4c);20,21 d) anodic oxidation 
(Scheme 1.4d);22 e) β-lactam ring expansion (Scheme 1.4e);23,24 and f) the direct 




Scheme 1.4. N-acyliminium ion generation via a) enamide protonation; b) photoredox; 
c) elimination; d) Shono oxidation; e) ring expansion of a β-lactam; and f) direct 
acylation of an imine. LG = leaving group. LA = Lewis acid. 
Obtaining an N-acyliminium ion through enamide protonation by a Brønsted acid is 
relatively straightforward, with the lone pair of the nitrogen facilitating this process 
(Scheme 1.4a). 
Scheme 1.4b involves a relatively new chemistry in the formation of N-acyliminium ions, 
discovered by Friestad et al.18 First a photoredox catalyst provides an electron to an alkyl 
halide (R4X), forming the halide anion and the alkyl radical (R4·). Next, the alkyl radical 
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adds to the π system of the enamine 19, forming a new C-C bond, and leaving a radical α 
to the nitrogen. Finally, the remaining unpaired electron on intermediate 20 is transferred 
to R4X with assistance from the nitrogen lone pair, leaving the molecule to generate more 
of the alkyl radical (R4·), and the N-acyliminium ion is formed. Masson et. al. expanded 
upon this work, trapping the N-acyliminium ions that were generated with alcohols.19  
The method shown in Scheme 1.4c, and used in this thesis, uses a Brønsted or Lewis acid 
to protonate or coordinate a leaving group situated α to the acylated nitrogen 23. The lone 
pair of electrons on the nitrogen assists in the elimination of the activated leaving group 
to generate the N-acyliminium ion 24. Throughout the literature this is the most common 
method, typically utilising an α-hydroxylactam where the hydroxy group is eliminated 
upon addition of a stoichiometric amount of Brønsted acid or Lewis acid. 
Shono oxidation is an electrosynthetic method of generating N-acyliminium ions, 
Scheme 1.4d.22 This method involves first the loss of an electron from the nitrogen of an 
amide or carbamate, which drives the elimination of an α-proton from radical cation 26 
and the loss of a second electron to generate the desired intermediate 24. Nucleophilic 
solvents are generally used to trap the formed N-acyliminium ion in this method, but this 
method has been developed to the extent that the N-acyliminium ion no longer has to be 
trapped. Instead, a “cation pool” is used which involves electrolysis of a carbamate to 
convert the carbamate to its N-acyliminium ion at low temperature, which can then be 
taken into non-oxidising conditions and warmed to introduce the nucleophile, since 
generally the nucleophile will be more readily oxidised than the starting carbamate.27 One 
of the main advantages of this method is the traceless nature of this electrochemistry, 
which does not require stochiometric oxidant or acid to generate the N-acyliminium ion. 
Additionally, this synthetic method of N-acyliminium ion generation has shown promise 
in a continuous flow cell, where Underwood and colleagues took N-formylpyrrolidine, 
formed its N-acyliminium ion electrochemically, then trapped it via a 1,2-addition 
reaction with methanol, the solvent.28  
Scheme 1.4e shows the ring expansion reaction of a β-lactam to a γ-lactam 
N-acyliminium ion. First described by Ikeda and co-workers in 199523 it was 10 years 
later when Kimpe and Brabant revisited this chemistry to explore its application as an 
N-acyliminium ion generation method.24 The method involves using a β-lactam 27 
functionalised with an exocyclic leaving group positioned δ to the nitrogen. When the 
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leaving group is eliminated, a carbenium ion is formed, which allows for a ring expansion 
to occur due to the strained nature of the four membered ring, and results in the desired 
ring expanded N-acyliminium ion. 
Direct N-acylation of an imine is the final way of forming the N-acyliminium ion Scheme 
1.4f. This reaction requires an acylating reagent, but can be modified to incorporate many 
carbonyl containing molecules including activated carboxylic acids, acid halides and 
anhydrides.  
1.5 Alkylation of N-Acyliminium Ions using Organo Silanes and Stannanes 
Carbon-carbon bond forming reactions are extremely valuable in the synthesis of 
alkaloids. The reactions of organo silanes and stannanes with N-acyliminium ions allows 
access to newly formed non-aromatic carbon-carbon bonds, tolerating a wide range of 
functional groups. A subset of these reactions is shown in Scheme 1.5, where elimination 
of TMSO, as [TMSOBF3]
- or (TMS)2O, from the acyclic N-acyliminium ion precursors 
32i-v, following the mechanism of Scheme 1.4c above generates the corresponding 
N-acyliminium ion, which can then undergo addition of the carbon nucleophile to give 
adducts 33 in excellent yields.29  
 
Scheme 1.5 Silane and stananne nucleophilic attack on an acyclic N-acyliminium ion.29 
Nishiyama reported high yields of cyanated products 35 and 36 from the reactions of 
optically active substrates 34i-iii using TMSCN or Bu3SnCN (Scheme 1.6).
30 Analogous 
results were obtained by Thaning and Wistrand where the cis product 38 was obtained 
from substrate 37 having a O-TBS protecting group and the trans product 37 was obtained 





Scheme 1.6 The stereoselective cyanation of optically active acetoxylactam 34.30 
 
Scheme 1.7 Stereoselective addition of silane nucleophiles to the N-acyliminium ion 
precursor 37.31,32 
1.6 Neighbouring Group Effects on Stereochemical Outcomes 
The basis for predicting the stereochemical outcome of reactions with  
3-substituted-pyrrolidinone N-acyliminium ions such as 40 and a nucleophile 
(Scheme 1.8), the focus of this project, were discussed in a review by Yazici and Pyne.4 
Several competing effects determine the diastereoselectivity of these reactions, namely, 
the substituents on O or N, the nucleophile used in the reaction, and the Lewis acid. There 
are three models that can be used to rationalise the reaction outcomes of these reactions, 
that of steric effects, neighbouring group participation (Scheme 1.8a), and the Cieplak 
effect (Scheme 1.8b). The first of these models involve steric effects, where the 
nucleophile will add trans to a bulky α-substituent to minimize unfavourable steric 
interactions. Neighbouring group participation of an acetate group can result in anti 
products being formed, resulting from nucleophilic addition to the opposite face of the 
bridged bicyclic cationic intermediate 41. An α-chelating group can also deliver the 
nucleophile, as is the case described in Section 1.7 (Scheme 1.9), which leads to syn 
addition. Finally, the Cieplak effect can be used to rationalise the addition of a nucleophile 
to the syn face of the iminium ion (Scheme 1.9b). Cieplak proposed that as a nucleophile 
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approaches an electrophile, the forming σ bond is lower in electron density than desired, 
making it a high energy state. This can be mediated by hyperconjugation from an adjacent 
σ bonding orbital to the forming antibonding orbital to facilitate bond formation at a lower 
energy. The case below shows C-H σ-bonding orbital of 40a, which is in 
hyperconjugation with the forming σ*-anti bonding orbital C-C of the iminium carbon 
and cyano nucleophile.  
 
Scheme 1.8 The trans or cis reaction control by the chelation effect (Blue, A) and the 
Cieplak effect (Red, B) respectively. 
It is important to note that reviews on the chemistry of N-acyliminium ions1,4 show a vast 
range of reagents and substrates favouring cis or trans reaction products, and thus far 
there is usually no good way to predict, and therefore control, which stereochemical route 
the reaction will go through. The examples above highlight this difference, where 
changing the R group from OTBS to OAc changes the selectivity of the reaction from 
trans to cis when the nucleophile is TMSCN (Scheme 1.7, i to ii), yet changes from cis 
to trans when the nucleophile is allylTMS (Scheme 1.7, iii to iv). 
1.7 Organoboron Reagents Enhance Selectivity 
Organoboronic acids1,34–36 and their related trifluoroboronates21,37,38 fulfil the same role 
as the alkylating agents previously discussed, as well as allowing the addition of aryl 
nucleophiles. Due to the widespread use of protected and unprotected hydroxy groups in 
N-acyliminium ion chemistry, the ability of the organoboron reagent to coordinate to the 
oxygen of a free hydroxy group in proximity to the iminium carbon makes for effective 




Scheme 1.9 Reactions of aryl boronic acids with piperidine 42. Adapted from Onomura 
et al. Major diastereomeric product pictured.34 
Having access to chelating (organoboron compounds) and non chelating (stannane and 
silane) nucleophiles allows greater flexibility in the stereochemical outcome of 
N-acyliminium ion alkylation and arylation reactions, and highlights the progress made 
in this field to control reaction selectivity by the nature of the reagents. 
1.8 Addition of Heteroatom-Based Nucleophiles (O, N, S, P, Se) to N-Acyliminium 
Ions 
In contrast, fewer publications have focused on the development of protocols for the 
addition of heteroatom nucleophiles to N-acyliminium ions. A recent study by Ferreira et 
al. investigated the addition of a range of alcohols to the N-acyliminium ion intermediate 
47 (Scheme 1.10).39 In this study, indium triflate catalyses the formation of the alcohol 
adducts 48 from the triacetoxy pyrolidinone derivative 46. The alcohol adduct 48 is 
favoured in the equilibrium by the use of an excess amount of the alcohol. 
 
Scheme 1.10 In(OTf)3 catalysed addition reactions of alcohols to N-acyliminium ion 
47.39 Major syn diastereomer pictured. 
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Nitrogen also has a role to play as a nucleophile in reactions with N-acyliminium ions, 
and has been shown to be an effective nucleophile when free25,40,41 or N-protected.42,43 
Other, less common heteroatom nucleophiles that have been studied undergoing addition 
reactions to N-acyliminium ions include S,44–47  P,48 and Se based nucleophiles.49  
1.9 Addition of Aromatic Nucleophiles to N-Acyliminium Ions 
Aromatic nucleophiles are versatile reagents in C-C bond formation. A variety of 
aromatic nucleophiles have been reacted with a large substrate scope of N-acyliminium 
ions. Yoshida et al. generated the linear N-acyliminium ion  50 (Scheme 1.11) via the 
cation pool method outlined in Scheme 1.4d, and reacted the resulting N-acyliminium 
ion with the aromatic nucleophiles shown in Table 1.1.50 These reactions were performed 
using a conventional batch method in round bottom flasks, but also were performed using 
micromixing, where reagents proceeded under flow cell conditions in very small 
volumes.  
 
Scheme 1.11 Cation pool formation of N-acyliminium ion 50 followed by aryl 
nucleophilic addition.50 
Monoalkylation of the N-acyliminium ion occurred with all aromatic substrates, with 
yields of adducts 52 ranging from poor to excellent. The use of micromixing was integral 
in avoiding or reducing the formation of dialkylated products 53 in the case of the more 
nucleophilic aromatics, indicated by a higher nucleophilicity parameter, such as methoxy 
benzenes (Entries 4 to 9), thiophene (Entries 10 and 11), furan (Entries 12 and 13) and 
N-methylpyrrole (Entries 14 and 15). It was thought that concentrated regions (spots) of 
the aryl nucleophiles in the reaction mixture resulted in the dialkylation products 51 being 
formed.  Aryl nucleophiles have also been tested with cyclic N-acyliminium ions.2 
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Table 1.1 Reactions of aromatic nucleophiles with N-acyliminium ion 50 adapted from 
Yoshida et al.50 
Entry Nucleophile 
Nucleophilicity  














0 67 0 
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1.10 Radical addition to N-Acyliminium Ions 
As was mentioned above, Yoshida et al. pioneered work on the cation pool method to 
generate N-acyliminium ions. This group also investigated radical additions to these ions 
to form a radical cation intermediate, obtaining optimised yields of final products 56 
ranging from 35 to 86% with alkyl and aryl halide radical precursors 55 (Scheme 1.12).51  
 
Scheme 1.12 Reactions of organic halides with N-acyliminium ions (n = 1,2) in the 
presence of hexabutyldistannane, adapted from Yoshida et al.51 
A proposed mechanism for these reactions is shown in Scheme 1.13. The 
hexabutyldistannane 57 undergoes homolysis to form the tributyltin radical 58, which 
then forms the alkyl radical 60 by halide abstraction. The alkyl radical then reacts at the 
iminium carbon of 54, generating the radical cation intermediate 61. Another molecule 
of hexabutyldistannane then reacts with this radical cation through an electron transfer 
process, making the radical cation 62 (or it makes the tributyltin cation 63 and tributyltin 
radical 58). Then a fluoride ion is transferred from BF4
- to the tributyltin cation 62, 
forming tributyltin fluoride and BF3, and reforming a tributyltin radical 58 to repeat the 
cycle. A comparison of the ionisation energies of the carbamate 61 being reduced to a 
neutral compound 56 verses the N-acyliminium ion 54 being reduced to the radical 
indicated that the carbamate reduction is thermodynamically more favourable than 




Scheme 1.13 Proposed reaction mechanism for the reactions of organic halides with 
N-acyliminium ions.51 
1.11 Synthesis of Multicyclic Ring Structures 
Building molecular complexity in a controllable fashion is an important part of synthetic 
organic chemistry. The following reactions showcase the reactions involving 
N-acyliminium ions that provide more complex cyclic and bicyclic structures from 
relatively simple acyclic or monocyclic precursors.  
In addition to the aforementioned alkylating agents, enol and enolate forming compounds 
are also effective nucleophiles. Quiroz et al. showcased their importance in 
N-acyliminium chemistry with their use in generating pyrrolizidine, indolizine and 
pyrroloazepinolizadine nuclei 69, from the TiCl4 catalysed reactions of the 




Scheme 1.14 Synthesis of azabicyclic nuclei. Modified from Quiroz et al.52 
Kimpe and co-workers showed the utility of β-lactams as stereocentre rich γ-lactam 
starting materials (Scheme 1.15).43 The method of N-acyliminium ion generation in this 
reaction is described earlier in Scheme 1.4e, where the silver cation coordinates to the 
chlorine atom of 70 and assists C-Cl heterolysis giving rise to the ring expansion of the 
β-lactam ring. Subsequently, the hydroxy or protected amine can undergo an 
intramolecular alkylation reaction giving mixtures of the bicyclic products 71 and 72 in 
moderate to good yields and diastereoselectivites. 
 
Scheme 1.15 β-Lactam ring expansions and cyclisations to form bicyclic products.43 
Another synthetic example of an azabicycle is the work of Blaauw and co-workers, who 
undertook a diastereoselective synthesis of the natural product (–)-dysibetaine PP 78.53 
During their synthesis, they investigated a cyclisation methodology that not only allowed 
synthetic access to bicyclic products, where N-C bonds were being formed, but also 





Scheme 1.16 Tandem cyclisation adapted from Blaauw et al.53 
More recent examples exist in the literature of multicyclic azacycles being formed 
through N-acyliminium ion chemistry.54 Abe and Yamada described the synthesis of the 
azepinoindole alkaloid Iheyamine A 82, using a tethered tryptamine derivative, Scheme 
1.17.55  
 
Scheme 1.17 Pentacycle formation via a crucial N-acyliminium ion intermediate, 
adapted from Yamada et al.55 
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Interestingly, alkynes as internal nucleophiles towards N-acyliminium ions has also been 
used in the synthesis of multicyclic structures through an aza-Prins cyclisation, resulting 
in substituted pyrroloisoindolone and pyridoisoindolones 87, Scheme 1.18.56 The 
proposed mechanism involves attack of the π electrons from the alkyne onto the 
N-acyliminium ion carbon, resulting in the vinylcarbocation 85. This can then undergo 
attack from water formed from the elimination of the hydroxy group with triflic acid 
giving a mixture of E/Z enol isomers 86. Finally, this compound can tautermerise to form 
the tricyclic product 87. This mechanism was supported by a further experiment where 
the alkene carbocation 85 was trapped with methanol. This study included 16 examples, 
however the reaction does not work when R = H, or Et, suggesting that the 
alkenylcarbocation required some resonance stabilisation by an aryl group to be efficient, 
since the reaction is reversible between intermediates 84 and 85. 
 
Scheme 1.18 Proposed mechanism and intramolecular tautomerisation of 
alkynylphthalimide derivatives 83, adapted from Saikia and Das.56 
1.12 Organocatalysis in Iminium Ion Chemistry 
N-acyliminium ion chemistry had its first true taste of organocatalysis with the work of 
Jacobsen et al. whereby the acyl-Pictet-Spengler reaction was developed in the presence 
of a chiral organocatalyst (Scheme 1.19).26 This reaction was developed with a 
tryptamine derived imine, where the imine nitrogen of compound 87 was N-acylated, 
generating the N-acyliminium ion 88 in situ. Intramolecular cyclisation then occured, 
followed by restoration of aromaticity through the loss of a proton giving the final 
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tetracyclic product 90 in good yield and excellent enantioselectivity. Chirality is 
introduced by the bulky and chiral stereogenic counterion, formed by H-bonding of the 
catalyst to the chloride ion as shown in intermediate 88.  
 
Scheme 1.19 Enantioselective acyl-Pictet-Spengler reaction. 
This work was further developed by Muratore with BINOL derived phosphoric acids, 
showing greater enantioselectivity and reaction rates than that of Jacobsen et al. on indole 
derivatives.57 Other catalyst designs and developments have been reported.58,59  
1.13 Syntheses of Spiroheterocyclic Compounds 
Intermolecular and intramolecular heteroatom and carbon nucleophile cyclisations have 
been utilised towards the synthesis of spiroheterocycles. As an exploration of a possible 
methodology towards the synthesis of the natural products marineosin A and B, which 
exhibit significant anticancer activities,60 Shi and co-workers undertook model studies on 
synthesising the core spirocyclic structure 93.61 This began with first synthesising the 
pyrroldinone 91, which when subjected to enamine protonation with TsOH formed the 
N-acyliminium ion 92 (Scheme 1.20). This intermediate then underwent cyclisation 
through nucleophilic attack by the hydroxy group onto the iminium carbon, giving the 
desired core structure 93, which could then undergo further modification towards the 




Scheme 1.20 Spirocyclisation through an N-acyliminium ion intermediate to form 
spiroaminal compound 93.61 
Vernon and co-workers developed methodologies for the synthesis of spiro 
2-pyrrolidin-5-ones, 2-piperidine-6-ones and 1-isoindolin-3-ones with tethered arene 
nucleophiles (Scheme 1.21),62 and alkene nucleophiles.63 The products 95a and 95b were 
isolated in excellent yields and proceeded with moderate diastereoselectivities, 
importantly giving a method for the generation of spiroheterocycles of various ring sizes. 
 
Scheme 1.21 Diastereoselective cyclisation to spiroheterocycles, compiled from Vernon 
et al.62 
Work undertaken by Kibayashi and co-workers examined a variety of spirocyclisations 
utilising N-acyliminium ions as key reactive intermediates, generated using formic acid 
(Scheme 1.22).64–66 These papers followed the same general procedure, which involved 
first activation of the ketone via protonation of 96, after which ring closure occurred via 
intramolecular nucleophilic attack by the amine 97. The tertiary hydroxy group was 
protonated and then eliminated to give the N-acyliminium ion 99, which during addition 





Scheme 1.22 Pyrrolidine formation via ring closing, then formic acid induced 
spirocyclisation. 
This work was further expanded upon by Abe and co-workers67 to synthesise racemic 
2-spiroindolines 105 (Scheme 1.23), for which there are few examples where a 
2-substituted indole has been used as the reaction substrate.68  
 
Scheme 1.23 2-Spiroindoline core synthesis from 2-substituted indoles.67 
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The reactions of tethered furans with N-acyliminium ions have resulted in the formation 
spirocycles as a single diastereomer throughout the literature.69 Formation of 
N-acyliminium ions 107 from the diacetates 106, followed by intramolecular attack by 
the furan formed the tricyclic intermediates 109 which upon aqueous workup gave the 
tricyclic lactones 110 as a single diastereomer (Scheme 1.24).70 
  
Scheme 1.24 Vinylogous Mannich reaction proposed mechanism.69 
Blakey et al. presented the synthesis of the stereochemically complex alkaloid 
malagashanine in 2017, involving the formation of a spirocycle and the bridged core 
structure through the use of an N-sulfonamidyliminium ion and an iminium ion, 
respectively.71 The first step of this one pot reaction is the reduction of the amide carbonyl 
with DIBAL-H, to provide an alkoxide intermediate which is quenched with TMS 
imidazole (Scheme 1.25). The OTMS group of 113 is then eliminated upon coordination 
with BF3·Et2O which allows for an intramolecular attack on the generated iminium ion 
by the indole moiety 114. The resulting imine is then susceptible to attack by the 
allylTMS moiety of 115 leading to the desired tetracycle 116 as a single diastereomer in 




Scheme 1.25 Synthesis of the core structure of 6-epi-malagashanine.71 
All methods discussed so far involve building the nucleophile into the structure before 
the spiro ring forming step, making the synthesis of analogues for biological testing 
tedious. Ideally a protocol for designing a late stage divergent synthesis to create 
spirocyclic cores via intermolecular addition is desirable. What follows is a discussion of 
substrates which do allow for late stage intermolecular nucleophilic attack of 
N-acyliminium ions, allowing potentially efficient access to libraries of spirocyclic 
compounds. 
In 2014 Vassilikogiannakis et al. reported a method to synthesis racemic azaspirocycles 
via the oxidation of substituted furans, (Scheme 1.26).72 Moderate yields were obtained 
for these one pot reactions, and the authors explored the Pictet-Spengler, aza-Prins and 




Scheme 1.26 One pot synthesis of various 1-azaspirocycles adapted from 
Vassilikogiannakis et al.72 Where RB means round bottom flask. 
These reactions can proceed through the singlet oxygen mediated oxidation of the furan 
126, followed by amine attack to generate a γ-lactam 132 where the R group is a late stage 
synthesis variation, which could then undergo an intramolecular cyclisation event to give 
spirocycle 134 (Scheme 1.27). 
 
Scheme 1.27 Proposed mechanism for the synthesis of 1-azaspirolactams.72,73 
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No work has been done on expanding this methodology to chiral compounds. This leads 
us to a promising class of compounds which could address this problem.  
1.14 The Reactivity of α,β-Unsaturated N-Acyliminium Ions 
A subclass within the N-acyliminium ion group are the α,β-unsaturated N-acyliminium 
ions 135, where a double bond exists in conjugation with the N-acyliminium ion π bond, 
which activates the double bond towards nucleophilic attack. The intermediates can allow 
for either 1,2- or 1,4-addition reactions to occur, increasing the structural diversity that 
can be achieved from non-conjugated N-acyliminium ions in a rapid manner (Scheme 
1.28). It does, however, introduce the problem of a competitive reaction site when one 
mode of addition is favoured over the other. 
 
Scheme 1.28 1,2- or 1,4-addition to an α,β-unsaturated N-acyliminium ions.  
1.15 The 1,2-Addition Reactions of α,β-Unsaturated N-Acyliminium Ions 
The first example in the literature of an α,β-unsaturated N-acyliminium ion 139 was its 
use in the synthesis towards the antibiotic and antifungal alkaloid streptazolin 142, 
(Scheme 1.29), by Kozikowski et al. in 1984.74 The reaction proceeds predominately via 
the 1,2-addition mode giving compound 140, although 2% of the 1,4-addition product 
141 was also formed. 
 
Scheme 1.29 Generation of the first α,β-unsaturated N-acyliminium ion synthon,75 
shown with target Streptazolin 142, isolated from Streptomyces viridochromogenes.76,77 
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A more recent example of a 1,2-addition to an α,β-unsaturated N-acyliminium ion is in 
the paper by Matsumara et al., where chirality is introduced during nucleophilic attack 
through the use of various bisoxazoline chiral ligands 146 (Scheme 1.30).78 The 
Cu-ligand catalyst is proposed to coordinate to the malonate anion during addition to the 
iminium carbon. This induces a temporary chirality to the nucleophile and leads to the 
induction of enantioselectivity. 
 
Scheme 1.30 Asymmetric introduction of a bis(alkoxycarbonyl)methyl group into the 2-
position of a piperidine skeleton.78  
1.16 1,4-Addition Reactions of α,β-Unsaturated N-acyliminium Ions 
Nucleophilic attack can also occur at the β- position of an α,β-unsaturated N-acyliminium 
ion. A report in 1984 by Kozikowski has examples of 1,4-additions as well as the 
previously mentioned 1,2-additions.74 An example of the 1,4-addition is shown below 
where the OMe group is eliminated to form the α,β-unsaturated N-acyliminium ion 148, 
which is then followed by 1,4-addition of ethanol (Scheme 1.31). This reaction is most 
likely under thermodynamic control leading to the more stable, conjugated 
N-acylenamine structure 149. 
 
Scheme 1.31 1,4-addition reaction of an α,β-unsaturated N-acyliminium ion, catalysed 




1.17 Diastereoselective Spirocycle Formation via Sequential Diels-Alder Reactions 
Diels-Alder reactions can be paired with nucleophilic addition to α,β-unsaturated 
N-acyliminium ions for the formation of spirocycles. For example, O’Connor et al. 
generated the α,β-unsaturated N-acyliminium ion 151 which reacted regioselectively as 
an electron deficient dienophile with the diene 152 to give tricycle 154 (Scheme 1.32).79 
Regioselective cycloaddition occurs due to the electron withdrawing effect of the 
N-acyliminium ion, which polarises the dienophile. The diene is also polarised by the 
electron withdrawing hydroxy group as well as the electron donating ethyl group, 
favouring a regioselective Diels-Alder reaction. Nucleophilic attack from the hydroxy 
group prior to the Diels-Alder reaction is reversible and the resulting adduct would be too 
deactivated to undergo an intramolecular Diels-Alder reaction under such mild reaction 
conditions.  
 
Scheme 1.32 Synthesis of a the tricyclic compound 154 through Diels-Alder cyclisation 
with an α,β-unsaturated N-acyliminium ion 151.79 
1.18 Di-addition Reactions of Exocyclic α,β-Unsaturated N-Acyliminium Ions 
Interestingly, sequential 1,4- and 1,2-addition reactions of α,β-unsaturated 
N-acyliminium ions can be carried out (Scheme 1.33). These types of reactions can be 
done with either two separate nucleophiles, Scheme 1.33 and Scheme 1.34, or by latent 
bisnucleophiles resulting in an intramolecular reaction as the final step, Scheme 1.35.  
 
Scheme 1.33 Sequential 1,4- and 1,2- addition of two nucleophiles. 
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An example of this sequential 1,4 and 1,2- addition of two nucleophiles is shown below, 
Scheme 1.34, in a one-pot reaction carried out by Yazici et al. In this reaction, 
diethylaniline was reacted first with the α,β-unsaturated N-acyliminium ions 161, after 
which indole was added to the reaction mixture giving the di-substituted pyrrolidinone 
164.  
 
Scheme 1.34 Sequential 1,4- and 1,2- addition by addition of diethylaniline and indole. 
Aromatics and allylsilanes can give rise to novel bicyclic spirocycles acting as latent 
bisnucleophiles in these types reactions. These reactions were investigated by the Yazici 
et al., with a focus on the α,β-unsaturated N-acyliminium ion precursor 160.80 An example 
of this is shown below, where a mixture of 160 and methoxybenzenes 165 were treated 
with BF3·Et2O (Scheme 1.35). 
 
Scheme 1.35 Sequential 1,4- and 1,2- addition reaction of methoxybenzenes 165 to 
α,β-unsaturated N-acyliminium ion precursor 160. The major diastereomers of 167i and 
167ii are pictured. 
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The addition of BF3·Et2O generates the α,β-unsaturated N-acyliminium ion, which then 
undergoes sequential 1,4- and 1,2-addition reactions with the methoxy benzene 165 to 
give the diastereomers of  167. The yields for the reactions using both 165i and 165ii were 
good, at 68% and 70%, respectively, however the diastereoselectivity of the spirocyclic 
products 167i,ii varied considerably with substitution. The reaction between 160 and 
indole 168 (Scheme 1.36) resulted in the formation of the spirocyclic product 169 in 
modest yield (45%) and moderate diastereoselectivity (dr = 75:25).  
 
Scheme 1.36 Sequential 1,4- and 1,2- addition reaction of indole to α,β-unsaturated 
N-acyliminium ion precursor 160. The major diastereomer of 169 is pictured. 
The reaction of 170, allyltrimethylsilane 172 and BF3·Et2O gave the tricyclic compound 
175 (Scheme 1.37). This reaction proceeds via an initial 1,4-addition to the 
α,β-unsaturated N-acyliminium ion 171, followed by protonation of the enamide 173. 
However, a completely unexpected result occurred where the benzyl oxygen took part in 
the final stages of the reaction. After protonation of 173 to reform an N-acyliminium ion 
174, a 1,2-addition reaction occurs where the developing cation from the reaction is 
stabilised by the lone pair on the benzylic oxygen.  This results in the fascinating case of 
two unique carbon-carbon bonds, one carbon-oxygen bond and two rings formed in a one 
pot synthesis.  
 
Scheme 1.37 Synthesis of a [5.5.6] spirotricycle 175 through a sequential 1,4- and 
1,2-addition reaction.80  
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The success of the α,β-unsaturated N-acyliminium ion in the synthesis of 5,5- and 
6,5-azaspirocycles leads to the question of how theoretically another carbon could be 
added into the non-aza ring of the spirocycle, giving n,6 azaspirocycles. This project aims 
to achieve that goal. 
1.19 The α-Cyclopropyliminium Ion 
As indicated earlier, the main aim of this project is to explore the scope and limitations 
of α-cyclopropyl-N-acyliminium ions forming substrates towards the synthesis of 
spirocyclic heterocycles, which theoretically will add an extra carbon into the desired 
spirocycles over methods using α,β-unsaturated N-acyliminium ions.  Before delving into 
the aims of this project however, it is important to consider the chemistry of the related 
α-cyclopropyliminium ions, used in the synthesis of 2-pyrrolines.6 The first reported 
instance of an α-cyclopropyliminium ion rearrangement was described in 1929 by 
Cloke,81 and was greatly expanded upon by Stevens using acid catalysis and high reaction 
temperatures of 110 – 150 ˚C to afford many alkaloids.82 The generally accepted acid 
catalysed reaction mechanism is as shown below (Scheme 1.38). The α-cyclopropylimine 
176 is subjected to a Brønsted or Lewis acid typically with a halide counterion, where the 
acid converts the imine 176 first to an iminium ion 177, followed by ring opening of the 
cyclopropyl group by the halide to give intermediate 178. Finally, a cyclisation can occur 
where nitrogen acts as a nucleophile and displaces the halogen, giving rise to the pyrroline 
179.  
 
Scheme 1.38 General mechanism of an α-cyclopropyliminium ion rearrangement. 
The high temperature necessary for this rearrangement reaction is possibly due to a 
number of factors, but in particular the fact that formation of the cis alkene is 
unfavourable (178) and the trans alkene must isomerise to the cis form to cyclise. Earlier 
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studies have shown that in both liquid and gas phase the anti-isomer of vinyl 
cyclopropane 180 accounts for approximately 75% of stable conformations.83,84 This is 
because the cyclopropyl group has π-like character due to its 60 ˚ bond angles between 
carbons which give the bonding orbitals a “bent” character, and allows them to 
hyperconjugate with the alkene π orbitals. Since the protons Ha and Hb of 180 are trans 
to each other, the ring opening of the cyclopropyl group by nucleophilic attack results in 
the formation of a trans alkene 181 (Scheme 1.39). 
 
Scheme 1.39 Preferred conformation of vinyl cyclopropane 180 and its ring opening. 
The ring opening of a cyclopropyl group where a carbon chain is effectively increased by 
one carbon is known as “homoconjugate” addition, but is not specific to the ring opening 
of cyclopropyliminium ions. An example of this reaction type was reported by May et al. 
as shown in Scheme 1.40, where cyclopropyl diesters 183  are ring opened with copper 
species 184 through a homoconjugate addition reaction, resulting in the enolate 186 and 
upon quenching gives the triester 187.85 
 




1.20 The α-Cyclopropyl N-acyliminium Ion 
The α-cyclopropyl N-acyliminium ion forming substrate 188 potentially allows two 
sequential nucleophilic attacks to occur in much the same way that the α,β-unsaturated 
N-acyliminium ion 156 reacts (Scheme 1.41). First, elimination of the α-hydroxy group 
with a Lewis acid or Brønsted acid results in the formation of the cyclopropyl N-
acyliminium ion 189, followed by a homoconjugate addition reaction onto the 
cyclopropyl ring. The N-acyliminium ion is then reformed through protonation of the 
double bond 190, and the second nucleophile can attack the iminium carbon through a 
1,2-addition reaction to give the ring opened product 192. 
 
Scheme 1.41 Hypothetical sequential homoconjugate and 1,2- addition reactions to the 
α-cyclopropyl N-acyliminium ion substrate 189.  
The employment of the cyclopropyl group in 195 should result in a spirocyclic product 
(196) in which the newly formed ring is one carbon larger than the product formed from 
the analogous α,β-unsaturated N-acyliminium ions, as a result of the homoconjugate 
addition when tethered nucleophiles are used (Scheme 1.42).  
 
Scheme 1.42 α,β-Unsaturated N-acyliminium ion 193 reacting with a latent 
bis-nucleophile compared to a cyclopropyl N-acyliminium ion 195.  
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The initial addition of a nucleophile to α-cyclopropyl N-acyliminium ion 195 can result 
in either homoconjugate addition or a 1,2-addition reaction product. The factors at work 
determining which of these two pathways occurs will be discussed in detail throughout 
subsequent Chapters of this thesis, as this understanding greatly influences the chemists 
power in predicting which products will occur from which reaction, and their ability to 
tailor reactions to bring about the desired outcome. 
1.21 Project Aim 1: Synthesis of α-Cyclopropyl N-Acyliminium Ion Precursor 
Substrates 
To expand the scope of the experiments going into the next phase of the project, the 
substrates 197, 199, 201 and 203 will be prepared to test the role of certain functional 
groups in the reaction of nucleophiles with α-cyclopropyl N-acyliminium ions. Four 
substrates were chosen, two substrates 197 and 199 will allow us to examine the effect of 
N substitution, the substrate 201 to examine the role of the OBn group, and a phthalimide 
analogue 203 to examine if this chemistry is significantly affected by adjacent electronic 
effects (Scheme 1.43). 
 
Scheme 1.43 The α-cyclopropyl N-acyliminium ion forming substrates. 
1.22 Project Aim 2: Optimisation of the Reaction Conditions with Potential Latent 
Bis-Nucleophile Veratrole and α-Cyclopropyl N-Acyliminium Ion Precursor 197 
Veratrole (1,2-dimethoxybenzene) 205 has been chosen as the initial nucleophile to study 
since it proved most promising in previous work in the Pyne group on the analogous α,β-
unsaturated N-acyliminium ion systems, and BF3·Et2O will be chosen as the initial Lewis 
acid for the same reason (Scheme 1.44). Veratrole also has the added advantage that 
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regioisomers are unlikely to be formed as the positions para to the methoxy groups are 
far more activated and less sterically hindered than any other positions in the molecule.  
 
Scheme 1.44 Possible 1,2-adduct 206 and sequential homoconjugate then 1,2-addition 
product 207 of α-cyclopropyl N-acyliminium ion precursor 197 and veratrole 205. 
1.23 Project Aim 3: Exploring the Scope of the Reactions of Other Aromatic 
Compounds and Allyltrimethylsilanes Additions to α-Cyclopropyl N-Acyliminium 
Ions 
After optimisation of the reaction of 197 with veratrole 205, the same reaction conditions 
will be carried over to other aromatic compounds and allyltrimethylsilanes. Since other 
reactions can potentially occur as opposed to the desired homoconjugate pathway 
followed by a 1,2-addition (cyclisation) reaction to form the spirocycle (Scheme 1.45), 
from this point onwards choosing which nucleophiles are appropriate to test in this 
reaction will be crucial to the success of this project.  
 
Scheme 1.45 Reaction of cyclopropyl N-acyliminium ion forming substrate 197 with 
aromatic 208 and allyltrimethylsilane 211 nucleophiles. 
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1.24 Project Aim 4: Investigating the Reactivity of Substituted Indoles with α-
Cyclopropyl N-Acyliminium Ions 
Upon completion of Aim 3, it became clear that indole and its derivatives were the most 
interesting nucleophiles for this reaction, and so an in depth understanding of the effect 
substituents on the indole made to the outcome of these addition reactions was sought 
(Scheme 1.46).  
 
Scheme 1.46. Possible 1,2-adduct 215 and sequential homoconjugate then 1,2-addition 
product 216 of the α-cyclopropyl N-acyliminium ion precursor 197 and indole 214. 
1.25 Project Aim 5: General Biological Screening of Novel Heterocycles 
As a final aim, the heterocyclic compounds obtained from this study will be subjected to 
biological screening through Eli Lily’s Open Innovation Drug Discovery Program, where 





2. Synthesis of α-Cyclopropyl N-acyliminium Ion Precursors and the 
Optimisation of Reaction Conditions with Veratrole. 
2.1 Aims Addressed in Chapter 2 
Two of the aims of this project are addressed successfully in this Chapter, the first of 
which (Aim 1) is the synthesis of α-cyclopropyl N-acyliminium ion precursor substrates, 
compounds 197, 199, 201, and 203 (Figure 2.1).  
 
Figure 2.1 The α-cyclopropyl N-acyliminium ion forming substrates 197-203. 
Aim 2 follows as the substrate 198 is treated with veratrole 205 in the presence of a Lewis 
acid to optimise the reaction conditions to generate and trap its resulting α-cyclopropyl 
N-acyliminium ion 198, analogous to that of the α,β-unsaturated N-acyliminium ion 
forming substrate 160 used in Yazici’s work (Scheme 2.1). 
 




There were two reaction pathways envisioned for this reaction, where either the α-
cyclopropyl N-acyliminium ion 198 reacts with veratrole 205 through a homoconjugate 
addition pathway to give adduct 217 which could potentially react further and yield the 
spirocyclic product 218, or a 1,2-addition pathway giving the 5,5-disubstituted 
pyrrolidine-2-one 219.  
The structure of the initial adduct 217 is important to address here, as the alkene could 
have either E or Z stereochemistry. The reasoning described in Chapter 1 (Section 1.19 
Scheme 1.39) regarding the favouring of the anti conformation of vinylcyclopropanes 
should hold true here for α-cyclopropyl N-acyliminium ions (Scheme 2.2). The 180˚ 
dihedral angle between C4 and Ha results in the formation of E alkene 220 as previously 
discussed, and the nucleophilic addition to the α-cyclopropyl N-acyliminium ion 198 
should occur on the top face of the molecule anti to the OBn group to prevent steric 
interactions. As veratrole is the nucleophile in Scheme 2.2, analogous reasoning is why 
the homoconjugate addition product 217 in Scheme 2.1 above is presented as the 
E-isomer. 
 
Scheme 2.2 The stereochemical outcome of homoconjugate addition of a nucleophile to 
α-cyclopropyl N-acyliminium ion 198. 
2.2 Synthesis of the N-Benzyl 5-cyclopropyl-4-benzyloxylactam 197 
The very first reaction carried out in this project was the condensation reaction of L-malic 
acid 221 and benzylamine 222 in toluene. This was performed under reflux conditions 
using a Dean Stark apparatus to remove excess water from the reaction to drive the 
reaction equilibrium towards the desired succinimide 223 (Scheme 2.3). This was a 
successful and straightforward reaction following the method outlined by Huang et al.88 
that initially recommended column chromatography (EtOAc/PS 2:3 as eluent) to purify 
the product. However, this was found to be unnecessary as the product could be isolated 
in excellent yield (87%) and purity by dissolving it in a minimal amount of EtOAc 
followed by crystallisation by addition of PS then cooling. Once the succinimide 223 was 
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in hand, the O-benzylation procedure from Huang et al.88 was again initially followed, 
but later modified, as it was found that excellent yields (95%) and purity could be 
achieved by crystallising the product rather than purification by the recommended column 
chromatography. Protection of the hydroxy group in 223 was thought to be necessary to 
avoid complications in the Grignard addition where one equivalent of Grignard reagent 
would be consumed in deprotonating this group, as well as avoiding the possibility of this 
group acting as a nucleophile once the α-cyclopropyl N-acyliminium ion is generated. 
 
Scheme 2.3 Synthesis of the α-cyclopropyl N-acyliminium ion precursors 197a and 
197b (diastereomers of compound 197). 
The O-benzyl protected compound 224 was then ready for the Grignard addition. Using 
standard conditions,88 the cyclopropyl product 197 was obtained in good yield (63%) and 
as a mixture of diastereomers (dr = 9:1 for 197a:197b) that were difficult to separate by 
column chromatography. However, small amounts of each diastereomer could be 
obtained pure after further purifications by column chromatography and these were used 
for characterisation purposes. As expected the reaction was highly regioselective for 
addition to the carbonyl group α to the OBn group,89 which is likely due to the electron 
withdrawing effect of this substituent making the C2 carbonyl more electrophilic than C5. 
The OBn group can also potentially coordinate the Grignard reagent, directing addition 
to the C2 carbonyl, and these effects are discussed in more detail after the structural 




The configurations of the major and minor reaction products were assigned using 1D and 
2D NMR spectroscopy and their structures were further characterised by low-resolution 
and high-resolution electron ionisation mass spectrometry and infra-red spectroscopy. 
This characterisation data was obtained and analysed for all novel compounds described 
in this thesis, as well as specific optical rotations for all chiral compounds where 
separation of diastereomers was successful.  
Assignment of the NMR spectra for the major diastereomer of 197a is as follows. Firstly, 
incorporation of the cyclopropyl group was evident from the resonances in the 1H-NMR 
spectrum between δH 1.0 – 0, integrating in total for 5 protons (Figure 2.2).  
 
Figure 2.2 1H-NMR spectrum (500 MHz, CDCl3) of compound 197a. 
These resonances were assigned to H6, H7 and H7'. In the gHSQC spectrum H6 shared a 
correlation with C6 (δC 17.7) and was a positive signal in the APT spectrum (Figure 2.3) 
indicating a CH group, whereas the resonances associated with H7 and H7' correlated 
with methylene carbons in the gHSQC spectrum. The resonance for C2 in the APT 
spectrum was in the expected region for an amide carbonyl, at δC 171.5. The 
diastereotopic H3 protons in the 1H-NMR spectrum both resonated as a doublet of 
doublets at δH 2.73 (J = 6.5, 17.2 Hz) and δH 2.56 (J = 4.0, 17.2 Hz) sharing a gCOSY 
correlation with the peak at δH 4.02 (J = 4.0, 6.5 Hz), also resonating as a doublet of 
doublets in the 1H-NMR spectrum, representing H4. The two benzyl CH2 groups could 
be distinguished by their level of shielding brought about by their proximity to an O or 










significantly more shielded than that of the OCH2Ph at δC 72.4, then their attached proton 
resonances were assigned from the gHSQC spectrum. The OH resonance (δH 3.55) was 
readily identified as it had no correlation in the gHSQC spectrum. 
 
 
Figure 2.3 APT spectrum (125 MHz, CDCl3) of compound 197a. 
ROESY NMR spectroscopy was used to determine the stereochemistry of the products. 
The resonances for H4 and OH showed a strong mutual correlation, whereas there was 
no correlation observed between H4 and H6 (Figure 2.4). The only evidence of a 
correlation between cyclopropyl protons and H4 was the weak cross-peak between the 
multi-proton signal of H7 H7’ and H4. Thus, the major diastereomer was the 
trans-diastereomer where we define the trans-diastereomer 197a as the diastereomer has 
the OH and OBn groups on opposite sides of the ring. This diastereomer which has 
resulted from the addition of the cyclopropyl group to the same side of the ring as the 















Figure 2.4 ROESY spectrum (CDCl3) of trans diastereomer 197a. 
The diastereoselectivity and regioselectivity observed in this reaction is well supported 
by what is expected from the literature. Huang et al. reported an approach to 
(4S,5R)-4-hydroxy-5-(α-hydroxyalkyl)-2-pyrrolidinones in which a variety of Grignard 
reagents were reacted with compound 224 (from Scheme 2.3),  in which all resulted in 
diastereotopic ratios favouring syn-addition over the anti-addition diastereomer in ratios 
ranging from 6:1 to 8:1, with the exception of benzylmagnesium bromide which led to a 
1:1 mixture of diastereomers.89 This does however mean that the addition of 
cyclopropylmagnesium bromide exhibited a higher diastereoselectivity than that of the 
literature, with a dr of 9:1.  
Computational modelling was undertaken  by Lu et al. to investigate the reason for the 
excellent regioselectivity and syn stereoselectivity of the Grignard addition reactions to 
the C2 carbon of pyrrolidinone 225 (Scheme 2.4).90 The study found that the α-chelation 
resulted in the preferential transition state 226, where the OMe group guides the methyl 
Grignard addition resulting in the high regioselectivity and syn-addition observed. The 
good diastereoselectivity observed is likely a result of the addition of planar rigidity to 
the five member ring brought about by the amide which flattens the ring, and which 
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therefore hinders rotation of the OMe group which would otherwise twist to 
accommodate a different transition state.90 
 
Scheme 2.4 The cis-α-chelated pathway of CH3MgCl·2Me2O to N-methyl-3-
methyloxy-2-pyrrolidin-2-one 227 (modified from Lu et al.90). 
2.3 Synthesis of the N-Methyl 5-cyclopropyl-4-benzyloxylactam 199 
Preparation of substrate 199 was straightforward, beginning with the commercially 
available starting material (S)-3-hydroxy-1-methylpyrrolidine-2,5-dione 228 (Scheme 
2.5). The hydroxy group was protected by O-benzylation to give 229 in excellent yield 
(99%), followed by addition of cyclopropyl magnesium bromide, giving the desired 
product 199 as a mixture of diastereomers (dr = 71:29), where the diastereomers could be 
isolated pure by additional column chromatography. A similar yield of 199 was obtained 
to that of the N-benzyl analogue 197, but with lower diastereoselectivity. A possible 
reason for this, is that the preferred conformer of compound 197 may have the phenyl 
ring of the NBn group close to the pyrrolidinone ring and anti to the OBn group, therefore 
further blocking anti addition of the cyclopropyl group through steric interactions. 
 
Scheme 2.5 Synthesis of the α-cyclopropyl N-acyliminium ion precursors 199a and 
199b (diastereomers of compound 199). 
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The major (199a) and minor (199b) diastereomers had similar 1H-NMR chemical shifts 
and coupling constants for the pyrrolidinone and cyclopropyl ring protons as 197a and 
197b, respectively.  
2.4 Attempted Synthesis of Parent α-Cyclopropyl N-Acyliminium Ion Precursor 
201 
The attempted synthesis of the parent compound 201 began with a simple N-benzylation 
of succinimide under basic conditions, which was undertaken without a search of the 
literature given the perceived simplicity of the reaction This resulted in the isolation of 
N-benzylsuccinimide 231 in a poor yield (39%). Presumably this is due to the poor 
nucleophilicity of the amide, as a later literature search revealed that the majority of these 
reactions, yielding above 85%, proceed at 80 ˚C or above in the presence of K2CO3.
91,92 
However, with this compound in hand the next step was Grignard addition and enough 
material was made for several reactions so further yield optimisation was not necessary.  
 
Scheme 2.6 The attempted synthesis of the cyclopropyl pyrrolidinone 201. 
The first conditions attempted for the Grignard reaction (Table 2.1, Entry 1) resulted in 
the ring opened product 232, presumably through the mechanism shown below in 
















Entry Mol Eq. Time Quench Yield Recovered SM Yield 
1 1.1 40 h NH4Cl sat. sol. 17% 22% 
2 1.9 30 min NH4Cl sat. sol. 33% -c 
3 1.3 1.5 h NH4Cl sat. sol. 21% 48% 
4 1.3 3 h TMSCl/NaHCO3 -c -c 
a. Reactions carried out in THF (0.1 M). 
b. Reaction carried out at 0 ˚C 
c. Reaction carried out at -40 ˚C  
d. Did not attempt to isolate 
The ring opened isomer 232 could form from either 233 or 234, where the driving force 
for its formation is the release of ring strain. The Rf values recorded for the two 
compounds after thin layer chromatography analysis are quite different, with the ring 
opened product, as expected, being significantly more polar. However, in this reaction 
and in the following experiments (Table 2.1, Entries 1-4), it was not possible to separate 
either of the two products as a pure compound, so presumably there is an equilibrium 
between the ring open and ring closed products that can take place on the chromatography 
column.  
 
Scheme 2.7 Proposed mechanism for cyclopropylmagnesium bromide addition to 
N-benzylsuccinimide 231 resulting in ring opening. 
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The first sign of concern about the outcome of this reaction was the appearance of a 
1H-NMR resonance at δH 6.37 in the crude reaction mixture, indicating the presence of 
an amide proton (Figure 2.5). The cyclopropyl resonances for H5-H7 in 232 appear to 
have been shifted significantly downfield compared to what is expected, due to the 
cyclopropyl group being adjacent to a carbonyl group. As expected, the resonances for 
H2 (δH 2.93, J = 6.5 Hz) and H3 (δH 2.45 J = 6.5 Hz) are triplets and share a gCOSY 
correlation. This spectrum also showed evidence for some of the ring closed product 201, 
marked as x in the spectrum. 
 
Figure 2.5 1H-NMR spectrum (500 MHz, CDCl3) of the mixture of compound 232, and 
201 marked as x. 
The significant difference between the reaction outcomes for the synthesis of parent 
succinimide 201, and that of the successfully synthesised compound 197 (Scheme 2.3), 
could be twofold. The first of these reasons for this difference in reaction outcome could 
be a result of the solubility of the salts 235/236 after addition of the Grignard reagent to 
compound 231. It was noted during this reaction that the solution was yellow upon 
addition of the cyclopropylmagnesium bromide but turned a cloudy grey 2 h later. After 
quenching with NH4Cl saturated solution the reaction mixture returned to a yellow colour. 
The cloudy grey of the reaction mixture, in stark contrast to the deep transparent purple 
solution of the previous reactions of 224 (Scheme 2.3) and 229 (Scheme 2.5) with 
cyclopropylmagnesium bromide, suggested that the MgBr salt 235/236 was not soluble 
in solution. This is likely because of its highly polar nature so it precipitated out of the 












salt 235/236 had precipitated it was no longer part of the equilibrium between products 
233/234 and 235, so the reaction would shift to accommodate the change due to Le 
Chatelier’s principle and more ring opened product would be formed. The second 
explanation for this result, is that the OBn group stabilises the ring closed alkoxide 
intermediate by chelation, thus disfavouring ring opening (Scheme 2.8).  
 
Scheme 2.8 Resonance structures of the MgBr+ salt of 197. 
The propensity of the ring opened product to form crystals was a significant reason for 
the difficulty found in the purification of the ring closed product 201. Below is a 
photograph of the ring opened product 232 self-crystallising after its elution from the 
chromatography column Figure 2.6. This issue presumably happened throughout the 
entirety of the column as the ring opened product spread throughout all collection tubes. 
 
Figure 2.6 Compound 232 crystallising after purification by column chromatography, 
directly after coming off of the column (Left), and 5 min later (Right). 
In order to maximise the amount of ring closed product being formed, two strategies were 
employed in the second optimisation experiment (Table 2.1, Entry 2). The first of these 
was an increase in the molar equivalents of cyclopropylmagnesium bromide, which 
would both increase the amount of reagent available to react with the amide carbonyl, but 
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also increase the amount of MgBr cation present to stabilise the oxide anion to prevent 
ring opening. The second strategy was to reduce the reaction time down from 40 h to 35 
min, this was to reduce the time that the oxide would be in solution once formed, again 
with the hope that the ring would not open. A reaction time of 35 min was chosen as the 
first 5 min of the experiment was during the Grignard reagent addition to the reaction 
mixture. With regard to the ring opened product 232, the highest yield of this compound 
was achieved with this method, and no ring closed product could be isolated pure. Two 
reactions followed this in an attempt to optimise the reaction, with the latter designed to 
trap the initial ring closed intermediate by O-silylation, but these were unfortunately 
unsuccessful (Table 2.1, Entries 3 and 4).   
2.5 Synthesis of Phthalimide α-Cyclopropyl N-Acyliminium Ion Precursor 203 
Due to the problems experienced during the synthesis of the parent succinimide 203, 
another racemic α-cyclopropyl N-acyliminium ion precursor was instead sought, using 
the easily accessible N-methylphthalimide, and performing a Grignard reaction (Scheme 
2.9).  
 
Scheme 2.9 Synthesis of 5,5-disubstituted N-methylphthalimide 203. 
N-methyl phthalimide was a good candidate, as the bicyclic nature of the molecule would 
favour the ring closed product in the equilibrium between 240 and 241, since the nitrogen 
and carbonyl would stay cis to one another on the phenyl ring after ring opening (Scheme 
2.9), rather than being on a linear flexible chain like 235 (Scheme 2.7). Additionally, the 
MgBr+ phthalimide salt 241 should be less polar than the parent MgBr+ salt 235/236 and 
so be less likely to precipitate out of the THF solution.  
This proved to be sound reasoning as the reaction proceeded well, finishing in 1.5 h with 
no ring opening product observed by 1H-NMR or isolated, and giving the desired product 
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203 in excellent yield (89%) after recrystallisation. Previous literature reports describing 
the use of different, but similar, Grignard reagents recommended purification by column 
chromatography, but recrystallisation was utilised due to the high purity of the crude 
product (Figure 2.7), as well as the fact that the compound had a high melting point, 
which indicated strong intermolecular forces. 
 
Figure 2.7 1H-NMR spectrum (500 MHz, CDCl3) of the crude reaction mixture of 
N-methylphthalimide and cyclopropylmagnesium bromide after quenching showing 
considerable purity of compound 203. 
2.6 Initial Reaction Investigations of the α-Cyclopropyl N-Acyliminium Ion 
Precursor 197 
 
Scheme 2.10 Reaction of veratrole 205 with α-cyclopropyl N-acyliminium ion 
precursor 197. 
With these α-cyclopropyl N-acyliminium ion precursors in hand, the next goal was to 
investigate the reactions of the precursor 197 with veratrole 205 in the presence of a Lewis 
acid (Scheme 2.10). The mixture of the diastereomeric tertiary alcohols 197 was 
subjected to the reaction conditions outlined by Yazici et al.80, by treating the mixture 
and veratrole (2 mol eq.) in CH2Cl2 with BF3·Et2O (2 mol eq.) at 0 ˚C (Scheme 2.10). 
TLC and 1H-NMR analysis indicated that a mixture of at least two products had formed, 











218 in poor yield (12%) and the spirocyclic furan 242 also in poor yield (32%). The 
desired spirocycle 218 was obtained in excellent diastereoselectivity (dr = 90:10) as a 
mixture of diastereomers favouring the syn diastereomer 218a. The spirofuran 242 was 
isolated as a mixture of diastereomers in good diastereoselectivity (dr = 76:24) also 
favouring the syn diastereomer 242a, where the major diastereomer was able to be 
isolated pure by further column chromatography. The syn diastereomer refers to the 
stereochemical relationship between the OBn group and the C-C or C-O bond formed in 
the final cyclisation step. The isolation of both of these products indicated the validity of 
the α-cyclopropyl N-acyliminium ion as a reactive intermediate, although there was 
clearly room for vastly improved yields and reaction pathway control. Initially from TLC 
analysis it appeared that the starting material 197 had not fully reacted, however this was 
due to the spirocyclic furan 242 having the same Rf as the starting cyclopropyl alcohol 
197.  
2.7 Assignment of NMR Signals for Spirocycle 218 
The structure of the major diastereomer 218a was confirmed through 1D and 2D NMR 
experiments, with comparisons made to the spirocycle 167a (Chapter 1, Scheme 1.35) 
reported by Yazici.80 In the 1H-NMR spectrum (Figure 2.8) the pair of doublet signals 
for the O- and N-benzylated groups were clearly evident and the resonances for the 
cyclopropyl ring protons were no longer present. Importantly resonances were also 
observed for the incorporation of the veratrole moiety into the molecule. Two sets of two 
pairs of doublets, labelled NCH2 (δH 4.57 J = 15.2 Hz and δH 3.96 J = 15.2 Hz) and OCH2 
(δH 4.05 J = 11.5 Hz and δH 3.85 J = 11.5 Hz) show the presence of the two benzyl groups. 
The resonances of H3ʹ (δH 3.89 – 3.87) and H4ʹ (δH 2.96, dd, J = 19.8, 6.9 Hz and δH 2.65, 
d, J = 17.8 Hz) share gCOSY correlations, and gCOSY identified positions H2-H4, where 
H4 was assigned from its downfield position induced by its benzyl ring. The ArOCH3 
methyl resonances in the spectrum were at δH 3.90 and δH 3.43 resonating as singlets with 




Figure 2.8 The 1H-NMR spectrum (500 MHz, CDCl3) of compound 218a, minor 
diastereomer 218b indicated by x. 
The resonances for H5 and H8 are differentiated below in the NOESY spectrum (Figure 
2.9). Evidence for the assignment of peaks of H2 and H4 come from gHMBC and NOESY 
spectra. H4ʹ shows NOE correlations with H2 and H3ʹ which allows the stereochemistry 
of C2ʹ to be assigned as S for the major diastereomer (Figure 2.10). An NOE correlation 
was also observed between H4 and H5, backing up the assignment of H2 and H4. Further, 
H2 shares a gHMBC correlation with C1, and H3ʹ shares a gHMBC correlation with C2.  
 
Figure 2.9 NOESY spectrum of spirocycle 218a focussing on H3'. 
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Figure 2.10 Compound 218a shown with assignment numbering left, strong gHMBC 
correlations shown as purple arrows and strong NOE signals shown as red arrows right. 
Examination of another section of the NOESY spectrum reveals H8 has a NOESY 
correlation to NCH2Ph (Figure 2.11), and it also has gHMBC correlation to C1. In 
addition to this, there are gHMBC correlations at H5-C4 and H4-C5. This is good 
evidence that the signals at position 5 and 8 have been properly assigned. With this 
knowledge, it is now possible to extrapolate from the data that H8 has no NOE correlation 
to H3', giving a second point of data that the 1,2-intramolecular cyclisation of 
dimethoxybenzene occurred syn to the OBn group. 
 
Figure 2.11 NOESY spectra of spirocycle 218a focusing on H5 and H8. 
The carbonyl C5ʹ and spiro C1 were assigned as they give quaternary non-aromatic 
carbon signals in distinct, isolated chemical shift regions. C6 and C7 are negative in the 
APT as expected and significantly downfield for aromatic signals, since they are α to 
methoxy groups. Conversely, signals C5 and C8 are shielded due to their increased 
electron density from being ortho to the methoxy groups. The ipso carbons of the two 
benzyl groups are also in the expected region. C8a (δC 131.5) which shares a gHMBC 
H5 H8 










correlation with H8 and H2, and C4a (δC 124.5) which shares a gHMBC correlation with 
H5 and H4 which allow these carbons assignment to be established. 
 
 
Figure 2.12 The APT-NMR spectrum (125 MHz, CDCl3) of compound 218a. 
Molecular modelling (DFT minimised, B3LYP/6-31G(d) basis set) was carried out to 
find the preferred conformer of the S,S compound 218a (final addition being cis to OBn) 
and the S,R compound 218b (final addition being anti to OBn) compounds. The preferred 
conformer for the S,S diastereomer 218a had a distance of 2.191 Å between H3ʹ and the 
closest proton on H2, Figure 2.13. The observation of a NOE crosspeak between these 
protons is expected and further supports the structure 218a. 
 
Figure 2.13. Molecular model (DFT minimised, B3LYP/6-31G(d) basis set) of S,S 
compound 218a (Final addition syn to OBn). 
The preferred conformer for the S,R diastereomer 218b had a distance of 3.46 Å between 
H3ʹ and H2 therefore weak NOE cross peaks between these protons are possible (but not 
observed). Of particular note from these results however, is that this conformer showed a 

























correlation in the NOESY. This therefore is good evidence that the correct assignment of 
stereochemistry has been made for these spirocycles. 
 
Figure 2.14. Molecular model (DFT minimised, B3LYP/6-31G(d) basis set) of S,R 
compound 218b (Final addition anti to OBn). 
The yield obtained for the desired spirocycle compound 218 was much lower than the 
reaction carried out by Yazici et al. with veratrole and α,β-unsaturated N-acyliminium ion  
precursor 160 in which spirocycle 167a was obtained (Chapter 1, Scheme 1.35). Using 
the same conditions, spirocycle 167 was obtained in 68% yield with a diastereoselectivity 
greater than 98:2, interestingly favouring the opposite diastereomer at C1. The disparity 
between the yields and selectivity was interesting but did indicate there should be scope 
for improvement in the yields.  
Similar to the Yazici et al. work, no 1,2-addition product 219 could be detected by 1H-
NMR analysis of the crude reaction mixture or could be isolated by column 
chromatography. In order to investigate why this might be the case, further computational 
studies were performed by A. Prof. Uta Wille (University of Melbourne) to help 
understand the energy profile of veratroles addition to the α-cyclopropyl N-acyliminium 
ion 243 through either the homoconjugate addition transition state (TS2) or the 1,2-
















Scheme 2.11 The reaction pathways modelled for the additions of veratrole to α-
cyclopropyl N-acyliminium ion 243. 
The α-cyclopropyl N-acyliminium ion that was modelled was the NMe, OMe analogue 
243 to the NBn OBn α-cyclopropyl N-acyliminium ion 198 that is formed in this Thesis. 
These studies revealed that the 1,2-addition product intermediate 246 of the 
α-cyclopropyl N-acyliminium ion 243 and veratrole 205 (modelled in CH2Cl2 solution) 
was the kinetically favourable pathway, showing that a lower activation energy (TS1, 
Figure 2.15) was necessary to form the transition state than that for the homoconjugate 
pathway (Transition State 2, Figure 2.15). The 1,2-addition intermediate 246 however, 
exists in a very shallow well and therefore is expected to form reversibly. What this means 
in terms of reaction outcomes, is that even if the 1,2-addition intermediate 246 does form, 
the thermodynamically favoured homoconjugate addition intermediate 244`will form 
over the course of the reaction, presumably due to the release of ring strain when the 
cyclopropyl group is cleaved. In comparison to the experiments carried out with α-
cyclopropyl N-acyliminium ion 198 in the lab, the difference in activation energies would 
arguable be lower between homoconjugate and 1,2-addition pathways, since there are 
bulky Bn groups that would shield the iminium carbon more effectively than the Me 




Figure 2.15. 1,2- and homoconjugate addition pathways of veratrole and  α-cyclopropyl 
N-acyliminium ion 243, in the gas phase (black) and CH2Cl2 solution (red). 
The proposed mechanism below Scheme 2.12, outlines how spirofuran 242 could be 
formed in the reaction, proceeding first by coordination of BF3 to the hydroxy group 
giving intermediate 248, followed by elimination of the HOBF3 anion. The HOBF3 anion 
can then act as a nucleophile, initiating a homoconjugate reaction resulting in the ring 
opening of α-cyclopropyl N-acyliminium ion 198, giving the enamide intermediate 249. 
The enamide can protonate and the iminium ion intermediate 251 can ring close with 
elimination of BF3, giving the spirocycle 242.  
 





Since this product could potentially form under any acidic conditions from compound 
197, the relatively lower yields observed from the Grignard reaction which forms product 
197, may be due to the formation of the α-cyclopropyl N-acyliminium ion 198 due to the 
acidic nature of the silica gel. However, we were never able to isolate the spirocyclic 
furan 242 after purification of the Grignard reaction product mixture.  
This reaction mechanism is juxtaposed against the equivalent, most likely reversible, 
reaction of the α,β-unsaturated N-acyliminium ion 171 of Yazici’s work, Scheme 2.13. 
Shown below is the mechanism by which after elimination of the hydroxy group from 
C5, the HOBF3 anion can participate in a 1,4-addition reaction to the α,β-unsaturated 
N-acyliminium ion to give compound 253, however after this, the α,β-unsaturated 
N-acyliminium ion 171 can be regenerated by elimination of that same species. 
Additionally, in the unlikely case that cyclisation of 253 forms the highly strained 
cyclobutyl species 254, this reaction is also reversible and since it would be neither 
kinetically or thermodynamically favourable, the equilibrium between 253 and 254 would 
firmly favour the formation of 253. 
 
Scheme 2.13 The most likely reversible reactions of the α,β-unsaturated N-acyliminium 
ion 171 with the HOBF3 anion. 
The resonances in the 1H-NMR spectrum of the major syn diastereomer spirocyclic furan 
242a were assigned as follows. Firstly, no cyclopropyl or veratrole related resonances are 
apparent in this spectrum. This indicated that ring opening had occurred, but that veratrole 
had not incorporated into the molecule. Similarly to the previously assigned compounds, 
the diastereotopic CH2Bn protons were assigned to the overlapping resonances that 
integrated for two protons at δH 4.74 – 4.65, and the two doublet resonances at (δH 4.53 J 
= 11.8 Hz, OCH2Ph) and (δH 4.31 J = 15.9 Hz, NCH2Ph). From the gCOSY spectrum, 
cross peaks were used to establish the contiguous spin systems for the protons H2-H4 and 
for H8-H9. The resonance of the H2 protons (δH 3.92, app. d., J = 7.0 Hz and δH 3.79 dd, 
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J = 14.0, 7.0 Hz) were established due to their deshielded positions, relative to those of 
H3 and H4, due to the oxygen substituent.  
 
Figure 2.16 1H-NMR spectrum (500 MHz, CDCl3) of compound 242a. 
 
Figure 2.17 APT spectrum (125 MHz, CDCl3) of compound 242a. 
The APT spectrum of spirocyclic furan 242a identified the quaternary carbons of C7 (δC 
172.8) and C5 (δC 103.3) as these had no 
1H-NMR correlations in the gHSQC spectrum. 
In the gHMBC spectrum, C5 showed correlations to H2, H4, H8 and H9 (Figure 2.18). 
H4 (δH 2.45) was assigned from its ROESY and gHMBC correlations to H9. The ROESY 
correlation between H4 and H9 suggests that position C5 had the S configuration, 
indicating that the final step of the cyclisation reaction occurs syn to the OBn group. This 
is synonymous to the favoured syn cyclisation observed after the homoconjugate addition 






















Figure 2.18 Compound 242a shown with assignment numbering left, strong gHMBC 
correlations shown as purple arrows and strong ROE signals shown as red arrows right. 
To further support our NMR analysis for the structure of the major diastereomer of 242a, 
it was important to determine the expected distances between protons in the preferred 
conformer. Molecular modelling of 242a revealed the distance between H4 and H9 was 
2.42 Å, whereas for the anti-addition product 242b, this distance was 3.68 Å. This means 
that the ROESY H4 to H9 cross-peak for the syn-addition product 242a would be strong, 
whereas for the anti-addition product 242b it would be weak or absent.  
 
Figure 2.19 Molecular model (DFT minimised, B3LYP/6-31G(d) basis set) of S,S 
compound 242a (Cyclisation cis  to OBn). 
 
Figure 2.20 Molecular model (DFT minimised, B3LYP/6-31G(d) basis set) of S,R 







2.8 Optimising the Lewis Acid Promoted Reaction of 197 with 
1,2-Dimethoxybenzene 205 
To assist in optimisation of the above reactions, 1H-NMR analysis of the crude reaction 
mixtures which had been doped with a specific amount of an internal standard were used 
to determine the yields of the formed products. Preliminary 1H-NMR predictions 
indicated that 2,5-dimethylfuran would be a desirable internal standard for quantification 
of yields, with two singlet resonances at approximately δH 5.8 and δH 2.2. This standard 
was selected due to its relatively low chemical reactivity, good solubility, acceptable 
volatility, and the fact that the two singlet resonances are not in the chemical shift regions 
of the spirocycles 218 or 242.93 Having two different peaks of internal standard in the 
1H-NMR  spectrum also has the added advantage, brought about by comparing the two 
integrations where δH 5.8 should integrate for 2H and δH 2.2 should integrate for 6H 
relative to each other. This should lead to concordance of results and therefore confidence 
in the integration values, rather than single peak internal references that has no such 
checks in place and opens up the possibility to choose any clear peak to estimate the yields 
of spirocycles 218 or 242. 
To test the validity of this method, the spirocycles 218a and 242a were mixed in known 
amounts with 2,5-dimethylfuran in CDCl3 and a 
1H-NMR spectrum was run. The signals 
of the spirocycle 218a and the spirocyclic furan 242a, are highlighted in Figure 2.21 
showing good separation of resonances from each other and the internal standard. Their 
calculated moles from the integrations of this 1H-NMR spectrum were identical to the 
added amounts of compound. Extra care was taken when preparing to carry out 1H-NMR 
analysis of these samples, as 2,5-dimethylfuran is a volatile substance, and as such after 
addition of the 2,5-dimethylfuran to the crude reaction mixture, the 1H-NMR sample was 




Figure 2.21 1H-NMR (500 MHz, CDCl3) spectrum of a mixture of compounds 218a 
(blue), 242a (green) and 2,5-dimethylfuran (red). 
 Once the method by which yields could be determined was established, the following 
optimisation protocol was followed to examine the yields and diastereoselectivities of the 
formation of desired spirocycle 218. The molar equivalence ratio of 
substrate:nucleophile:Lewis acid was first altered to achieve the best compromise 
between yield and diastereoselectivity. Next, different Lewis acids and Brønsted acids 
were used and the best acid from those tested was carried through to the next set of 
experiments. Finally, temperature was to be taken into account to balance 
diastereoselectivity of the final 1,2-addition step and the yield.  
The initial experiment was carried out by adding BF3·Et2O to the starting material at 0˚C, 
an hour before addition of the veratrole in order to reduce as much 1,2-dimethoxybenzene 
reacting with itself as possible to ensure an easy workup. However, due to the 
intramolecular nature of the reaction, the order of nucleophile and acid addition clearly 
needed to be switched in an effort to improve yields of the desired spirocycle 218, with 
BF3·Et2O added after the veratrole. This had a profound effect on the overall yield, 
changing from an isolated yield of 12% for spirocycle 218 to 54% while retaining the 
same diastereoselectivity (Table 2.2, Entry 10). This change was carried forward into 
subsequent optimisations. 
 




Table 2.2 Optimisation conditions for Lewis acid/Brønsted acid catalysed reactions of 
197 with veratrole.a,b  
 
     
Entry Acid Mol Eq. Yieldc Yieldd Yieldc Yieldd Yieldd 
1 LiOTf 2 - - - - - 
2 In(OTf)3 2 - - 92% 70% - 
3 PTSA 2 - - - - - 
4 Cu(OTf)2 2 5% - -e - - 
5 TMSOTf 2 - - - - - 
6 CSA 2 - - - - - 
7 Sc(OTf)3 2 - - - - - 
8 AlCl3 2 - - - - 76% 














a. Reactions performed at 0.2 M in anhydrous CH2Cl2, 12 h, 0 ˚C to rt. 
b. Diastereoselectivities did not appear to significantly change with different acids. 
c. Yields determined by 1H-NMR  
d. Isolated yields after purification by column chromatography 
e. Significant 1H-NMR peak broadening, yield not obtained 
With the intent to improve the yield of this reaction further, a variety of different Lewis 
acids and Brønsted acids at different molar equivalents were tested (Table 2.2, Entries 
1-11). The ratio of diastereomers from these reactions was difficult to determine from the 
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1H-NMR spectrum due to overlapping peaks, however when isolated the 
diastereoselectivities of the peoducts were the same as that previously reported for 
spirocycles 218 and 242. 
The Lewis acids in Entries 1,5 and 7 and the Brønsted acids in Entries 3 and 6 failed to 
generate the α-cyclopropyl N-acyliminium ion from the precursor 197, as only unreacted 
starting material was observed in the 1H-NMR spectra of the crude reaction mixtures from 
these reactions (Table 2.2). The use of the Lewis acid Cu(OTf)2 (Table 2.2, Entry 4) did 
result in the production of the desired spirocycle 218, but in only 5% yield.  
The use of 1.2 equivalents of BF3·Et2O shown in Table 2.2, Entry 9 lead to the 
spirocyclic furan product 242 in much higher yield when compared to the 2 molar 
equivalents or 5 molar equivalents used in Table 2.2, Entries 10 and 11, respectively. 
This is likely due to the role of BF3·Et2O in binding in a 2:1 stoichiometric ratio with the 
O atom of the eliminated OH group (Scheme 2.15), when there is an excess of BF3·Et2O 
giving dianion 258. In Entry 9 1.2 molar equivalents of BF3·Et2O was added to the 
reaction, which results in a comparatively larger concentration of the monoboron 
compound 256, which is more nucleophilic than the diboron species 258. The diboron 
species 258 withdraws more electron density away from the oxygen atom than the 
monoboron species 256, and provides more steric effects around the oxygen, making it a 
weaker nucleophile. 
 
Scheme 2.15 The role of BF3 in hydroxy elimination. 
A similar argument can be made for the reaction product of Table 2.2, Entry 2, when 
In(OTf)3 coordinates to the OH group of 197, the hydroxy oxygen has a higher electron 
density than that of the BF3·Et2O coordinated species, resulting in a more nucleophilic 
atom (Scheme 2.16). The use of In(OTf)3 as a Lewis acid gave, within relative error, the 
same diastereoselectivity (dr = 3:1) as the reaction using BF3·Et2O, favouring the syn 
product. Another possible reason for the higher yield of 242 is that the larger In species 
is hindered from forming the di-In(OTf)3 species 261 due to the steric bulk of the In in 
comparison to B, as well as the size difference between ligands (OTf) and F. This would 
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lead to a preferential formation of 260 which is more nucleophilic than the di-In(OTf)3 
species 261 or diboron species 258, which would explain the high yield of the spirocyclic 
furan 242.  
 
Scheme 2.16 The role of In(OTf)3 in hydroxy elimination. 
When this reaction was undertaken with AlCl3 as the Lewis acid (Table 2.2, Entry 8), 
the primary chloride 263 was obtained in 76% yield. The proposed mechanism below 
outlines how this compound could have been formed, Scheme 2.16. Free chlorine anions 
from AlCl3 or [AlCl3OH]
- can act as a nucleophile and ring open the α-cyclopropyl N-
acyliminium ion 198 giving compound 262, which undergoes isomerisation upon 
protonation to give the thermodynamically more stable conjugated product 255. The 
product 255 had no optical rotation, which provides further supportive evidence for the 
mechanism proposed (Scheme 2.17). 
 
Scheme 2.17 Proposed addition of chloride to α-cyclopropyl N-acyliminium ion 198 
and alkene isomerisation. 
The use of halides in ring opening of α-cyclopropyl iminium ions occurs during the first 
step of Cloke-Stevens-Boeckman rearrangements,6 through solely nucleophilic 
addition,94 and α-cyclopropyl iminium ions through homoconjugate adduct of halides5 
have both been observed in the literature, and so this result is not entirely unexpected. 
From this result, we can presume that there are far less free fluoride ions in reactions 
62 
 
undertaken in the presence of BF3·Et2O as compared to the amount of free chloride ions 
present in reactions undertaken with AlCl3, since the fluoride anion is a better nucleophile 
than the chloride anion. 
2.9 Spectroscopic Time Dependent Investigation of Spirocyclic Furan 242 
Formation 
Curious about the rate at which the spirocyclic furan 242 formed under the now optimised 
conditions, BF3·Et2O (2 mol eq., 0.1 M in CDCl3) was added dropwise to α-cyclopropyl 
N-acyliminium ion precursor 197 in a solution of deuterated chloroform (0.2 M). The 
solution was then analysed over time by 1H-NMR spectroscopy. In order to present these 
results clearly with a good point of reference, below in Figure 2.22 is the 1H-NMR 
spectrum of the starting material 197a and that of the spirocyclic furan product 242a. The 
stand out differences in their spectra lie with the cyclopropyl signals between δH 0.85 – 
0.2 in the spectra of compound 197a, compared to the methylene protons at δH 1.9 – 1.7 
of the spirocyclic furan 242.  
 
Figure 2.22 1H-NMR spectra (500 MHz, CDCl3) of the α-cyclopropyl N-acyliminium 
ion forming substrate 197a (red) and the spirocyclic furan 242a (green). 
Two other points of reference should be established before delving into the timed results 
for the sake of clarity. The first of which is shown in Figure 2.23, representing compound 
197a in the presence of BF3·Et2O, 2 min after addition, which shows a significant change 
in 1H-NMR signals throughout the spectrum, but retention of the characteristic 




Figure 2.23 1H-NMR spectrum (500 MHz, CDCl3) in the absence of veratrole of 
compound 197a 2 min after addition of BF3·Et2O. 
The second point of reference is Figure 2.24 which compares the 1H-NMR spectrum of 
the crude reaction mixture at 24 h shown in blue, to that of the reaction mixture after 
workup as shown in red, both of which retain the characteristic peaks at δH 1.9 – 1.7 for 
the spirocyclic furan product 242a. 
 
Figure 2.24 1H-NMR spectra (500 MHz, CDCl3) of the reaction mixture in the absence 
of veratrole 24 h after addition of BF3·Et2O, pre-workup (blue) and post-workup (red).  
Since these characteristic peaks are still observable, it is possible to monitor the relative 
ratios of the uncyclised starting material 197a, to spirocyclic furan 242a over time 
(Figure 2.25). The red box shows the appearance of the H3 and H4 resonances for 242 
over time in the 1H-NMR spectrum, and the green box shows the disappearance of the 
cyclopropyl resonances indicating ring opening presumably through homoconjugate 






Figure 2.25 1H-NMR spectrum (500 MHz, CDCl3) of reaction 2 min (blue), 20 min 
(green), 40 min (grey), 2 h (magenta), 3.5 h (yellow), and 24 h (red) after addition of 
BF3·Et2O (2 mol eq.) in the absence of veratrole. 
Figure 2.25 shows that the critical time in this reaction occurs between 40 min (grey) and 
2 h (magenta), where an appreciable amount of the spirocyclic furan 242a begins to be 
formed. What can be taken away from this, is that by generating α-cyclopropyl 
N-acyliminium ions from the 3-hydroxypyrrolidinone 197, nucleophiles that are slower 
reacting relative to veratrole will result in lower yields of desired adducts due to the 
formation of the spirocyclic furan 242. With this in mind, the next chapter approaches the 
reaction substrate with a variety of nucleophiles.  
2.10 Future Studies: Attempts to Ring Open and Trap the Spirocyclic Furan 242 
It should be possible to obtain a new class of compounds derived from the spirocyclic 
furan 242. Although the ring opening of the α-cyclopropyl N-acyliminium ion 198 to form 
the alcohol is irreversible Scheme 2.18a, the step which forms the bicyclic spirofuran 242 
is under no such restrictions, and therefore it should be possible to isolate 1,2-addition 






Scheme 2.18 Nucleophilic addition to spirocyclic furan 242. 
Literature precedent does exist for ring opening of [5.5] azaspirocycles, related to 
compound 242, as shown in Kende et al.95 in which compound 266 is reacted with furan 
267, to give the ring opened product 268 in 27% yield, along with 41% recovery of 
starting material (Scheme 2.19). What is particularly curious about this example is that 
the conditions that resulted in the formation of the desired product are the conditions that 
were being used in reactions in this study where the spirocyclic furan 242 was formed. 
The difference here perhaps is the relative nucleophile strength, where the substituted 
furan 267 is a strong enough nucleophile that is it unlikely to be eliminated.  
 
Scheme 2.19 Ring opening of spirofuran 266 with an activated  furan 267 adapted from 
Kende et al.95 
Looking to other related compounds that form iminium rather than N-acyliminium ions 
for inspiration, the spiroindolinone derivatives 269 and 272 has been used to provide ring 




Scheme 2.20 a) Adapted from Patel et al.96 and b) Adapted from Yin et al.97 showing 
nucleophilic addition of indoles to  sprioindolinones. 
These three examples involve a key piece in their reaction which the work presented in 
this Chapter so far has been missing; a highly electron rich nucleophile. A nucleophile 
such as the electron dense substituted furan 267 (Scheme 2.19) or the various indoles 270 
and 273 (Scheme 2.20) could potentially be reacted with the spirocyclic furan 242 under 
acidic conditions to obtain a library of analogues that could be further functionalised.  
2.11 Conclusions 
The product of an initial homoconjugate addition of veratrole to the α-cyclopropyl N-
acyliminium ion 198 followed by cyclisation has been isolated in good yield with high 
diastereoselectivity after optimisation, proving the validity of the proposed reaction 
substrate to access novel azaspirocyclic cores in a relatively short number of steps. The 
configuration of the major diastereomer was determined from a ROESY spectrum and 
was supported by molecular modelling evidence, indicating that the cyclisation step of 
the reaction occurred syn to the OBn group of the pyrrolidinone core.  
The other conclusion that can be drawn from this Chapter is that perhaps more highly 
activated nucleophiles relative to veratrole can serve two key functions in the next 
Chapter to address the problems that have so far been encountered. First, it will hopefully 
react faster than the BF3OH anion through a homoconjugate addition to the α-cyclopropyl 
N-acyliminium ion, out competing that reaction pathway which leads to the spirocyclic 
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furan 242. If that reaction pathway is out competed initially by the reversible 1,2-addition 
of a strong nucleophile to the iminium ion, it is likely that over time the [BF3OH]
- is 
converted to its [BF3OBF3]
2- counterpart, reducing the chance of ring opening by 
[BF3OH]
-, and increasing the time the nucleophile has to undergo a homoconjugate 
addition.  Secondly, if the nucleophile does react with the iminium ion after the 
nucleophilic ring opening of the α-cyclopropyl N-acyliminium ion by [BF3OH]
-, it may 















3. The reactions of Aryl and Allyl nucleophiles with α-Cyclopropyl 
N-Acyliminium Ions 
3.1 Aims addressed in Chapter 3 
As explored throughout the Introduction, a variety of different nucleophiles have 
undergone reactions with N-acyliminium ions and α,β-unsaturated N-acyliminium ion. In 
this Chapter, the scope of the reactions of aryl and allyl nucleophiles with α-cyclopropyl 
N-acyliminium ions will be explored. These nucleophiles include methoxy substituted 
benzenes (Section 3.1), furan and substituted furans (Section 3.2), allyltrimethylsilane 
and their substituted versions (Section 3.3) and aromatic heterocycles (Section 3.4). This 
will be towards the fulfilment of Aim 3 outlined in the Introduction.  
3.2 The Reactions of Methoxy Substituted Benzenes with α-Cyclopropyl 
N-Acyliminium Ions 
 
Scheme 3.1 Reaction of methoxy substituted benzenes with α-cyclopropyl N-
acyliminium ion forming precursor 197. 
A key problem with the reaction of the α-cyclopropyl N-acyliminium ion 198 derived 
from 197 was the competing formation of the spirocyclic furan 242. To outcompete this 
process, we predicted that a higher yield of desired spirocyclic products (eg. 276) could 
be obtained using a nucleophile of more electron density than 1,2-dimethoxybenzene. To 
examine this further, four different methoxy substituted benzenes were tested as 
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nucleophiles under the optimised conditions determined in Chapter 2, and these outcomes 
are outlined in Table 3.1.  
Table 3.1 Reaction of methoxy substituted benzenes 275 with the α-cyclopropyl N-
acyliminium ion precursor 197.a,b 
  276i-v 242 
Entry Nucleophile 
Nucleophilicity  










90:10 28%c - 
2b 
 
-1.18 - - 72% 76:24 
3b 
 
- - - 74% 76:24 
4b 
 






75:25 30%c - 
a.  Reactions performed at 0.2 M in anhydrous CH2Cl2, 275i-v (2 mol eq), BF3·Et2O (2 mol eq) added 
dropwise, 12 h, 0 ˚C to rt. 
b. Yields are based on isolated compound after purification by column chromatography. 
c. Yields are estimated by 1H-NMR analysis of the crude reaction mixture.  
When anisole, 1,4-dimethoxybenzene and 3,4-dimethoxyphenylboronic acid (Table 3.1, 
Entries 2-4) were used as nucleophiles, only the spirocyclic furan 242 could be isolated 
and none of the desired spirocyclic product 276 was formed. These three 
methoxybenzenes are comparatively lower nucleophilicities compared to veratrole and 
1,2,3-trimethoxybenzene for the following reasons. Anisole only has one electron 
donating methoxy group, leading to lower electron density in the nucleophile and no 
isolation of desired spirocyclic product (Table 3.1, Entry 2). The lack of formation of 
the desired spirocyclic product from the reaction of 3,4-dimethoxyphenylboronic acid 
(Table 3.1, Entry 4) could also be attributed to the electron withdrawing effect of the 
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boronic acid substituent which reduced the electron density of the aromatic ring. No 
desired spirocyclic product was formed from the analogous reaction of 1,4-
dimethoxybenzene (Table 3.1, Entry 3) which could be a result of the steric hindrance 
of the methoxy group that is ortho to the carbon involved in the homoconjugate addition 
pathway, since the similarly electron rich veratrole results in spirocycle 276i.  
In contrast, when 1,2,3-trimethoxybenzene was treated with the α-cyclopropyl N-
acyliminium ion forming precursor 197 under the previously optimised reaction 
conditions, the desired spirocyclic product 276v was obtained in 58% yield as a mixture 
of inseparable diastereomers (dr = 75:25). 1,2,3-Trimethoxybenzene was used as a 
nucleophile in the work of Yazici et al. who obtained slightly better yields (70%), but 
slightly worse diastereoselectivity (dr = 70:30), in the similar reaction with an α,β-
unsaturated N-acyliminium ion precursor 160 (Section 1.18 Scheme 1.35).80 The lower 
yield for this reaction is attributed to the formation of the spirocyclic furan 242 (estimated 
as 30% from 1H-NMR analysis of the crude reaction mixture) which was observed in the 
1H-NMR spectrum of the crude reaction mixture, however this compound was not 
isolated after column chromatography separation. The comparable yield of spirocyclic 
furan 242 when comparing the reaction of 1,2,3-trimethoxybenzene (Table 3.1, Entry 5) 
and veratrole (Table 3.1, Entry 1) initially appears counter intuitive. However, DFT 
calculations indicate the opposite with 1,2,3-trimethoxybenzene being calculated as being 
less nucleophilic than both 1,2- and 1,4-dimethoxy benzene.98 The first step in the 
reaction of 1,2,3-trimethoxy benzene and α-cyclopropyl N-acyliminium ion 198 is 
reaction is less sterically hindered as attack by the arene occurs meta to a methoxy group, 
in contrast to the ortho attack necessary for addition of 1,4-dimethoxy benzene, which 
explains the difference in results. 
The regiochemistry of the major 276va and minor 276vb diastereomeric products were 
confirmed from the gHMBC correlation between H8 (δH 6.39 (s) for 276va and δH 6.09 
(s) for 276vb) and the quaternary carbon C1 (δC 70.5 for 276va and δC 69.6 for 276vb) 
The NMR spectroscopic data of the major syn-diastereomer 276va was assigned in an 
analogous way to that of the 1,2-dimethoxybenzene spirocyclic analogue (Figure 3.1). 
The stereochemistry of the major diastereomer was assigned through the ROESY 
correlation between H2 and H3ʹ, and the lack of NOE correlation between H8 and H3ʹ 
(Figure 3.1). This indicated that the stereochemistry at position 1 was S, resulting from 
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the cyclisation step being syn to the OBn group. Additionally, the regioselectivity that 
was decided from NMR analysis concurred with that of Yazici’s paper with the analogous 
reaction of the α,β-unsaturated N-acyliminium ion.80 
 
Figure 3.1 ROESY spectrum (CDCl3) of compound 276va. Minor diastereomer 276vb 
indicated by x. 
3.3 The Reactions of Furan and Substituted Furans with of α-Cyclopropyl 
N-Acyliminium Ion 198 
The next logical step to explore the scope and reactivity of the α-cyclopropyl N-
acyliminium ion substrate was to move to a more electron dense set of aromatic 
nucleophiles.  In this vein, the reactions of furans 277 with α-cyclopropyl N-acyliminium 
ion forming precursor 197 were investigated (Scheme 3.2). Interestingly, these reactions 
proceeded through a different reaction pathway than observed for the previously isolated 






















Scheme 3.2 Reaction of furan 277i and substituted furans 277ii-v with the 
α-cyclopropyl N-acyliminium ion forming precursor 197. 
Table 3.2 Reaction of furan 277i and substituted furans 277ii-v with the α-cyclopropyl 






















88:12 - - - - 
3 
 
- - - - 53% 89:11 
4 
 
- - 70% 76:24 - - 
5 
 
- - 72% 76:24 - - 
a. Reactions performed at 0.2 M in anhydrous CH2Cl2, 278i-v (2 mol eq), BF3·Et2O (2 mol eq) added 
dropwise, 12 h, 0 ˚C to rt. 
b. Also attempted at -40 ˚C but no reaction was observed. 
c. Reaction performed at -18 ˚C for 48 h. 
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The first reaction studied in the series was furan (Table 3.2, Entry 1), which resulted in 
the 1,2-addition product 278i being isolated in 37% yield as a mixture of partially 
separable diastereomers (dr = 68:32), and the spirocyclic furan 242 also being isolated 
(12%, dr = 75:25). There appeared to be a much greater proportion of the 1,2-addition 
product from 1H-NMR analysis of the crude reaction mixture than the yield would 
indicate, but subsequent repeats of this reaction did not result in a higher yield. To try and 
improve the yields and diastereoselectivity of the reaction, the reaction was repeated at -
40 ˚C, but only starting material was isolated. 
The 1H-NMR spectrum of a partially separated fraction enriched in the major 
diastereomer 278ia showed resonances for the presence of the intact cyclopropyl group 
with resonances observed for H1ʹʹʹ-H3ʹʹ (Figure 3.2) which formed part of a contiguous 
spin system in the gCOSY spectrum. The presence of these resonances indicated that the 
reaction had not proceeded through a homoconjugative addition pathway leading to a 
cyclopropyl ring opened product.  The signals for H3 (δH 2.69, 2H, app. d, J = 8.3 Hz) 
had a lower degree of diastereotopic splitting, and resonated as a doublet, in contrast to 
previous compounds where two doublet of doublets are observed for two diastereotopic 
methylene protons in this chemical shift region. Following from this, H4 (δH 3.62 J = 8.3 
Hz) resonates as a triplet and has a gCOSY correlation with H3. The two sets of 
diastereotopic benzyl methylene protons resonate as two pairs of doublets, assigned to 
NCH2Ph (δH 4.86, 1H, J = 15.5 Hz and δH 4.01, 1H, J = 15.5 Hz) and OCH2Ph (δH 4.47, 
1H, J = 12.0 Hz and δH 4.39, 1H, J = 12.0 Hz), showing similar coupling constants to 
those observed in previous compounds. All three furan proton resonances are visible in 
the 1H-NMR spectrum resonating as a doublet for H3ʹ (δH 6.37, 1H, d, J = 2.5 Hz), a 
multiplet for H4ʹ (δH 6.33 – 6.30, 1H, m), and a doublet for H5ʹ (δH 7.36, 1H, d, J = 0.8 




Figure 3.2 1H-NMR spectrum (500 MHz, CDCl3) of compound 278ia. Minor 
diastereomer 278ib indicated by x. 
Determination of the stereochemistry of the major diastereomer of the reaction was 
achieved from ROESY experiments (Figure 3.3). As shown below, H4 shares a strong 
crosspeak with H2'' in the ROESY spectrum, indicating that the furan nucleophile adds 
syn to the OBn group, resulting in the R stereochemistry at C5 for the major diastereomer 
(Figure 3.3). 
 
Figure 3.3 A ROESY spectrum (CDCl3) excerpt of compound 278ia. 
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The analogous reaction using 2-methylfuran as a nucleophile (Table 3.2, Entry 2), was 
initially attempted at -40 ˚C however there was no reaction and only starting material was 
recovered. Next the reaction was attempted at -18 ˚C which resulted in a moderate yield 
of the 1,2-addition product 278ii (41%) similar to that obtained using furan (Table 3.2, 
Entry 1). This is expected as the methyl group would only slightly increase the 
nucleophilicity of the furan by hyperconjugation. What did change between these two 
substrates was the diastereoselectivity of the reaction (dr = 88:12), which is likely due to 
the reduced reaction temperature at which the reaction proceeded, rather than the 
increased steric size of the 2-methylfuran since the methyl substituent is remote from the 
site of nucleophilic attack. 
Next, 2-methoxyfuran was used as a nucleophile (Table 3.2, Entry 3), and the 1,2-
addition product 279 in which the furan ring had undergone hydrolytic ring opening, was 
obtained in moderate yield (53%) similar to that obtained in the analogous reaction of 
furan and 2-methyl furan. The product was isolated as a mixture of 
diastereomers (dr = 89:11), where the major diastereomer 279a was the product of syn 
addition, and could be obtained pure after separation by column chromatography.  
The assignment of the NMR signals for compound 279a was analogous to the protocol 
established for the previous compounds formed through the 1,2-addition reaction of 
substituted furans with the α-cyclopropyl N-acyliminium ion 198, but with the marked 
differences as follows. The appearance of a clear OCH3 peak (δH 3.67), resonating as a 
singlet in the 1H-NMR spectrum suggested that the 2-methoxyfuran had reacted with the 
α-cyclopropyl N-acyliminium ion 198. However, no aromatic furan resonances were 
observed in the 1H-NMR or APT spectra, and there was the appearance of methylene 
proton signals which integrated for 4H, labelled as H2 and H3 (Figure 3.4). Additionally, 
the aromatic region integrated for 10 H rather than 13H as would be expected if 2-





Figure 3.4 1H-NMR spectrum (500 MHz, CDCl3) of compound 279a. 
Further evidence of furan ring hydrolysis was obtained by an additional carbonyl peak at 
δC 173.6 in the ester range, which shared a gHMBC correlation with the proton signal of 
the OCH3 indicating a methyl ester has been formed.  
Protons H2 and H3 were distinguished by their chemical shifts and gHMBC correlations. 
The chemical shifts which corresponded to H2 were δH 2.71 – 2.60 (m) and δH 2.33 (1H, 
dt, J = 17.1, 5.9 Hz) indicating it was adjacent to the ester group as the stronger electron 
withdrawing effect of the ketone further deshielded H3 to δH 3.14 – 3.03 (1H, m) and 2.85 
– 2.75 (1H, m). The H2 resonance correlated to the OMe (δC 51.9) in the gHMBC 




Figure 3.5 APT-NMR spectrum (125 MHz, CDCl3) of compound 279a. 
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In the APT spectrum the ketone resonance C4 was not visible, however it was observed 
at δC 207.6 in the gHMBC spectrum. The C4 resonance shared a gHMBC correlation with 
H2, H3, H3ʹ and H1ʹʹ. In the ROESY spectrum, H2ʹʹ and H3ʹ shared a crosspeak 
indicating the 2ʹR configuration, much like that of the other furan 1,2-addition products. 
Previous kinetic studies of the ring opening of furans in the 1970s has shown that the 
likely mechanism for 2-substitued furans with an electron donating substituent is 
protonation at the β-carbon as shown in Scheme 3.3.99,100 This mechanism is likely 
because the protonation occurs at the most electron rich carbon that is not blocked by 
substitution. 
 
Scheme 3.3 Proposed mechanisms for the ring opening of the 1,2-addition product 280 
under acidic conditions. 
The reactions of 197 either with the nucleophiles 2,5-dimethylfuran or benzofuran, in the 
presence of BF3·Et2O (Table 3.2, Entries 4 and 5), did not result in the isolation of any 
desired products except the spirocyclic furan 242. The likely reason for this is the reduced 
reactivity of these nucleophiles in comparison to the furans in Table 3.2, Entries 1-3, 
where 2,5-dimethylfuran has a lower reactivity than furan due to the steric effect of the 
methyl substituents, and the phenyl group of benzofuran withdraws electron density from 





3.4 The Reactions of Allyltrimethylsilanes with the α-Cyclopropyl N-Acyliminium 
Ion 198 
The reactions of the α-cyclopropyl N-acyliminium ion precursor 197 with 
allyltrimethylsilanes were carried out with the anticipation that these reactions would 
proceed through the following mechanism (Scheme 3.4). After homoconjugate addition 
and protonation of the resulting enamide 285, the iminium ion is re-formed and is then 
attacked by the alkene 286. The loss of a proton may then form an alkene to give the 
spirocycle 288 (Scheme 3.4 Pathway A), or, as was the case in the analogous reaction of 
an α,β-unsaturated N-acyliminium ion result in intramolecular O attack of the cation (See 
Chapter 1, Scheme 1.37) which in this case would result in the spirocycle 289 (Scheme 
3.4 Pathway B).  This reaction may provide compounds with a handle on the newly 
formed ring to make a range of chemical modifications, possibly becoming a key scaffold 
for analogue synthesis.  
 
Scheme 3.4 Mechanism for the conjugate addition of allyltrimethylsilanes to α-
cyclopropyl N-acyliminium ion 198, pathway A in blue, pathway B in red. 
In order to investigate the validity of this reaction mechanism, three allyltrimethylsilanes 
290i-iii were used as nucleophiles with the intent to obtain the spirocycle of type 288 
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(Scheme 3.5). These reactions were found to proceed at a slower rate than the optimised 
reaction, and were quenched after the disappearance of the α-cyclopropyl N-acyliminium 
ion precursor 197 observed by thin layer chromatographic analysis. 
 
Scheme 3.5 Reaction of allyltrimethylsilanes 290i-iii with the α-cyclopropyl 
N-acyliminium ion forming precursor 197. 
Table 3.3 Reaction of allyltrimethylsilanes with α-cyclopropyl N-acyliminium ion 
precursor 197.a 
 290i-iii 291i-iii 242 292 




(syn:anti) Yield dr 
1b 
 
78% 77:23     
2c 
 
18% 84:16 42% 75:25 13% >95:5 
3b,d 
 
- - - - - - 
a. Reactions performed at 0.2 M in anhydrous CH2Cl2, 290i-v (2 mol eq), BF3·Et2O (2 mol eq) added 
dropwise, 12 h, 0 ˚C to rt. 
b. Reaction quenched after 22 h. 
c. Reaction quenched after 48 h. 
d. Complex mixture, no pure products were isolated.  
The reaction of allyltrimethylsilane and the α-cyclopropyl N-acyliminium ion precursor 
197 resulted in the 1,2-addition product 291i, echoing the result of the furan. The yield 
for the reaction was good (78%) and the diastereoselectivity was moderate (77:23). A 
small amount of the major syn diastereomer could be obtained in high diastereomeric 
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purity after additional purification of the diastereomer mixture by column 
chromatography. 
The assignment of the NMR resonances took place in a similar manner to that of the 1,2-
addition furan product 278i. The significant difference between the NMR spectra of these 
compounds is of course the presence of the allyl group in place of the furan, which is 
assigned to these following resonances in the 1H-NMR spectrum. H2ʹ resonated as a 
multiplet (δH 5.83) in the expected region for an alkene proton, and coupled in the gCOSY 
spectrum with the resonances assigned to H3ʹa (δH 4.95, d, J = 17.3 Hz), H3ʹb (δH 5.03 
d, J = 10.3 Hz) and H1ʹ (δH 2.36, dd, J = 13.8, 7.0 Hz and 2.24, dd, J = 13.8, 7.9 Hz). 
H3ʹa and H3ʹb were distinguished by their coupling constants, where the larger coupling 
constant of H3ʹa indicated a trans relationship with H2ʹ. 
 
Figure 3.6 1H-NMR spectrum (500 MHz, CDCl3) of compound 291ia. Minor 
diastereomer 291ib indicated by x. 
There was also strong evidence for the incorporation of the allyl group in the APT 
spectrum. The appearance of a positive peak in the APT at δC 133.6 was assigned to C2ʹ, 
with the resonance for the terminal carbon of the alkene (C3') in the expected position at 
δC 119.3. A gHSQC experiment was used to distinguish the resonances of C3 (δC 37.0) 
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Figure 3.7 APT-NMR spectrum (125 MHz, CDCl3) of compound 291ia. 
To increase the steric bulk at the reaction centre without overly affecting the 
nucleophilicity of the allyltrimethylsilane, 3-methylallyltrimethylsilane was next 
examined as a nucleophile. Increasing the steric bulk near the nucleophilic (terminal) 
carbon should favour homoconjugate addition since attack at either of the cyclopropyl 
methylene carbons should be less sterically hindered than the C of the iminium ion.  
This proved to be sound reasoning, however the additional bulk of the nucleophile lead 
to a decrease in the allyltrimethylsilane reactivity towards the α-cyclopropyl N-
acyliminium ion, resulting in the formation of the spirocyclic furan 242 as the major 
product (42%) and as a mixture of diastereomers (dr = 75:25). What was isolated 
alongside this however, was some of the 1,2-addition product 291ii in poor yield (18%) 
but good diastereoselectivity (dr = 84:16), and the unexpected gem-dimethylcyclopentane 
product 292 (13% yield, dr >95:5). The assignment of the NMR resonances for the 1,2-
addition product 291iia was carried out in an analogous manner to its parent compound 
291ia. 
The gem-dimethyl product 292 presented quite a different set of NMR spectra. 
Homoconjugate addition resulting in cyclopropyl ring opening was evidenced by a lack 
of signals in the δH 0.5 to -0.5 region of the 
1H-NMR spectrum, and the lack of resonances 
at approximately δH 2.6 signified the disappearance of the methylene protons in the 
pyrrolidinone core. Two methyl singlet resonances (δH 1.06 and 0.89) were observed in 
the 1H-NMR spectrum, both integrating for 3 protons. The two sets of benzyl methylene 
proton peaks resonated as doublets, assigned to NCH2Ph (δH 5.38 J = 15.5 Hz and δH 3.92 
J = 15.5 Hz) and OCH2Ph (δH 4.92 J = 11.6 Hz and δH 4.89 J = 11.6 Hz). The 

















in contrast, the OCH2Ph diastereotopic protons resonated at very similar chemical shifts 
consistent with their further distance from a stereocentre. A tertiary alkene proton 
resonating as a singlet was observed at δH 5.23, influenced by the opposing anisotropic 
effect of the adjacent amide carbonyl, and the electron donating effect of the ether O. H5 
was assigned at δH 3.97 resonating as a doublet, and was shifted downfield due to the 
electron withdrawing influence of the adjacent amide and alkene. Starting from the 
resonance for H5 resonance, gCOSY correlations were used in conjunction with gHSQC 
data to allow for the assignment of protons and carbons in the cyclopentane ring.  
 
Figure 3.8 1H-NMR spectrum (500 MHz, CDCl3) of compound 292. 
The presence of an O-substituted alkene in this molecule is well supported by the APT 
spectrum (Figure 3.9). C4 (δC 176.7) is at the β-position of an α,β-unsaturated carbonyl 
system and so is strongly deshielded, and then this carbon is further deshielded by the 
electron withdrawing benzyloxy O. C3 (δC 95.5) is strongly deshielded by the adjacent 
lactam carbonyl, however this is mitigated somewhat by the electron donating effect of 
the benzyloxy group since C3 is β to it. C5 (δC 60.1) and C1ʹ (δC 47.8) both were positive 
in the APT spectrum and shared a gHSQC correlation with their respective assigned 
protons in the 1H-NMR spectrum. The assignments of NCH2Ph (δC 43.6) and C3’ (δC 
43.5), although very close in chemical shifts, were discerned through gHSQC 
correlations. Finally, the methyl group resonances were observed to be both positive, and 
in the expected chemical shift region of the APT spectrum.  
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Figure 3.9 APT-NMR spectrum (125 MHz, CDCl3) of compound 292. 
Although 292 was quite an unusual structure, a viable reaction mechanism for its 
formation is outlined below (Scheme 3.5). The reaction proceeds through the 
homoconjugative addition of the 3-methylallylsilane to the α-cyclopropyl N-acyliminium 
ion 198 to yield the enamine 293. Rather than reforming the iminium ion by protonation, 
as shown in Scheme 3.4, the terminal alkene 293 is protonated to form the tertiary 
carbocation 294. This can then undergo attack by the enamine π-bond which forms the 
N-acyliminium ion 295. Isomerisation to the most stable structure, facilitated by the acidic 
conditions of the reaction then occurs to give product 292. A potential reason for the 
formation of the gem-dimethyl compound 292 over the expected 7-member ring product 
is the energetic favourability of 5-membered ring formation over the formation of a 7-
membered ring.101 
 
Scheme 3.5 Proposed mechanism for the formation of the gem-dimethyl compound 292 
























The reaction of (2-(chloromethyl)allyl)trimethylsilane noted in Table 3.4, Entry 3 
resulted in an inseparable and complex mixture of products, none of which could be 
isolated in sufficient purity to identify by NMR analysis.  
3.5 The Reactions 5-Member Aromatic Heterocycles with α-Cyclopropyl 
N-Acyliminium Ion Precursor 197 
The nucleophiles pyrrole, thiophene, and imidazole did not result in any conversion of 
the α-cyclopropyl N-acyliminium ion precursor (Table 3.4). Two outcomes appeared to 
occur in these reactions, in the first of these the reaction led to the sole recovery of 
reactants. This is perhaps due to their strong coordination to BF3·Et2O which would halt 
any reaction progress, which was the case for thiophene and imidazole as it effectively 
reduces the concentration of BF3·Et2O in solution. The second outcome occurred when 
pyrrole was used as a nucleophile (Table 3.4, Entry 1), where the reaction mixture 
quickly formed a precipitate due to the apparent polymerisation of pyrrole due to its 
highly electron rich nature. In all cases the majority of the starting material was recovered.  
Table 3.4 Attempted reactions of 5-membered aromatic heterocycles with α-cyclopropyl 
N-acyliminium ion 197.  
 
  










a. Reactions performed at 0.2 M in anhydrous CH2Cl2, nucleophile (2 mol eq), BF3·Et2O (2 mol eq) 
added dropwise, 12 h, 0 ˚C to rt. 
This led us to next examine the reactions of indoles which could have an advantage over 
pyrrole as a nucleophile, which is that the nucleophilicity of the pyrrole moiety is reduced 
by the bridged phenyl ring, which could reduce dimerization and polymerisation. 
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However, indole could still be reactive enough to outcompete formation of the spirocyclic 
furan 242. 
3.6 Conclusions 
In this Chapter, the scope and limitations of the nucleophilic additions to α-cyclopropyl 
N-acyliminium ion 198 were further explored. It was found that increasing the electron 
density of nucleophiles overall appeared to lead to a greater ratio of addition products 
over that of the spirocyclic furan product 242. In the case of the relatively unhindered and 
electron rich furan reactions (Table 3.2 Entries 1-3) 1,2-addition reaction products were 
obtained rather than the homoconjugate addition products which were desired. And, in 
the case of pyrrole which was the most electron rich nucleophile tested, only dimerization 
and polymerisation of the nucleophile was observed.   
It was also discovered that the enamine formed after homoconjugate addition to an α-
cyclopropyl N-acyliminium ion can act as a nucleophile, as was the case in the 
intramolecular attack on the tertiary carbocation 294 in the reaction with 3-





4. Reactions of α-Cyclopropyl N-Acyliminium Ions with Indoles 
4.1 Aims Addressed in Chapter 4 
Project Aim 4 is successfully addressed in this Chapter, with a large variety of substituted 
indoles being reacted with the α-cyclopropyl N-acyliminium ion precursors that were 
described in Chapter 2. 
4.2 Initial Experiments with Indole as a Nucleophile 
The first reaction of indole (2.0 mol eq.) with the α-cyclopropyl N-acyliminium ion 
precursor 197 was first carried out under the conditions optimised in Chapter 2, giving 
solely the 1,2-addition product 296 in moderate yield (43%) and as a mixture of separable 
diastereomers (dr = 52:48) (Table 4.1, Entry 1). Significantly, no homoconjugate 
addition product of indole to the α-cyclopropyl N-acyliminium ion 198 was observed in 
this reaction, but encouragingly no spirocyclic furan 242 could be detected in the crude 
reaction mixture by 1H-NMR analysis. The reaction conditions used in this reaction will 
be referred to throughout this Chapter as General Method A. 
 
Scheme 4.1 Indole addition to α-cyclopropyl N-acyliminium ion precursor 197. 
In comparison to other 1,2-addition reactions between indole and similar tertiary 
N-acyliminium ions in the literature (Scheme 4.2 b102 and c103) the yield (43%) was lower, 
compared to 93% and 97%, for similarly sterically demanding substrates. These higher 
yields for related reactions indicated that this reaction should be able to be further 




Scheme 4.2 Indole addition to tertiary N-acyliminium ion examples, reactions a80, b102, 
and c103. 
The diastereoselectivity of this reaction also required optimising (dr = 52:48), given the 
close to equal diastereomic ratio of products being formed, especially when compared to 
the diastereoselectivity of the indole additions in Scheme 4.2b where selectivity was 
induced by a chiral catalyst Y and Scheme 4.2c where it was achieved with a bulky chiral 
anthracene to result in a single diastereomer. It was therefore prudent to tailor the reaction 
conditions to accommodate the increased reactivity of the indole in comparison to 








Table 4.1 Effects of temperature on the yield and diastereoselectivity of 1,2-addition 
compound 296.a 
    296 
Entry Temperature Solvent Time % Yield dr (syn:anti) 
1 rt CH2Cl2 26 h 43% 52:48 
2b rt CH2Cl2 26 h 70% 52:48 
3b -40 ˚C CH2Cl2 26 h 74% 92:8 
4b Reflux CH2Cl2 3 h 73% 21:79 
5b,c Reflux CH2ClCH2Cl 3 h - - 
a. Reactions were carried out with indole (2 mol eq.), BF3·Et2O (2 mol eq. added via syringe pump 
over 1 h in 0.3 M solution CH2Cl2) at a concentration of 0.2 M in CH2Cl2 
b. Acetone was used to dissolve the precipitate that formed. 
c. Complex mixture of products formed, no pure products were isolated.  
It was noted that a significant amount of precipitate was formed by the end of the reaction, 
which presented itself as a possible reason for the low yields. This reaction was then 
repeated with two modifications (Table 4.1, Entry 2), the first of which was the slow, 
dilute addition of BF3·Et2O, which by the end of the reaction appeared to have 
significantly reduced the volume of precipitate that had formed. The introduction of 
BF3·Et2O to the reaction mixture was achieved as a solution of BF3·Et2O in CH2Cl2 
(1 mL, 0.3 mol/L) contained in a syringe and delivered over the course of 1 h via a syringe 
pump to a solution of the α-cyclopropyl N-acyliminium ion precursor 197 and the indole 
in CH2Cl2. The second modification was implemented during the reaction workup, where 
a minimal volume of acetone was added after the reaction was quenched with saturated 
sodium bicarbonate solution, to dissolve the red precipitate formed during the reaction. 
The reason this was done was to recover any product trapped in the precipitate, and these 
two implemented methods increased the yield from 43% to 70%, showing significant 
improvement with these simple steps and validating the reasoning behind the poor yields. 
This methodology together is referred to throughout the rest of this Chapter as General 
Method B. Additionally, this gave the best yield so far of nucleophilic addition to the α-
cyclopropyl N-acyliminium ion 198 which is why the indoles were focussed on as a 
nucleophile as the project continued. 
We speculate that this precipitate may be an indole oligomer. Indole has been shown to 
undergo electrophilic substitution, forming a dimer and therefore reacting with itself 
rather than the substrate in the presence of a Lewis acid (Scheme 4.3),104 and the 
polymerisation of indoles under acidic conditions to form dimers and trimers is well 
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understood.105 This is the likely mechanism that formed the problematic precipitate that 
was previously observed. The dimer of indole 301 was isolated in significant yield (21%), 
meaning that of the 2 equivalents of indole available in the reaction, at least 0.42 mol eq. 
were used up making the dimer. Due to the fact this mechanism of reaction consumes 
indole and therefore reduces the available moles of nucleophile available to react with the 
α-cyclopropyl N-acyliminium ion 198, more electron dense indoles that would more 
readily dimerise and polymerise were used at a mol eq. of 3 rather than 2, relative to the 
α-cyclopropyl N-acyliminium ion forming precursor 197. This was to ensure that an 
adequate amount of indole was always available to react with the α-cyclopropyl N-
acyliminium ion throughout the reaction. Since the molar equivalents of indole used in 
this particular reaction did not have a significant effect on the reaction outcome, good 
yields were eventually obtained. However, for indole analogues with electron donating 
groups where dimer formation will be more favourable, the molar equivalents of indole 
were increased to 3 for this reason. This is noted in the experimental section for electron 
rich indole analogues.   
 
Scheme 4.3 Proposed mechanism for the dimerisation of indole. Modified from 
Duperye et al.104 
The α-cyclopropyl N-acyliminium ion 198 does not undergo the desired spirocyclisation 
reaction with indole like the α,β-unsaturated N-acyliminium ion (Scheme 4.2a). This 
again shows the second key reactive pathway difference between the α-cyclopropyl 
N-acyliminium ion and the α,β-unsaturated N-acyliminium ion that was outlined in 
Chapter 3. This Chapter will show this to be more prevalent, where spirocyclisation is 
much less favourable than 1,2-addition to α-cyclopropyl N-acyliminium ions. 
The next step towards yield optimisation was to lower the reaction temperature, with the 
hope of forming more of the kinetically favoured diastereomer with this highly reactive 
nucleophile. This proved to be solid reasoning, as cooling the reaction mixture to -40 ˚C 
resulted in a comparable yield (74%) and drastically improved diastereoselectivity (92:8), 
interestingly favouring the cis-addition product (Table 4.1, Entry 3). Initially we 
considered that the anti-addition product should be the kinetic product, due to fewer steric 
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interaction in the molecule as the bulky indole and OBn groups will be on opposite sides 
in the product. To investigate whether this is the case, the reaction was repeated at reflux 
temperature in CH2Cl2 over 3 h, which gave the desired product again in a comparable 
yield (73%), this time favouring the anti-addition diastereomer 296b (21:79). At this point 
it appeared clear that the anti-addition product 296b was the thermodynamically more 
stable product. Anticipating that a higher reaction temperature would lead to a greater 
proportion of the anti-addition diastereomer or encourage a switch to the homoconjugate 
reaction pathway if this 1,2-addition reaction was reversible, the reaction was heated to 
reflux in 1,2-dichloroethane was used as the solvent. Unfortunately, this lead to a mixture 
of side products likely due to the Lewis acid promoting decomposition of the products at 
the higher temperature (Table 4.1, Entry 5). The structures of the 1,2-additon products 
296a (major diastereomer) and 296b (minor diastereomer) were assigned in an analogous 
way to the 1,2-additon products of Chapter 3 (Figure 4.1, 4.2). 
 
 
Figure 4.1 1H-NMR spectrum (500 MHz, CDCl3) of compound 296a. 
 
 
H1’ H4’ H7’ 
ArCH 
H2’ NCH2 NCH2 
OCH2 
H4 H3 H3 




Figure 4.2 APT-NMR spectrum (125 MHz, CDCl3) of compound 296a. 
Figure 4.3 shows a portion of the 1H-NMR spectra of the crude reaction mixtures from 
Table 4.1, Entries 3 and 4 that have been overlayed to show the significant difference in 
the 1H-NMR resonances of the two diastereomers. Fortunately, the spectra of these crude 
reaction mixtures were very clean making a comparison between the reaction outcomes 
clear. The most dramatic of these differences are the chemical shifts of the resonances for 
H4, highlighted below, which differ by 1.5 ppm.  
 
Figure 4.3 1H-NMR spectra (500 MHz, CDCl3) where compound 296a the cis-addition 
product was major (blue, Table 4.1, Entry 3) and where trans-addition compound 296b 
(red, Table 4.1, Entry 4) was major. 
Below are the ROESY spectra of the two 1,2-addition diastereomers, compound 296a 
Figure 4.4, and compound 194b Figure 4.5. The analyses of these spectra were 
straightforward, showing correlation between H4 and H1ʹʹ for the syn-addition product 























Figure 4.4 ROESY NMR spectrum (CDCl3) of the syn 1,2-addition product 296a. NOE 
correlation indicated by red arrows. 
The anti-addition product does not show these correlations at all, as shown by the absence 
of crosspeaks outlined by red boxes. This conclusion is further expanded upon when X-
ray crystallography was undertaken on the cis and trans addition products described later 
in this Chapter.  
 
Figure 4.5 ROESY NMR spectrum (CDCl3) of the anti 1,2-addition product 296b. 




















Computational modelling was carried out on the C4 OMe and N1 Me analogues rather 
than the C4 OBn and N1 Bn analogues by Associate Professor Uta Wille at the University 
of Melbourne. The first of these presented in this Chapter compare the energies of the 
homoconjugate addition reaction pathway, against that of the anti and syn 1,2-addition 
pathway (Scheme 4.4). 
 
Scheme 4.4 The reaction pathways modelled for the additions of indole to 
α-cyclopropyl N-acyliminium ion 243. 
In Figure 4.6 the energies of the reaction intermediates 303 and 305 are compared to the 
ground state of the free reactants. This is then followed by the reactants coming together 
and interacting with each other, which accounts for an increase in the energy required. 
The transition states of either homoconjugate addition or 1,2-addition through the syn or 
anti pathways are next shown, and finally the resulting intermediates 303 and 305 of these 
addition types are depicted. The anti-addition intermediate has a deeper well than the syn-
addition product and a higher internal energy, and so at higher temperatures when the 
activation energy is overcome to form the anti-intermediate, it is less likely to proceed 
through the reverse reaction. However, once the anti-intermediate 303 eliminates a proton 
to restore aromaticity, it is likely that the anti-product 306 would be lower in energy than 
the syn-product 306 as the bulky OBn and indole groups would be on opposite faces of 
the molecule, therefore reducing internal steric effects. This makes the anti-addition 




Figure 4.6 Computational relative energies of possible reaction pathways in the 
reaction of indole with α-cyclopropyl N-acyliminium ion 343, computed in the gas 
phase. 
A prohibitively high energy barrier exists for the formation of the homoconjugate addition 
product in comparison with the 1,2-addition products, and so this product is too 
kinetically unfavourable to be made in the reaction (Figure 4.6). It is plausible that if the 
temperature could be raised enough to overcome that barrier and make the very stable 
homoconjugate addition product, a non-reversible product after ring opening, the desired 
spirocycle could possibly be obtained as it exists in a very deep energy well. However, as 
previously mentioned, additional heating resulted in a complex mixture of side products 
and none of the desired spirocycle. Since none of the desired spirocycle was obtained, 
this indicates that the substrate is not undergoing any homoconjugate addition. 
Mechanistically homoconjugate addition should be non-reversible in contrast to 1,2-
addition, and resulting in the formation of the spirocycle over time, even if the 1,2-
addition pathways was kinetically favoured pathway.  
A reaction was undertaken with the 1,2-addition reaction product, whereby pure 






a week, with the hope that the reaction would slowly proceed through the irreversible 
homoconjugative addition mechanism as the product proceeds reversibly through 
elimination of indole, followed by 1,2-addition (Scheme 4.5). Unfortunately, this was not 
the case as it appeared by 1H-NMR analysis that the indole was eliminating and forming 
the dimerised and polymerised products above (Scheme 4.3). Due to this, all that was left 
after workup was a very complex mixture, and a trace amount of the spirocyclic furan 
product 242, presumably due to a small amount of water in the reaction mixture.  
 
Scheme 4.5 Long term exposure of 1,2-addition product 296a to Lewis acid conditions. 
4.3 Exploring the Substrate Scope of α-Cyclopropyl N-Acyliminium Ions 
To explore how functional groups around the α-cyclopropyl N-acyliminium ion affected 
its chemistry, two substrate modifications were made. First the N-benzyl group was 
changed to an N-methyl group to examine the role of the sterics around the nitrogen of 
the iminium carbon.  
This substrate proved exceptional at forming the 1,2-addition product. The reaction of 
199 (0.2 M in CH2Cl2) and indole (2 mol eq.) with BF3·Et2O (2 mol eq. added via syringe 
pump over 1 h in 0.3 M solution CH2Cl2) was complete after 3 h and gave the product 
307 in excellent yield (98%) and as a mixture of separable diastereomers (Scheme 4.6), 
which favoured the syn-addition product (dr = 90:10). It appeared that the N-benzyl group 
provides a significant steric hinderance, as the N-methyl substrate 199 had a reaction time 
of 3 h in comparison to 26 h for the N-benzyl analogue, and a more easily accessed 
iminium carbon improved yields from 74% to 98%. The latter yield and selectivity much 
closer to those literature values shown in Scheme 4.2. Clearly the smaller N-methyl group 
would also favour the 1,2-addition reaction pathway over the homoconjugate addition 




Scheme 4.6 The reaction of α-cyclopropyl N-acyliminium ion precursor 199 with 
indole. 
The major diastereomer was able to be isolated pure from this reaction, and its X-ray 
crystal structure confirmed it was the syn 1,2-addition product. Below is the crystal 
structure result, shown at two angles as well as the crystal itself (Figure 4.7). 
  
Figure 4.7 Crystal structure of the major syn-addition product 307a at two angles, and 
the isolated crystal under a microscope. 
4.3.1 1,2-Addition Product from the Reaction of the Phthalimide α-Cyclopropyl 
N-Acyliminium Ion Precursor 203 and Indole 
The phthalimide α-cyclopropyl N-acyliminium ion precursor 203 also proved to be 
excellent at forming the 1,2-addition product after some modification of the original 
reaction conditions. The reaction was initially carried out using the previously optimised 
conditions, a syringe pump was used for the BF3·Et2O addition at 0 ˚C then the reaction 
mixture was warmed to room temperature and stirred for 2 h before quenching 
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(Scheme 4.7). Unfortunately, purification by column chromatography was not viable 
because the product 308, would not dissolve in a variety of loading solvents despite being 
subjected to heating and sonication. Attempts made to purify the compound by column 
chromatography were unsuccessful as the compound crystallised in the column during 
purification, resulting in significant loss of material. To overcome this problem, the 
purification method was changed from column chromatography to crystallisation, and the 
ratio of indole to reaction substrate was changed from using 2 mol eq. to 1.2 mol eq. 
These modifications worked exceptionally well, and the yield of 308 was enhanced from 
19% to 86% (Scheme 4.7). 
 
Scheme 4.7 1,2-addition reaction of substrate 203 and indole. a) Purified by column 
chromatography. b) Purified by crystallisation. 
In this case, the 1,2-addition product 308 was most likely favoured due to the accessibility 
of the iminium carbon of the α-cyclopropyl N-acyliminium ion 204, because of the flatter 
more sp2 hybridised pyrrolidinone ring.  
The assignment of NMR resonances for this product and related 1,2-addition products 
derived from compound 203 and a substituted indole can be carried out using the 
methodology outlined here. In the 1H-NMR spectrum of 3-cyclopropyl-3-(1H-
indol-3-yl)-2-methylisoindolin-1-one (Figure 4.8), the most downfield resonance was a 
broad singlet which had no gHSQC correlation and was this assigned as H1ʹ (δH 8.34). A 
gCOSY correlation between the assigned H1ʹ resonance and that of H2ʹ indicated the 
assignment of H2ʹ (δH 7.65). The NMe proton signal was assigned as the singlet 
integrating for 3H in expected region at δH 2.94. The proton resonances of the cyclopropyl 
group were at the expected chemical shifts in the 1H-NMR spectrum and shared gCOSY 
correlations and integrated for 5H in total. With the assistance of gHSQC data the 
assignment of the H1ʹʹ (δH 0.83), and the pairs of protons for H2ʹʹ and H3ʹʹ was possible. 
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The assignment of the remaining resonances at this point was not possible by just 1H-
NMR, but a gCOSY spectrum was used to verify which proton resonances were grouped 
together on the contiguous spin systems belonging to H4-H7 and H4ʹ- H7ʹ.  
 
Figure 4.8 1H-NMR spectrum (500 MHz, CDCl3) of compound 308. 
After 1H-NMR assignments were made the gHSQC spectrum was used to allow the 
assignments of the discussed resonances in the APT spectrum (Figure 4.9). The carbonyl 
resonance for C1 (δC 168.2) was isolated from the other resonances. The assignment of 
the quaternary carbon C3 (δC 68.0) was also straightforward as it had negative phasing in 
the APT and had no correlation in the gHSQC.  
 































In the gHMBC spectrum correlations were observed between C1 and two proton signals 
H7 (δH 7.93, d) and H6 (δH 7.45 – 7.38, m) (Figure 4.10). This information allowed the 
1H-NMR spectrum resonances for H4-H7 and H4ʹ- H7ʹ to be assigned as belonging to 
the phthalimide core and indole core, respectively.  
 
Figure 4.10 3-cyclopropyl-3-(1H-indol-3-yl)-2-methylisoindolin-1-one 308. Pertinent 
HMBC correlations (purple arrows) are indicated.  
There are many related 1,2-addition reactions to N-acyliminium ions derived from related 
phthalimide substrates resulting in the formation of a new quaternary carbon. For 
example, Tang et al. demonstrated that the chiral phosphoric acid catalyst 312 can be used 
to catalyse reactions with various indoles to give products 311 in yields ranging from 59 
– 99% and ee from 56 – 95% (Scheme 4.8).106 Similar yields and slightly better 
enantioselectivities were obtained by Gredičak et al., who reported in 2017 using a 
different catalyst and a wider array of indoles but still only making modifications on the 
5,6 and 7 positions of indole substrates (Scheme 4.9). Of particular note in the Gredičak 
study, was that the catalyst would only impact the stereoselecivity of the reaction if there 
was an unprotected NH on the phthalimide substrate.107 Examples of phthalimide 
additions of indoles with functional groups at the 1,2 and 3-positions are found in the 
work of Samanta et al (Scheme 4.10).108 
Scheme 4.8 Adapted from Tang et al.106 
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Scheme 4.9 Adapted from Gredičak et al.107 
 
Scheme 4.10 Adapted from Samanta et al.108 
Interestingly, this method was used to arrive at indole containing 5,6-azaspriocycles 317 
through a two-step synthesis from the N-acyl iminium ion precursor 312 (Scheme 4.11).  
Scheme 4.11 Adapted from Samanta et al.108 
These examples listed show that although the reaction that was performed with the 
phthalimide derived α-cyclopropyl N-acyliminium ion 204 worked well for a 1,2-addition 
product, these types of products are well documented, except for ones with a cyclopropyl 
substituent. However, the search for novel indole homoconjugate additions products from 




4.3.2 The Reaction of 5-Substituted Indoles 
 
Scheme 4.12 Reactions of 5-substituted indoles with α-cyclopropyl N-acyliminium ion 
precursor 197. 
Next 5-substituted indoles were used to examine electronic effects on the nucleophile, 
well away from the reaction centre formed as the indoles react with the α-cyclopropyl N-
acyliminium ion to rule out possible steric effects (Scheme 4.12, Table 4.2).  
The electron rich indole, 5-methoxyindole, was used first to evaluate the impact 
additional electron density had on dimer formation, and the impact on yield and 
diastereoselectivity (Table 4.2, Entries 1-3). At -40 ˚C the reaction had a higher yield 
(85%) and comparable diastereoselectivity (88:12) (Table 4.2, Entry 1) compared to 
indole (yield = 74%, dr = 92:8) under the same conditions (Table 4.1, Entry 3). The 
reactions were allowed to proceed for 12 h to favour homoconjugate addition in case the 
that 1,2-addition reaction was reversible, but by TLC analysis the starting material had 
been consumed after 1 h for each reaction and no further changes were observed past this 
point.  
Further increases in diastereoselectivity and yield were achieved when the reaction was 
cooled to -40 °C rather than 0 °C for the BF3·Et2O addition and kept at that temperature 
for the duration of the reaction (Table 4.2, Entry 2). When the first methodology 
(General Method A) was used where BF3·Et2O was added neat over the period of 1 h, 
and no acetone was used to break up the precipitates, the yield decreased substantially to 





Table 4.2 Reactions of 5-substituted indoles with α-cyclopropyl N-acyliminium ion 
precursor 197. 
 322i-vi  323i-vi 








85% of 323ia,b 
70% of 323ia 






2 h 89% of 323iic 89:11c 
5 
 
2 h 76% of 323iiic >95:5c 
6 
 
2 h 92% of 323ivc >95:5c 
7 
 
12 h 61%a of 323va 84:16a 
8 
 
12 h 70% of 323via 93:7a 
a. Reactions were carried out with indole 322 (2 mol eq.), BF3·Et2O (2 mol eq. added via syringe 
pump over 1 h in a 0.3 M solution CH2Cl2) at a concentration of 0.2 M in CH2Cl2 (General 
Method B). 
b. Reaction done at -40 °C rather than rt. 
c. BF3·Et2O (0.2 mol eq) was added dropwise, acetone was not added to dissolve precipitate 
(General Method A). 
Next, the impact of reducing the electron density of the indole was examined, using three 
haloindoles (Table 4.2 Entries 4-6), the first of which was 5-fluoroindole (Table 4.2 
Entry 4). Due to the reduced nucleophilicity of the indole, much less dimerisation of the 
indole derivative was observed in this reaction, leading to less precipitation, and General 
Method A therefore proved to be adequate, affording the compound in excellent yield 
(89%) and similarly good diastereoselectivity (dr = 89:11) favouring the syn addition 
product. Strong C-F coupling was observed in the 13C-NMR spectrum (Figure 4.11), 
showing an expected exponential decrease in strength as the bond order coupling 
increased, where C5’:1J = 233.9 Hz, C6’:2J = 26.9 Hz, C4’:2J = 25.0 Hz, C7’:3J = 9.6 
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Hz, and C3’:4J = 4.8 Hz. This data further strengthens the veracity of the assignments 
made from the 2D NMR data about the indole functional group. 
 
Figure 4.11 A section of the 13C-NMR spectrum (125 MHz, CDCl3) of compound 
323iia, where C-F coupling is highlighted in red. 
The reaction of 5-chloroindole with the α-cyclopropyl N-acyliminium ion precursor 197 
carried out under General Method A conditions gave an unexpectedly lower yield but 
better diastereoselectivity, the yellow solid isolated in 76% yield was a 95:5 mixture of 
diastereomers (Table 4.2, Entry 5). A better yield of 323iv (92%) with similarly excellent 
diastereoselectivity (dr >95:5) favouring the syn-1,2-addition product 323via was 
obtained from the reaction of 5-bromoindole, which again was formed uner the conditions 
of General Method A (Table 4.2, Entry 6).  
After investigating 5-haloindoles, indoles that incorporate stronger electron withdrawing 
groups were sought, with the idea that the substituted indole would approach a similar 
level of nucleophilicity as 1,2-dimethoxybenzene. The reaction of methyl indole-5-
carboxylate and α-cyclopropyl N-acyliminium ion precursor 197 under General Method 
B conditions gave a yield of 61% of the 1,2-addition product 323vii with relatively good 
diastereoselectivity (dr = 84:16), but did not yield any of the desired spirocyclic product 
(Table 4.2, Entry 7). 
The reaction of 5-cyanoindole and the α-cyclopropyl N-acyliminium ion precursor 197 
under General Method B conditions gave the major syn 1,2-addition product 323viii in 
a good yield (70%) and as a mixture of diastereomers (dr = 93:7), where the major 
diastereomer 323viiia could be isolated from the minor diastereomer 323viiib (Table 4.2, 





















4.3.3 The Reactions of Deactivated 5- and 7-Substituted Indoles with 
α-Cyclopropyl N-Acyliminium Ion Precursor 197 Resulting in Spirocycles.  
The reaction of 5-nitroindole and α-cyclopropyl N-acyliminium ion precursor 197 under 
General Method B conditions gave the major syn 1,2-addition product 325a in a 
moderate yield (56%) and as a pure diastereomers (dr = >95:5), where the major 
diastereomer could be isolated from the minor diastereomer and the spirocycle (Scheme 
4.13). Gratifyingly, this reaction also gave the desired spirocycle 326, isolated in 15% 
yield and as a mixture of diastereomers (dr = 95:5).  
Scheme 4.13 The reaction of 5-nitroindole and α-cyclopropyl N-acyliminium ion 
precursor 197. 
Confirmation of the structure of the major diastereomer of the spirocycle 326a was 
achieved through the following NMR experiments. The lack of cyclopropyl proton 
resonances in the 1H-NMR spectrum indicated homoconjugate addition to the 
α-cyclopropyl N-acyliminium ion 198 had occurred. The two sets of benzyl methylene 
proton peaks resonating as doublets were assigned to NCH2Ph (δH 4.41, J = 15.2 Hz and 
δH 4.16, J = 15.2 Hz) and OCH2Ph (δH 4.23, J = 11.2 Hz and δH 3.93, J = 11.2 Hz), again 
showing the similar coupling constants observed in previous compounds. After the benzyl 
methylene peaks were assigned, H3ʹ (δH 3.98, d, J = 6.14 Hz) was assigned as the 
remaining resonance in the region, and the gCOSY spectrum correlations of this 
resonance made it possible to assign the H4ʹ protons (δH 2.91 – 2.84, 1H, m and δH 2.72 




Figure 4.12 1H-NMR spectrum (500 MHZ, CDCl3) of compound 326a. Minor 
diastereomer 326b indicated by x. 
Of the remaining methylene resonances, H2 (δH 2.01 – 1.99, m) shared a ROESY 
spectrum correlation with H3ʹ (Figure 4.13), which indicated that these protons were on 
the same side of the pyrrolidine ring, indicating that the final ring closing step of the 
spirocyclisation mechanism proceeded most favourably through a syn addition, likely due 
to the Cieplak effect (Chapter 1, Section 1.6), giving (S) stereochemistry at position C1. 
From this point the methylene groups from C2 to C4 were assigned from the gCOSY and 
gHSQC spectra.  
 
Figure 4.13 Partial ROESY-NMR spectrum (CDCl3) of compound 326a. 
H9 H5 H7 
ArCH 
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Assignment of the indole moiety began at H9 (δH 8.92, bs) as the most downfield 
resonance in the 1H-NMR spectrum, and showing no gHSQC correlation. Following this, 
three remaining resonances were of interest for the indole ring, these were H5 (δH 8.54, 
d, J = 1.5 Hz) which had characteristic meta coupling, H7 (δH 8.08, dd, J = 9.0, 1.5 Hz) 
which had characteristic ortho and meta coupling, and H8 (δH 7.06, d, J = 9.0 Hz) which 
had characteristic ortho coupling. These characteristic coupling patterns allowed for their 
unequivocal assignments.  
The quaternary carbon resonances were assigned as follows from the 13C-NMR spectrum 
(Figure 4.14) and the lack of signal from gHSQC. The only resonance in the chemical 
shift region for a carbonyl was assigned as C5ʹ (δC 173.7). Likewise, C1 (δC 68.0) was 
assigned as the only quaternary resonance in the expected chemical shift region. 
 
 
Figure 4.14 13C-NMR spectrum (125 MHZ, CDCl3) of compound 326a. 
Assignment of the remaining quaternary carbons was achieved from gHMBC spectrum 
NMR analysis (Figure 4.15). C9a (δC 133.6) shared a crosspeak in the gHMBC spectrum 
with H2 and H4. C4a shared a crosspeak in the gHMBC spectrum with H3 and H4. C6 
(δC 139.4) shared crosspeaks in the gHMBC spectrum with H5 and H7. C4b (δC 125.7) 
shared a gHMBC spectrum correlation with H8 and H9.  C8a (δC 141.5) was relatively 


























Figure 4.15 Compound 326a shown with assignment numbering left, strong gHMBC 
correlations (purple arrows) and strong ROESY correlation (Red arrows) right. 
To facilitate our understanding of the outcomes of the reaction of 5-nitroindole, molecular 
modelling of the reaction of 5-nitroindole with α-cyclopropyl N-acyliminium ion 243 was 
carried out (Scheme 4.14). Comparable computation results were obtained for the 
addition of 5-nitroindole to 243 in comparison to indole, and unfortunately did not afford 
a deeper understanding of why the addition of 5-nitroindole to α-cyclopropyl N-
acyliminium ion 198 can result in spirocyclisation but indole cannot.  
 
 
Scheme 4.14 The reaction pathways modelled for the additions of 5-nitroindole to 
α-cyclopropyl N-acyliminium ion 243. 
After the homoconjugate addition has occurred to the α-cyclopropyl N-acyliminium ion, 
the spirocyclisation step can occur via the intermediate 332, resulting in either the syn or 




Scheme 4.15 The reaction pathways modelled for the cyclisations of 332i-ii. 
Computational modelling indicated that the thermodynamically favoured product in these 
reactions are the syn addition products (Figure 4.16). Although the anti addition 
transition state is slightly lower in energy, meaning that it is the kinetically favoured 
diastereomer to form from this reaction, the syn addition intermediate exists in a much 
deeper well. Therefore, it is entirely reasonable that this reaction is reversible in the anti 
addition pathway, but not in the syn addition pathway, leading to the high 
syn-diastereoselectivity observed in the spirocyclisation pathways of 5-nitroindole and α-




Figure 4.16 Free energy graph of syn and anti reaction pathways resulting from the 
spirocyclisation of N-acyliminium ions 332i and 332ii in the gas phase. 
5-Aminoindole was used as another example of a 5-substituted indole in these 
nucleophilic additions to α-cyclopropyl N-acyliminium ion 198, but  1H-NMR analysis 
after work up of the reaction after 48 h revealed only unreacted starting material (197). A 
significant amount of precipitate was formed during this reaction, which led to the 
suggestion that the 5-aminoindole polymerised rather than the generation of with the 
α-cyclopropyl N-acyliminium ion 198. 
After this set of results, a working theory can be developed for accessing the 
5.6-spirocycles, related to the activity of the nucleophile used in the reaction (Figure 
4.17). A nucleophile which is too electron rich will result in the 1,2-addition product 
(337), whereas an electron poor nucleophile with cause the formation of the spirocyclic 
furan 242. The perfect amount of nucleophilicity results in homoconjugate addition, 
which can be followed by intramolecular cyclisation resulting in a spirocycle (338). In 
reality, a mixture of these possible products will be obtained, as was the case with the 
nucleophile 5-nitroindole. This is because the energy well in which the 1,2-addition 








products into the thermodynamically favoured spirocycle over time. Whatever the 
nucleophile, computational results and real world experimental data support the 
conclusion that at room temperature, syn-addition on the same face as the C4 ether group 
is the most likely reaction outcome, both kinetically and thermodynamically.  
Figure 4.17 Working theory of reaction outcomes via nucleophilic additions to 
α-cyclopropyl N-acyliminium ions. 
Exercising the theory that the indoles require more electron density withdrawn from them 
to result in higher yields of spirocycles, two related electron deficient 7-substituted 
indoles were reacted with the cyclopropyl-N-acyliminium ion forming substrate 197 
(Table 4.3).  
Scheme 4.16 Reactions of 7-substituted indoles 339i-ii with α-cyclopropyl 
N-acyliminium ion precursor 197. 
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Table 4.3 The reactions of α-cyclopropyl N-acyliminium ion 198 and electron deficient 
indoles.a  
  340 341 242 




















73% 84:16 5% >95:5 - - 
4 
 
- - 12% 62:38 49% 75:25 
a. Reactions were carried out with indole 339i-ii (2 mol eq.), BF3·Et2O (2 mol eq. added via syringe 
pump over 1 h in 0.3 M solution CH2Cl2) at a concentration of 0.2 M in CH2Cl2 (General Method 
B). 
b.  BF3·Et2O (0.2 mol eq) was added dropwise, acetone was not added to dissolve precipitate 
(General Method A). 
The reaction of α-cyclopropyl N-acyliminium ion precursor 197 and 7-fluoroindole in the 
presence of BF3·Et2O under the optimised conditions presented in Chapter 2 resulted in 
the formation of the 1,2-addition product 340i in good yield (73%) and good 
diastereoselectivity (dr = 84:16), as well as the desired spirocycle 341i in poor yield (5%) 
but excellent diastereoselectivity (dr = >95:5) favouring the syn spirocyclisation product 
341ia as expected (Table 4.3 Entry 3). In comparison to the reaction of 5-fluoroindole 
and the α-cyclopropyl N-acyliminium ion precursor 197 where a yield of 89% and a dr = 
89:11 was obtained, the reaction gave reduced yields and comparable diastereoselectivity. 
The major difference of course between these related reactions was the formation of the 
desired spirocycle 341i, which is likely due to the stronger induction effect of the 7-
position being occupied by a fluoro substituent, closer to the nitrogen and therefore 
withdrawing more electron density from the 3-position of the indole, reducing its 
nucleophilicity. 
The reaction of α-cyclopropyl N-acyliminium ion precursor 197 and 7-nitroindole 
resulted in a comparable amount of spirocycle (12%) compared to the reaction of 
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5-nitroindole (13%), as pure separated diastereomers (dr = 62:38) (Table 4.3 Entry 4). 
The spirofuran 242 was also isolated as a clear oil in good yield (49%) as a mixture of 
diastereomers in the now expected ratio (dr = 75:25). It appeared that 7-nitroindole as a 
nucleophile was on the edge of not being nucleophilic enough to react with the 
α-cyclopropyl N-acyliminium ion 198, which resulted in the significant isolation of the 
spirocyclic furan 242. As a nucleophile 7-nitroindole, in comparison to 5-nitroindole, 
resulted in a far less selective spirocyclisation step, which could be due to the inability of 
the reactant to overcome the activation energy of the syn pathway (Figure 4.16 analogous 
to 5-nitroindole cyclisation), leading to the generation of more of the kinetic anti product. 
It is important to note that a reduction in the electron density of the indole nucleophiles 
did in fact lead to the favourability of homoconjugate addition of these indoles, and 
therefore to greater yields (albeit low) of the desired spirocycles.  
The promising result of 5-substituted indoles with the α-cyclopropyl N-acyliminium ion 
precursor 197, brought hope that an analogous spirocycle could be formed with the 
phthalimide substrate (Figure 4.17). Unfortunately, 5-nitroindole does not appear to be 
an appropriate nucleophile for the formation of spirocycle on the phthalimide substrate, 
possibly due to the lesser amount of steric hindrance on the iminium carbon because of 
the planarity of the ring, allowing for greater access of the nucleophile to the iminium 
carbon and resulting in a more kinetically favourable addition, the result of which is the 
sole production of the 1,2-addition product 342. With the new protocol for isolation of 
these 1,2-addition phthalimides, the product was isolated in an exceptional yield of 93%. 
Again, the crude mixture was extremely clean, and the only yield losses were likely in 
the crystallisation step.  
 
Scheme 4.17 Reaction of 5-nitroindole with phthalimide α-cyclopropyl N-acyliminium 
ion precursor 203 using General Method B conditions. 
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4.3.4 Reactions of 1-Substituted Indoles and α-Cyclopropyl N-Acyliminium Ion 
Precursor 197 
With a deeper understanding of the electronic effects of indole addition to α-cyclopropyl 
N-acyliminium ion 198, the α-cyclopropyl N-acyliminium ion reactivity with 1-
substituted indoles were investigated, with the hope that steric bulk closer to the reaction 
site would favour the homoconjugate products over those resulting from 1,2-addition 
(Scheme 4.14, Table 4.4). 
Scheme 4.14 Reaction of 1-substituted indoles with α-cyclopropyl N-acyliminium ion 
forming precursor 197. 
Table 4.4 Reactions of 1-substituted indoles with α-cyclopropyl N-acyliminium ion 
precursor 197.a  
  344 242 
Entry Nucleophile Yield  dr (syn:anti) Yield  dr (syn:anti) 
1 
 
69% of 344i 53:47 - - 
2 
 
48% of 344ii 68:32 - - 
3 
 
69% of 344iii 81:19 - - 
4 
 
- - 60% 75:25 
5 
 
- - 65% 76:24 
a. Reactions were carried out with indole (2 mol eq.), BF3·Et2O (2 mol eq. dropwise) at a 
concentration of 0.2 M in CH2Cl2 (General Method A). 
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The reaction of 1-methylindole with the α-cyclopropyl N-acyliminium ion precursor 197 
resulted in a good yield (69%) of the 1,2-addition product 344i as an almost equal mixture 
of diastereomers 53:47 (Table 4.4, Entry 1). Fortunately, the minor diastereomer 344iib 
of the reaction was able to be crystallised and X-ray crystallographic analysis was carried 
out, validating the stereochemical assignments that had been made using both NOE NMR 
data and the information gained from molecular modelling.  
 
Figure 4.18 The crystal structure of compound 344iib. 
The reaction of 5-fluoro-1-methylindole and the α-cyclopropyl N-acyliminium ion 
precursor 197 (Table 4.4 Entry 2) resulted in the solely the 1,2-addition compound 344ii 
in moderate yield (45%) and as an inseparable mixture of diastereomers (dr = 68:32). The 
diastereomers could not be separated (Figure 4.19a), but after multiple attempts at 
column chromatography to isolate a singular isomer, fraction enriched in the major 
diastereomer mixed with impurities was isolated from the chromatography column 
(Figure 4.19b). Unlike the previous 5-fluoro and 7-fluoro addition reactions, the 1-
methyl-5-fluoroindole addition reaction is at a disadvantage for NMR assignment due to 





Figure 4.19 Overlay of the 1H-NMR spectra of diastereomeric mixture of compounds 
344iia and 34iib spectrum a, and the major diastereomer 34iia enriched spectrum b. 
The reaction of 5-bromo-1-methylindole with substrate 197 resulted in the 1,2-addition 
product 344iii as an inseparable mixture of diastereomers (dr = 81:19) in good yield 
(69%). These diastereomers were inseparable, but assignment of the compounds was 
achievable by 2D NMR (See Chapter 7 for details).   
Once it was established that 1-substituted indoles would work as effective nucleophiles, 
albeit with poorer diastereoselectivities and difficult separations, the next 1-substituted 
indoles that were attempted were indoles bearing electron withdrawing groups. N-
acetylindole and N-carboxybenzylindole were both used as nucleophiles, but 
unfortunately these reactions resulted solely in the spirocyclic furan 242 in 60% and 65% 
yields, respectively in the expected diastereoselectivities of 75:25 and 76:24. It appears 
that putting an electron withdrawing group on the nitrogen impedes the ability of the 
indole to react competitively with the iminium ion intermediate 198.  
Now with the crystal structures in hand of compounds 307a and 344iib (representing the 
syn and anti diastereomers of 1,2-addition products), NOE data, and the previous 
molecular modelling work, it is important to see if there are major features within the 1H-
NMR spectra that differentiate the syn and anti 1,2-addition reaction products of indoles 
and α-cyclopropyl N-acyliminium ion 197. In the two figures below, the marked 
difference between the syn-addition products (Figure 4.20), and the anti-addition 










Figure 4.20 Red box showing major 1H-NMR features of the syn 1,2-addition product. 
Product spectra a, b, and c belong to compounds 296a, 323ia and 344ia respectively. 
 
Figure 4.21 Red box showing major 1H-NMR features of the anti 1,2-addition product. 
Product spectra a, b, and c belong to compounds 344ib, 323ib and 296b respectively. 
The syn-1,2-addition product results in the H4 proton resonances at approximately 1.3 
ppm upfield than that in the anti 1,2-addition product, showing much greater proton 
shielding. Likewise, the splitting of the cyclopropyl methylene protons is much more 
pronounced in the syn-addition products, uniformly giving proton resonances spread over 
δH 0.8 – -0.4, compared to the bunching of proton signals between δH 0.25 to δH 0.45 of 
the anti-addition product. The placement of the H4 proton is particularly useful and was 






















4.3.5 Reactions of 3-Substituted Indoles and α-Cyclopropyl N-Acyliminium Ion 
Precursor 197. 
Scheme 4.15 The reactions of 3-substituted indoles with α-cyclopropyl N-acyliminium 
ion precursor 197. 
Continuing the trend of making changes closer to the reaction centre of substituted indoles 
with α-cyclopropyl N-acyliminium ion 197, 3-substituted indoles were tested with 
surprising results (Table 4.5).  
First, the reaction of the simplest of the 3-substituted indoles, 3-methylindole, with the α-
cyclopropyl N-acyliminium ion precursor 198 was examined. This reaction was of 
particular interest as the reaction could result in either position 1 or 2 of the indole acting 
as the nucleophilic carbon, or perhaps position 3 would react and result in the 












Table 4.5 Reactions of 3-substituted indoles with α-cyclopropyl N-acyliminium ion 
precursor 197.a 
  346 347 348 
Entry Nucleophile Yield  
dr 
(syn:anti) Yield  
dr 


























a. Isolated yields. 
b. Ratio of major diastereomer to other minor diastereomers in the mixture. 
c. Reactions were carried out with Indole (2 mol eq.), BF3·Et2O (2 mol eq. added dropwise) at a 
concentration of 0.2 M in CH2Cl2 (General Method A). 
d. Reactions were carried out with Indole (2 mol eq.), BF3·Et2O (2 mol eq. added via syringe pump 
over 1 h in 0.3 M solution CH2Cl2) at a concentration of 0.2 M in CH2Cl2 (General Method B). 
e. Approximate yield, as it was isolated in a mixture. 
The reaction of 3-methylindole with α-cyclopropyl N-acyliminium ion 198 resulted in 
two interesting products. The first of these was the spirocycle 346ia which was isolated 
by column chromatography in a yield of 27% and as a pure diastereomer (dr >95:5). This 
product could arise through the following mechanism outlined in Scheme 4.16. The 
homoconjugate attack of 3-methylindole through its 2-position on the α-cyclopropyl N-
acyliminium ion 198 ring opens the cyclopropyl group through the standard 
homoconjugate addition pathway. This could be followed by elimination of a proton from 
compound 349 to restore aromaticity, then protonation of compound 350 to reform an 
iminium ion 351. Finally, cyclisation of the compound through the indole nitrogen 
attacking the iminium ion gives spirocycle 352 which upon elimination of a proton gives 




Scheme 4.16 Proposed reaction mechanism for the spirocyclisation of 198 with 
3-methylindole. 
The assignment of NMR resonances for spirocycle 346ia was carried out as follows. 
Benzyl methylene resonances in the 1H-NMR spectrum form the regular pattern for the 
NCH2Ph peaks (δH 4.89, d, J = 15.6 Hz and δH 3.50, d, J = 15.6 Hz) and OCH2Ph (δH 4.27, 
d, J = 11.6 Hz and δH 4.23, d, J = 11.6 Hz) resonances, with very similar coupling 
constants to the other compounds reported throughout this thesis (Figure 4.22). The 
resonance for H3' (δH 4.70, appr. t, J = 8.2 Hz) occurs as an apparent triplet in the expected 
region. The gCOSY spectra shows correlation between H3ʹ and H4ʹ (δH 2.90 – 2.85, m 
and δH 2.70, dd, 16.8 Hz, 8.3 Hz) allowing the assignment of H4ʹ. The contiguous protons 
from H7 to H9 were identified as pairs from gCOSY and gHSQC spectra, with the H8 
protons (δH 2.06 – 1.96, m and δH 1.73 dd, J = 9.3, 4.0 Hz) assigned to the methylenes in 
the middle of the chain from this data. H7 (δH 2.41, d, 13.6 Hz and 1.66 td, 13.6, 3.0 Hz), 
and H9 (δH 2.97 – 2.91, m and δH 2.53 – 2.47, m) were tentatively assigned at this point, 
due to the electron withdrawing effect of the indole group deshielding H9 resulting in its 
more downfield position relative to that of H7. These resonances were water 




Figure 4.22 1H-NMR spectrum (500 MHz, CDCl3) of compound 346ia. 
The stereochemistry at C2ʹ was determined to be S from the fact there was no crosspeaks 
between H3ʹ and H7, H8 or H9 in the ROESY NMR spectrum. This is indicative of anti-
addition of the indole nitrogen to the iminium ion of the final spirocyclisation step, in 
contrast to previous spirocyclisations which proceeded through a final syn addition. This 
could be due the nucleophile being N rather than a C, and therefore the nature of the bond 
forming may not be supported by the adjacent OBn group donating electron density to 
the forming bond in the same manner (Ceiplak effect), therefore no longer favouring syn 
addition. Instead, the reaction may be proceeding through the anti-addition pathway to 
minimize the electronic repulsion between nitrogen and the OBn group. Alternatively, 
this stereocentre may be under thermodynamic control thus favouring the observed 
isomer in which the electronegative N5 is anti to the electronegative O of the OBn group. 
Other useful information was obtained from the ROESY NMR spectrum where a strong 
crosspeak between the aromatic CH3 (δH 2.25) and H1 was observed, allowing assignment 
of positions 1 to 4 using the gCOSY and gHSQC spectra.  
Assignment of the APT-NMR spectrum began first with the gHSQC spectrum being used 
to assign already identified proton resonances to their attached carbons (Figure 4.23). 
Carbonyl C2 (δC 171.2) was the only viable peak in the region for an amide carbonyl. 
Assignment of C6 (δC 82.2) was consistent with results expected from the final step of 
spirocyclisation proceeding through the N of indole, giving a more downfield peak at C6 
then had been seen for previous indole spirocycles. In comparison, these other spirocycles 
had resonances of δC 68.0 for 5-nitroindole spirocycle 326a, δC 65.7 for 7-fluoroindole 
spirocycle 341iia, δC 67.7 for the major diastereomer of 7-nitroindole spirocycle 341iiia 
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Figure 4.23 APT-NMR spectrum (125 MHz, CDCl3) of compound 346ia. 
The gHMBC spectrum was used as confirmation that the assignment of C6 was correct, 
as there were correlations of C6 with NCH2Ph, H3ʹ and H7 (Figure 4.24).  This method 
also allowed H7 and H9 to be definitively differentiated, as H9 did not share a gHMBC 
spectrum correlation with the spirocycle carbon C6. The quaternary carbons of indole 
were next assigned, with C10a (δC 130.6) sharing a gHMBC correlation with the aromatic 
CH3 protons, and with H1. A gHMBC correlation between C10 (δC 107.2) and the protons 
of H9 and the aromatic CH3 allowed for its assignment. A gHMBC correlation between 
C9a (δC 134.9) and the protons of H9 and the aromatic CH3 allowed for its assignment, 
in the more deshielded 2-position of the indole compared to C10. Finally, C4a (δC 134.1) 
was assigned from its gHMBC crosspeak with H4.  
 
Figure 4.24 Compound 348ai shown with assignment numbering left, and strong 
gHMBC correlations shown as purple arrows and strong NOE signals shown as red 
arrows right. 
The other novel product formed from this reaction fascinatingly resulted in the 
dearomatisation of the five-member ring of the indole moiety, as well as the induction of 
four new stereogenic centres from just one stereocentre, which lost its own chirality. This 




















compound using NMR spectroscopy, as the mass of the compound is identical to that of 
the standard 1,2 addition product or spirocycle. The 1H-NMR spectrum had no signals 
between δH 1 – -0.5, indicating the ring opening of the cyclopropyl group (Figure 4.25). 
The significant upfield shifts of the aromatic protons was indicative of a substituted 
aniline type structure and therefore dearomatisation, with one proton signal appearing 
below δH 6.5, and additionally, the CH3 peak now appeared around δH 1.35, in contrast to 
an aromatic CH3 peak which are expected above δH 1.5. A new singlet had appeared at 
δH 5.25 assigned as H3ʹ in the 
1H-NMR spectrum, giving good indication that an alkene 
had formed, of which one side was quaternary. The two pairs of diastereotopic benzyl 
methylene resonances were also evident.  
 
Figure 4.25 1H-NMR spectrum (500 MHz, CDCl3) of compound 348ia. 
The gCOSY spectrum allowed the assignment of H1 (δH 1.86 dd, 12.2, 6.5 Hz, and δH 
1.52 dt, 12.4, 6.1 Hz), H2 (1.80 – 1.72, m and δH 1.68, dt, J = 12.5, 6.3 Hz) and H3 (2.19 
– 2.13, m). However, the assignments of H3a (δH 3.87, d, J = 4.7 Hz) and H5ʹ (4.19, d, J 
= 6.5 Hz) were determined with the NOESY spectrum since H3 correlated to both of these 
resonances in the gCOSY spectrum. In the NOESY spectrum there were crosspeaks 
between CH3, H3a and H3, indicating that they were all on the same face on the tricyclic 
ring substructure. H5' did not share a NOESY correlation with the CH3 group as it was 
too far away. The NOESY spectrum was also used to assign H8 (δH 6.96, d, J = 7.5 Hz) 
as it shared a crosspeak with the CH3 and was a doublet indicating only ortho coupling, 
ArCH 
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then gCOSY and gHSQC experiments were then used to assign proton and carbon 
resonances at C7, C6, and C5 in that order. 
From the APT spectrum, it was possible to assign C8b (δC 53.5) as it is the only 
unassigned negative peak in the region, and there is no gHSQC spectrum crosspeak 
indicating that the carbon is quaternary (Figure 4.26). Likewise, C4a (δC 150.8) and C8a 
(δC 137.2) were negative in the APT spectrum and had no gHSQC spectrum correlations 
and were assigned initially on the basis that C4a was more downfield due to the secondary 
amine deshielding the carbon.  
 
 
Figure 4.26 APT-NMR spectrum (125 MHz, CDCl3) of compound 348ia. 
The APT showed two resonances in the range of  δC 170 – 180, one of which was 
presumably associated with the carbonyl peak and the other C4ʹ. The furthest downfield 
resonance had a gHMBC correlation to OCH2Ph was therefore assigned as C4’ (δC 175.9), 
with the shift attributed to the fact that without the OBn group, the carbon would be the 
β-carbon of an α,β-unsaturated carbonyl group which should have a 13C-NMR chemical 
shift around δC 160, which when paired with the electron withdrawing OBn group, as is 
the case here, further deshields the position to δC 175.9. This then lead to the assignment 
of the amide carbonyl C2ʹ which shared a gHMBC correlation with the methylene proton 
signals of the NCH2Ph.  C4a (δC 150.8) and C8a (δC 137.2) had strong gHMBC 























Figure 4.28. Compound 348iia shown with assignment numbering left, and strong 
gHMBC correlations (purple arrows) and strong NOE signals (red arrows right). 
The mechanism for the formation of compound 348i is proposed as follows (Scheme 
4.17). First the α-cyclopropyl N-acyliminium ion is formed 198, followed by nucleophilic 
attack of the 3-substituted indole, giving the iminium ion 353. This can then undergo 
cyclisation to form a favourable 5-membered ring, but destroying the aromaticity of the 
pyrrole ring.   
Scheme 4.17 Proposed mechanism for the formation of tetracycles of type 348. 
Since there are four stereocentres formed in this reaction, there are possible 16 
stereoisomers (8 diastereomers and their enantiomers) that could be formed from this 
reaction, indicating that the significant favouring of one of these diastereomers over the 
others which has been observed is remarkable. It is however important to note a few 
things about that selectivity, foremost of which is that during the cyclisation step from 
compound 353 to 354 (Scheme 4.17)¸ it is unlikely that H3a and the CH3 group would 
be trans to each other. Therefore, we suggest the reaction proceeds through the cyclisation 
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of the intermediate 353b to give rise to the observed stereochemistry at C3, C3a and C8 
(Scheme 4.18).  
Scheme 4.18 Stereochemical outcome of the cyclisation product 355. 
Next, the reaction of 3-isopropylindole and α-cyclopropyl N-acyliminium ion 197 under 
the optimised conditions was carried out. The reaction product mixture was very complex, 
and the only relatively pure fraction isolated by column chromatography is shown in 
Figure 4.29. The major compound in the mixture is likely 348ii, the analogous compound 
to that obtained in the reaction with 3-methylindole 348iia. Characteristic resonances in 
the 1H-NMR spectrum include the upfield aromatic peaks of H5-H8 which show the 
doublet, triplet, triplet and doublet pattern, the alkene singlet of H3’, and the two 
isopropyl methyl resonances. 
 
Figure 4.29 1H-NMR spectrum (500 MHZ, CDCl3) mixture where the major product is 
presumably compound 348ii. 
Due to the difficulty of obtaining a pure sample, we next examined the reaction of 













diastereoselectivity of the reaction with the large steric bulk of the cyclohexyl moiety 
(Table 4.5, Entry 3). The increase of the steric bulk by the cyclohexyl group next to the 
indole 2-position appears to lead to a lower diastereoselectivity (dr = 73:27) than that 
observed with 3-methylindole (<95:5) for the spirocyclisation product 346iii. This is 
perhaps due to the main directing effect of compounds observed so far is the Ceiplak 
effect favouring syn addition whereas the bulk of 3-cyclohexylindole has more steric 
interaction with the OBn group than 3-methylindole and therefore the reaction favours 
more anti addition product. 
After multiple purifications by column chromatography, it was possible to isolate both 
diastereomers of the spirocycle 346iii. ROESY spectra help to confirm the assignment 
made of 346iiia from the reaction of 3-cyclopropylindole and α-cyclopropyl 
N-acyliminium ion precursor 197 which was assigned as the syn addition product. 
Labelled below in Figure 4.31 and Figure 4.32 are the two ROESY spectra for 
comparison, where it is clear that the compound assigned as the anti-addition spirocycle 
346iiib has a ROESY spectrum correlation between H3ʹ of the pyrrolidinone and H4 of 




Figure 4.30 ROESY-NMR spectrum (500 MHz, CDCl3) of compound 346iiib. NOE 
correlation indicated by red arrows. 
In contrast, the ROESY spectrum of the syn addition product, spirocycle 346iiia showed 
a weak correlation between H3ʹ and H7 of the alkyl chain, indicating that the groups are 












Figure 4.31 ROESY-NMR spectrum (500 MHz, CDCl3) of compound 347iiia. NOE 
correlation indicated by red arrows. 
A unique product was discovered where the N of the indole had acted as a nucleophile in 
the homoconjugate addition to the α-cyclopropyl N-acyliminium ion 198, and this was 
isolated in 5.3% yield as a single diastereomer 347iii (Table 4.5, Entry 3). There was 
literature precedent for the nucleophilic addition of the 3-substituted indole to the 
N-acyliminium ion 358 via the N of the indole under Lewis acid conditions, resulting in 












Scheme 4.19 Addition of a 3-substituted indole 356 to an acyliminium ion 358 through 
the 1- and 2-position. 
The proposed mechanism for the formation of compound 347iii is shown below (Scheme 
4.20). Homoconjugate addition of the N of the 3-cyclohexylindole to the α-cyclopropyl 
N-acyliminium ion 197 results in enamine 361. Next, either a proton eliminates from the 
nitrogen cation and the enamine is protonated to form the iminium ion 362, or a one-step 
intramolecular proton transfer occurs where the enamine double bond takes the proton 
from the N of the indole moiety. Either way, once the N-acyliminium ion 362 is reformed 
the spirocyclisation can occur where the 2-position of the indole attacks the N-
acyliminium ion in a stereoselective manner to form spirocycle 363. Finally, elimination 
of a proton restores aromaticity to the indole and provides product 347iii. 
 




The next reaction carried out was the reaction of the phthalimide α-cyclopropyl 
N-acyliminium ion precursor 203 and 3-methylindole under standard conditions. The 
product was purified by column chromatography rather than crystallisation since the 
crude product failed to form crystals. The structure of the product 364 was readily 
assigned from its NMR spectra in a similar manner to previous 1,2-addition product 308. 
The lower yield (52%) obtained with this reaction in comparison to that with indole was 
likely due to the different method of purification as explored earlier in this Chapter, as 
the product does not stay solubilised on the column, and therefore makes for a difficult 
purification.  
 
Scheme 4.21 The 1,2-addition reaction of substrate 203 and 3-methylindole. 
4.3.6 Reactions of 2-Substituted Indoles and α-Cyclopropyl N-Acyliminium Ion 
Precursor 197. 
Next the reactivity of α-cyclopropyl N-acyliminium ion 197 in the presence of 
2-substituted indoles was investigated (Scheme 4.22, Table 4.6). 
Scheme 4.22 Reaction products of 2-substituted indoles and α-cyclopropyl 





Table 4.6 Reactions of 2-substituted indoles with α-cyclopropyl N-acyliminium ion 
precursor 197.a  
  366 367 242 
Entry Nucleophile Yield 
dr 



















- - - - - - 
a. Reactions were carried out with indole (2 mol eq.), BF3·Et2O (2 mol eq. added via syringe pump 
over 1 h in 0.3 M solution CH2Cl2) at a concentration of 0.2 M in CH2Cl2 (General Method B). 
b. Complex mixture formed, no pure compounds were isolated. 
The first reaction attempted was with 2-methylindole which did not result in any 
homoconjugate addition product being formed in contrast to 3-methylindole, instead 
leading to the 1,2-addition product 366i being formed in good yield (75%) and good 
diastereoselectivity (dr = 86:14) favouring the syn addition product 366ia. The syn 
stereochemistry of the major diastereomer was assigned analogously to the previous 1,2-
addition products of the reaction of α-cyclopropyl N-acyliminium ion 197 and indoles.  
It appears that blocking the 2-position of the indole has a less marked effect upon the 
reaction pathway of nucleophilic addition to the α-cyclopropyl N-acyliminium ion 198 
than blocking the 3-position. An attempt was made to favour homoconjugate addition by 
incorporating what was learnt with the 5- and 7-substituted indoles. Thus the less electron 
richindole, 2-methyl-5-nitroindole was examined as the next nucleophile in this series, 
and the hypothesis established earlier held true with only homoconjugate addition 
products being isolated, leading to the bis-addition product 367ii and spirocyclic furan 
242. Although this led to bis-addition product rather than a spirocycle, this was expected, 
as blocking the 2-position of the indole effectively stopped the indole from a second 
nucleophilic attack on the reformed iminium ion. Instead, a second molecule of 2-methyl-
5-nitroindole was able to act as a nucleophile and attack the N-acyliminium ion through 
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a 1,2-addition reaction. Fortunately, both diastereomers of this bis-adduct were able to be 
isolated, and their NMR characterisation was carried out as follows below. Some form of 
bis-addition product was confirmed by low and high resolution mass spectrometry, which 
was calculated for the sodiated ion peak of [C39H38N5O6Na]
+ as m/z 672.2822, and the 
peak found by high resolution mass spectrometry was m/z 672.2844.  
The lack of cyclopropyl proton resonances in the 1H-NMR spectrum was convincing 
evidence that homoconjugate addition had taken place, and the appearance of two 
aromatic NH resonances, where no gHSQC correlation was observed, and two methyl 
groups resonances, which indicated that bis-addition was likely as they represented two 
separate 2-methyl-5-nitroindole moieties (Figure 4.32). Specific assignments of 
resonances began with the 2 diastereotopic benzyl methylene pairs NCH2Ph (δH 4.91 d, J 
= 15.1 Hz and 3.81 d, J = 15.1 Hz) and OCH2Ph (4.25 1H, d, J = 11.4 Hz) which, as 
described earlier, had their characteristic coupling and splitting patterns.  
 
 
Figure 4.32 The 1H-NMR spectrum (500 MHZ, CDCl3) of compound 367iia. 
The gCOSY spectrum in conjunction with gHSQC spectrum were used to determine the 
contiguous spin systems in the molecule. The major diastereomer was assigned as 
compound 367iia where the 1,2-addition reaction proceeds syn to the OBn face. The 
ROESY spectrum allowed the assignment of H4' as it fortunately shared a correlation 




















stereochemistry at C5 (Figure 4.34). Without this correlation, the assignment would have 
been ambiguous as one of the OCH2Ph signals overlaps with the signal of H4 in the 
1H-
NMR spectrum (Figure 4.32). The 2-methyl-5-nitroindole moieties were difficult to 
distinguish from one another by any means other than ROESY due to their similar signals 
in the 1H-NMR spectra. The ROESY spectrum was used to determine which indole NH 
and methyl group belonged to the same indole ring, as the two 2-methyl-5-nitroindole 
moieties shared distinct resonances here. The minor anti-isomer of bis-adduct 367iib was 
assigned analogously. 
 
Figure 4.33 ROESY NMR spectrum (CDCl3) excerpt of compound 367iia. NOE 
correlation indicated by red arrows. 
The third reaction undertaken between a 2-substitued indole and α-cyclopropyl N-
acyliminium ion precursor 197 used tetrahydrocarbazole (Table 4.6 Entry 3). This 
reaction resulted in a complex mixture of side products, where no species could be 
isolated pure enough to characterise. 
4.3.7 Reactions of 2-Substituted Indoles and Phthalimide α-Cyclopropyl 
N-Acyliminium Ion Precursor 203 
The reaction of phthalimide α-cyclopropyl N-acyliminium ion precursor 203 and 2-
methylindole lead to the 1,2-addition product 368 in the same yield (52%) as that of the 












to be crystallised for purification purposes and had to be purified by column 
chromatography where significant losses occurred, resulting in the moderate yield. 
 
Scheme 4.23 Reaction of 2-methylindoles and phthalimide α-cyclopropyl N-
acyliminium ion precursor 203 
The reaction of phthalimide α-cyclopropyl N-acyliminium ion precursor 203 and 
tetrahydrocarbazole led to the homoconjugate addition pathway yielding compound 369 
as a yellow solid (18%) and as a mixture of diastereomers (E/Z = 86:14 from 1H-NMR 
analysis of the crude reaction product) (Scheme 4.24).  
  
Scheme 4.24 Reaction of tetrahydrocarbazole and phthalimide α-cyclopropyl 
N-acyliminium ion precursor 203 
The E/Z isomer ratio was determined by ROESY NMR, where a weak correlation 






Figure 4.34 The ROESY spectrum (500 MHz, CDCl3) of 369a. NOE correlation 
indicated by red arrows. 
These products could not be crystallised for purification purposes, and again this is likely 
the reason for the poor yield. It was gratifying to have isolated this compound, as it 
represents the only homoconjugate addition product of the phthalimide α-cyclopropyl N-
acyliminium ion 204 made in this Thesis, and the first homoconjugate addition to the 
phthalimide α-cyclopropyl N-acyliminium ion 204 since its synthesis was implied in 
Breuer and Zbaida’s 1975 paper.5  
4.4 Future Directions 
After the analysis of the reactions undertaken in this Chapter and those preceding it, the 
author has determined that the major problem for these reactions is the presence of the 
hydroxy leaving group. An α-cyclopropyl N-acyliminium ion precursor that did not have 
this hydroxy leaving group would offer a variety of advantages that would favour 
desirable reaction outcomes. An example of a α-cyclopropyl N-acyliminium ion precursor 
with no hydroxy leaving group would be enamine 370, potentially accessible from a 
Wittig or samarium iodide reaction between a cyclopropyl halide and benzylated 
pyrrolodinone. The foremost advantage that this α-cyclopropyl N-acyliminium ion 
precursor would offer is that that BF3OH
- species would not form in the first place, which 
would block that pathway that the spirocyclic furan 242 is formed by. The second 
advantage is that rather than using 2 mol eq. of BF3·Et2O in the reaction, which was 
necessary to form BF3OBF3








of a Brønsted acid should be a viable source of protons in solution for the formation of 
the α-cyclopropyl N-acyliminium ion 198.  
 
Scheme 4.25 Formation of α-cyclopropyl N-acyliminium ion 198 from 
cyclopropylenamide 370. 
This method alone would work well with slow reacting nucleophiles, since it is not their 
instability that is stopping the reaction from occurring, but the inability of the nucleophile 
to outcompete attack by the BF3O
- anion. Thus, this method provides a potentially more 
productive alternative to the chemistry established with α-cyclopropyl N-acyliminium ion 
precursor 197. 
 Reactive species that react with themselves too quickly (activated indoles) or reactive 
species which bind strongly with BF3 (thiophene for instance) could be instead added to 
a cation pool as described in Chapter 1, Section 1.4, and subjected to microreactor flow 
cell conditions so the nucleophile is introduced to the α-cyclopropyl N-acyliminium ion 
at low concentration.  
Without modifying the currently developed methodology, the 3-substituted indoles 
provide the most scope for favourable homoconjugate additions, yielding only 
homoconjugate addition pathway reaction products from the experiments that were 
carried out (Table 4.5). This makes them a particularly interesting nucleophile subset to 
develop further, with one potential possibility being the 3-position of indole having a 
substituent that can act as a leaving group (for example TMS). The reason why this would 
be interesting, is that although the mechanism shown below in pathway A the 3-TMS 
substituent could eliminate to reform the indole aromaticity, which should be 
energetically favourable over the loss of aromaticity and alkene formation by pathway B 
(Scheme 4.26). This could potentially be used as a generic way to provide 4,5,6 and 




Scheme 4.26 Possible Homoconjugate addition reaction pathways of a 3-TMS 
substituted indole with an effective leaving group. 
4.5 Conclusions 
In summary, the reactions of substituted indoles with α-cyclopropyl N-acyliminium ion 
precursors have been explored, and the chemistry of α-cyclopropyl N-acyliminium ions 
greatly expanded. It has been established that for α-cyclopropyl N-acyliminium ion 198 
reactions with indole, the syn-addition products of both 1,2-addition and cyclisations are 
favoured, through experimental findings and molecular modelling studies.  
A working theory of nucleophile addition to α-cyclopropyl N-acyliminium ions was also 
been established in this Chapter, where nucleophiles that are too reactive will proceed 
through a 1,2-addition reaction and, nucleophiles that are not reactive enough will result 
in formation of the spirocyclic furan 242, and homoconjugate addition will occur in the 
reactivity space between those two points.  
A variety of novel core structures have been synthesised in this Chapter, showing the 
versatility of α-cyclopropyl N-acyliminium ion towards the formation of new compounds, 







5 General Biological Screen 
5.1 The Open Innovation Drug Discovery Program 
This chapter is a brief analysis of the results obtained from the Eli Lilly Open Innovation 
Drug Discovery (OIDD) program where a general biological screen was undertaken on a 
subset of the novel compounds synthesised in this Thesis. The OIDD makes use of 
proprietary in vitro biological assays which assesses the impact that a compound has on 
a multicellular system, rather than using a mechanistic approach in order to find lead 
compounds.86 Compounds that are accepted to run in these assays must be novel and have 
reasonable drug-like characteristics as determined by Eli Lilly. As of 2014, approximately 
170000 virtual structures were submitted but only 70,000 had been accepted.86 
Fortunately, the subset of compound structures submitted to the OIDD were generally 
accepted, with the exception of the tetracycles of type 348 (Chapter 4, Scheme 4.15) 
which were rejected as they contained a potential Michael acceptor within the 
pyrrolidinone ring.  
Two of the screens that were carried out that gave promising results, were for PCSK9 
inhibition (Section 5.2) which is of interest for the treatment of heart disease, and malarial 
parasite treatment (Section 5.3). It is worth mentioning that a series of compounds were 
tested in a single point assay for activity inhibiting or regulating Tau protein translation 
(an Alzheimer’s disease treatment target) gave close to 100% inhibition of Eli Lilly’s 
target at 40 µM, but unfortunately showed no specificity. 
5.2 Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibition Towards 
Lower LDL Cholesterol Levels.  
5.2.1 The Need for PCSK9 Inhibition 
Although it is possible that up to 90% of cardiovascular disease is preventable,110 it is 
currently the leading cause of death in the world being responsible for 13.3% of all deaths 
in 2010,111 and projections have identified Ischaemic Heart Disease as continuing to be 
the leading cause of death worldwide in 2030.112 Reviews and clinical trials identified 
that the level of low density lipoprotein (LDL) cholesterol in plasma has a significant 
impact on the incidence of cardiovascular adverse events, making it the main therapeutic 
target for reducing the number of deaths to coronary artery disease, and leading to the 
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development of the drug class statins, which are HMG-CoA (3-hydroxy-3-methyl-
glutaryl-coenzyme A) reductase inhibitors (Figure 5.1).113,114  
 
Figure 5.1 Drug and first discovered member of the statin class Lovastatin 375, isolated 
by Endo et al.115 
Proprotein convertase subtilisin/kexin type 9 (PCSK9) was identified as a significant 
contributor to cholesterol homeostasis in 2003116, and soon became a significant target 
for drug discovery as it promotes intracellular degradation of LDL cholesterol 
receptors.117 This interest lead to the development of two monoclonal antibodies 
Evolocumab (Amgen) and Alirocumab (Aventis/Regeneron), which are FDA approved.  
Eli Lilly through their Open Innovation Drug Discovery program (OIDD) seek small 
molecule inhibitors of PCSK9, which is carried out using a PCSK9 SI phenotypic module 
designed to identify compound that inhibit synthesis of PCSK9 in human hepatoma cell 
lines (HepG2). In particular compounds that inhibit PCSK9 transcription without 
suppressing Apo-A1 and LDLR transcription were of interest to Eli Lilly. 
5.2.2 Results and Preliminary Structure Activity Relationship 
After the assays were run, four indole derived compounds (Table 5.1) were of particular 
interest as PCSK9 inhibitors in an SAR study. Specificity is shown as a ratio of PCSK9 
AlphaLisa Huh7 cell inhibition at 10 µMol over PCSK9 Huh7 viability cells at a 
concentration of 5 µM. This is for ease of comparison rather than as a quantitative value, 
as when PCSK9 Huh7 viability approaches 0% the specificity ratio will become 





















Cell Viability  
1 
 
72.27 17.71 4.1 
2 
 
15.08 1.179 12.8 
3 
 
6.516 -0.7158 -a 
4 
 
5.668 -6.993 -a 
a. No cell viability issue detected at 5 µMol of compound.  
The highest performing compound in this test was compound 344iia (Table 5.1 Entry 
1), which had 72% inhibition of the PCSK9 AlphaLisa Huh7 cell at a concentration of 
10 µM, and a 5% inhibition of the PCSK9 Huh7 Viability cells at a concentration of 
5 µM. Removal of the N-methyl group in 323iia results in a large decrease in activity, 
from 72% inhibition of the PCSK9 AlphaLisa Huh7 cell at a concentration of 10 µM to 
just 15%, showing that the indole N-methyl group has a significant impact upon the 
molecules activity towards PCSK9 resulting in an approximately 5 fold drop when it is 
not present (Table 5.1, Entry 2). Specificity however is increased by the loss of the 
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methyl group, with the ratio of specificity for Entry 1 = 4.1 in comparison to 
Entry 2 = 12.8 where a higher number is better specificity.  
Removal of the fluoro group from the indole moiety shows more of a reduction in activity 
than removal of the N-methyl group, but importantly shows that the PCSK9 Huh7 
Viability assay can result in negative numbers, which shows a level of inaccuracy in this 
test as the % inhibition approaches 0. This further shows the qualitative nature of the 
relative specificity value. Finally, Entry 4 shows that substitution from fluoro to chloro 
at the 5-position of the indole moiety results in a reduction in activity, indicating that 
either less electron density in the indole moiety is favourable for PCSK9 inhibition with 
these compounds, or that the increased steric bulk at the 5-position reduces PCSK9 
inhibition. 
The concentration response curve of compound 344ii and its inhibition of PCSK9 appears 
to be valid, showing a gradual increase in points and leading to a IC50 = 13.1 µM which 
is approximate to the values found in the single point assay, although with worse activity. 
The cell viability response curve should be rerun with more points of data around the 
IC50, as the IC50 value here of 16.5 µM is very different to the 17.7% inhibition at 5 µM 
observed in the single point assay (Table 5.1, Entry 2). 
 
Figure 5.2 The concentration response curves of PCSK9 inhibition (Left) and cell 
viability (Right) for 344iia. 
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From these results, it is possible to extrapolate the findings to hopefully favour better 
PCKS9 inhibition and greater specificity. There are many different analogues that could 
be made of these compounds that are easily accessed by the chemistry established in this 
Thesis, but the compounds tested provide a good starting point for a way forward.  
5.3 Primary Assay for Activity Against Malaria Causing Parasites  
5.3.1 The Need for Novel Anti-Malarial Therapeutics 
Malaria is a serious illness resulting in a 445000 deaths in 2016, and a reported 216 
million cases worldwide.118 To combat this disease, Eli Lilly and Medicines for Malaria 
Venture partnered together to find compounds capable of treating the disease through the 
OIDD program.  
5.3.2 The Targets for Malaria Treatment 
The screening modules that were developed measure the inhibition of the asexual blood 
stages of Plasmodium falciparum, the liver stage of the parasitic strain of Plasamodium 
berghei, and HepG2 as a non-specific cytotoxicity screen. HepG2 is a well understood 
immortal liver cell line that has been shown to be an effective model of the metabolism 
of xenobiotics (synthetic compounds foreign to the body), and so is effective as a model 
to assess the cytotoxicity of the compounds screened.119 
5.3.3 Results of the Primary Assay. 
The promising results of this screen are shown below (Table 3.2), where all these 
compounds show close to or greater than 100% inhibition of the asexual blood stages of 
Plasmodium falciparum at 2 µM. Entries 1-4 show moderate inhibition of liver stage P. 











Table 5.2. Primary assay results from OIDD related to Malarial parasite 








at 10 µM 
HepG2 cytotoxicity 
Viability 











































Many of these hits appear to have good biological activity and selectivity, but it is not 
possible to undertake an SAR study due to the structural dissimilarity between the 
compounds. Concentration response curves are necessary to properly assess the potency 
of these compounds, particularly since the inhibition approaches or is over 100% for 




5.4 Conclusions and Future Directions 
Through the OIDD the biological activity of a range of structural archetypes that were 
synthesised throughout this Thesis were probed with proprietary assays. The PCSK9 
inhibition assay and Malarial Parasite inhibition assay showed that compounds 
synthesised by nucleophilic additions to α-cyclopropyl N-acyliminium ion 197 can 
provide good activity and selectivity towards drug targets. 
Some structure activity relationships were able to be established from the results of the 
PCSK9 inhibition screen, which could lead to the development of more potent and 
selective PCSK9 inhibitors generated from the chemistry of α-cyclopropyl N-











The chemistry of α-cyclopropyl N-acyliminium ions has been successfully initiated, 
developed and leveraged towards the synthesis of novel scaffolds including spirocycles 
and multicyclic heterocycles.  
In Chapter 2 the synthesis of three novel α-cyclopropyl N-acyliminium ion precursors 
was reported, N-benzyl 4-benzyloxy-5-cyclopropyl-5-hydroxypyrrolidin-2-one 197 was 
synthesised in 63% yield and with a diastereoselectivity of 9:1 favouring the diastereomer 
formed from addition of the cyclopropyl group to the OBn face of the pyrrolidinone, as 
the Grignard reagent coordinated to the C4 OBn substituent. Likewise, the N-methyl 4-
benzyloxy-5-cyclopropyl-5-hydroxypyrrolidin-2-one 199 was isolated in a similar yield 
(67%) but lower diastereoselectivity of 71:29, still favouring the syn addition 
diastereomer. Synthesis of the parent N-benzyl 5-cyclopropyl-5-hydroxypyrrolidin-2-one 
201 was unsuccessful due to purification issues, and the unexpected formation of the ring 
opened product 323. Instead N-methylphthalimide was used as a non-chiral platform to 
synthesise the α-cyclopropyl N-acyliminium ion precursor 203 in 89% yield.   
The optimisation of addition reactions of veratrole to the α-cyclopropyl N-acyliminium 
ion precursor 197 was also discussed in Chapter 2, where the synthesis of spirocycle 218 
in 54% yield as a mixture of diastereomers (dr = 90:10) supported the hypothesised 
sequential homoconjugate and 1,2-addition pathway towards spirocycles. The spirofuran 
242 was the major product when conditions were not optimised to favour 218 synthesis, 
resulting from the homoconjugate addition of the eliminated hydroxy group coordinated 
to a Lewis acid. 
In Chapter 3, the scope and limitations of the nucleophilic additions to α-cyclopropyl 
N-acyliminium ions was explored with methoxybenzenes, furan and substituted furans, 
allyltrimethylsilanes and several aromatic heterocycles. These reactions were undertaken 
under the conditions optimised in Chapter 2, and favoured syn addition products. It was 
discovered that electron rich nucleophiles lead to increased yields of addition products 
but often favoured 1,2-addition over homoconjugate addition. Too little electron density 
in the potential nucleophile, however, led to the sole formation of the undesired 
spirocyclic furan 242.  
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In Chapter 4, the reactions of α-cyclopropyl N-acyliminium ion forming precursors 197, 
199 and 203 with substituted indoles was explored. It was clear after Chapter 4 that the 
balance between 1,2-addition and homoconjugate addition reactions of the α-cyclopropyl 
N-acyliminium ions being a factor of the electron density of the nucleophile that was 
hypothesised in Chapter 3 holds true. In addition to this, Chapter 4 showed that as steric 
bulk is increased at the transition state for 1,2-addition, the homoconjugate addition 
products became more favourable. Additionally, this Chapter showcased the validity of 
the α-cyclopropyl N-acyliminium ion as an effective synthetic intermediate towards the 
rapid generation of complex molecules, creating a range of novel spirocyclic and 
multicyclic heterocycles.  
The crystal structures of syn 1,2-addition product 207a and anti 1,2-addition product 
344iib were presented in Chapter 4, confirming the assignment of stereochemistry for 
these diastereomers, and providing strong evidence for the assignment of stereochemistry 
made to the other 1,2-addition compounds based on extensive 1D and 2D NMR 
spectroscopic methods. 
Finally, Chapter 5 presented the biological activity of a subset of the compounds 
synthesised throughout the thesis. The assays carried out through Eli Lilly’s Open 
Innovation Drug Discovery program revealed that many of the small molecules generated 
in this study showed good activity as PCSK9 inhibitors and anti-malarial therapeutics.  
In summary this Thesis has detailed how to generate and utilise α-cyclopropyl 
N-acyliminium ions towards the synthesis of complex heterocyclic molecules in a rapid 
fashion with a reasonable level of predictability. The α-cyclopropyl N-acyliminium ions 
show promise as synthetic intermediates towards the synthesis of complex target 
molecules, and towards the rapid generation of small molecules with unique cores for 







7. Experimental Methods 
7.1 Foreword 
Experimental methods: The solvent for all 1H NMR (500 MHz) and 13C NMR (125 MHz) 
experiments was CDCl3. Abbreviations used for recording of NMR data are:  
s = singlet, d = doublet, t = triplet, dd = doublet of doublets, dt = doublet of triplets, bs = 
broad singlet, bd = broad doublet, m = multiplet and app. = apparent. The recorded 
coupling constants (J) are measured in hertz. Chemical shifts are reported as parts per 
million (ppm) from tetramethylsilane and are corrected to 0.00 (TMS) ppm for 1H NMR 
and 77.16 ppm (CDCl3 centreline) for 
13C NMR. 1H and 13C NMR assignments are based 
upon gCOSY, gHSQC and gHMBC NMR correlations. Ipso-OCH2Ph and ipso-NCH2Ph 
refers to the ipso carbon of the aromatic ring. PS refers to petroleum spirit fractions 40-
60 °C. Reactions requiring external heating were performed in an oil bath heated on a 
hotplate with a magnetic stirrer and temperature was monitored with a thermometer. 
Unless otherwise stated all reactions were stirred with a magnetic stirrer bar in the 
reaction mixture. Glassware for all reactions was oven dried at 110 °C and cooled in a 
desiccator. Anhydrous THF, CH2Cl2, Et2O and DMF were obtained from an anhydrous 
solvent dispenser, and 1,2-dichloroethane (DCE) was obtained from Sigma Aldrich 
Chemical Co. Column chromatography was performed using Merck (35-70 μm) flash 
column silica gel and the solvents specified.  
7.2 Starting Material Synthesis 
7.2.1 Pyrrolidinone Derivatisation 
1-Benzylpyrrolidine-2,5-dione (231) 
Prepared following the method of Cadoret et al.120 Potassium hydroxide 
(1.2 g, 22 mmol) was added to a solution of succinimide (2.0 g, 20 mmol) 
in DMF (20 mL) with stirring. After 30 min, benzyl bromide (2.6 mL, 
22 mmol) was added to the mixture and the reaction was stirred for 18 h. 
Water (40 mL) and Et2O (40 mL) were then added, and the organic layer was separated 
and the aqueous layer was extracted with Et2O (40 mL). The combined organic layers 
were washed with water (2 x 120 mL) then dried over anhydrous MgSO4 and filtered, 
then concentrated in vacuo.  The crude was then purified by two successive EtOH 
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crystallisations giving a white solid 231 (1.64 g, 8.67 mmol, 39%). The NMR data were 
consistent with those reported in the literature.120  
δH 7.43 - 7.25 (5H, m), 4.66 (2H, s), 2.71 (4H, s). δC 177.0, 135.9, 129.1, 128.8, 128.1, 
42.6, 28.3. 
(S)-1-Benzyl-3-hydroxypyrrolidine-2,5-dione (223) 
 (L)-(–)-Malic acid (5.0 g, 0.037 mol) and benzylamine (4.0 g, 4.1 mL, 
0.037 mol) were heated at reflux in xylene (80 mL) for 2 h in a round 
bottom flask connected to a Dean Stark apparatus. The mixture was then 
allowed to cool to room temperature. Xylene was evaporated in vacuo, 
then the remaining crude product was dissolved in a minimal amount of EtOAc. The 
product was then crystallised from solution using PS, yielding compound 223 (6.62 g, 
0.032 mol, 87%) as a white solid. The NMR data were consistent with those reported in 
the literature.88 
δH 7.39 – 7.35 (1H, m, ArCH), 7.34 – 7.28 (4H, m, ArCH), 4.66 (2H, d, J = 2.2 Hz, 
NCH2Ph), 4.62 (1H, ddd, J = 8.5, 4.7, 1.1 Hz, H3), 3.13 – 3.00 (1H, m, H4), 2.68 (1H, 
ddd, J = 18.1, 4.9, 1.1 Hz, H4).  
LRMS (ESI) m/z calcd for C11H12NO3 [M + H]
+ 206, found 206. 
(S)-1-Benzyl-3-(benzyloxy)pyrrolidine-2,5-dione (224) 
To a solution of (S)-1-benzyl-3-hydroxypyrrolidine-2,5-dione 223 (2.0 
g, 9.7 mmol) and benzyl bromide (4.0 g, 2.8 mL, 23 mmol)) in Et2O 
(100 mL) under a nitrogen atmosphere cooled in an ice bath, was added 
Ag2O (4.5 g, 19 mmol). The resulting suspension was allowed to reach 
room temperature and stirred in the dark for 16 h. The mixture was then filtered through 
a pad of Celite and the solids were washed with Et2O. The filtrate was concentrated in 
vacuo and purified by flash column chromatography (1:4 EtOAc/PS), yielding a white 
solid 224 (2.74 g, 95%). The NMR data were consistent with those reported in the 
literature.88 
δH 7.37 – 7.25 (10H, m, ArCH), 4.97 (1H, d, J = 12.0 Hz, OCH2Ph), 4.77 (1H, d, J = 11.5 
Hz, OCH2Ph), 4.67 (1H, d, J = 14.0 Hz, NCH2Ph), 4.63 (1H, d, J = 14.0 Hz, NCH2Ph), 
4.34 (1H, dd, J = 4.0, 8.2 Hz, H3), 2.93 (1H, dd,  J = 8.5, 18.2 Hz, H4), 2.65 (1H, dd,  J 
= 4.5, 18.5 Hz, H4). 
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δC 175.7 (C5), 173.9 (C2), 136.8 (ipso-OCH2Ph), 135.5 (ipso-NCH2Ph), 128.9 (ArCH), 
128.8 (ArC), 128.7 (ArC), 128.7 (ArC), 128.4 (ArC), 128.3 (ArC), 128.2 (ArC), 127.7 
(ArC), 127.1 (ArC), 73.1 (NCH2Ph), 72.2 (OCH2Ph), 42.4 (C4), 36.4 (C3). 
 LRMS (ESI) m/z calcd for C18H18NO3 [M + H]
+ 296, found 296. 
(S)-3-(Benzyloxy)-1-methylpyrrolidine-2,5-dione (229) 
 To a solution of (S)-3-hydroxy-1-methylpyrrolidine-2,5-dione 228 (1.0 
g, 7.74 mmol) in Et2O (78 mL) cooled in an ice bath under a nitrogen 
atmosphere, benzyl bromide (3.2 g, 2.23 mL, 19 mmol) and Ag2O (3.16 
g, 13.6 mmol) were slowly added. The resulting suspension was allowed 
to reach room temperature and stirred in the dark at room temperature for 48 h. The 
mixture was then filtered through a pad of Celite and the solids were washed with Et2O. 
The filtrate was concentrated in vacuo and purified by flash column chromatography (1:2 
EtOAc/PS), yielding a white solid 229 (1.69 g, 99%). The NMR data were consistent with 
those reported in the literature.88 
δH 7.41 – 7.24 (5H, m, ArCH), 4.95 (1H, d, J = 11.7 Hz, OCH2Ph), 4.75 (1H, d, J = 11.2 
Hz, OCH2Ph), 4.32 (1H, dd, J = 7.8, 3.9 Hz, H3), 2.96 (3H, s, NCH3), 2.89 (1H, dd, J = 
18.1, 7.8 Hz, H4), 2.61 (1H, dd, J = 18.1, 3.9 Hz, H4);  
δC 176.1 (C5), 174.4 (C2), 136.8 (ipso-CH2Ph), 128.8 (ArCH), 128.4 (ArCH), 128.1 
(ArCH), 126.8 (ArCH), 72.9 (C3), 65.2 (CH2Ph), 36.2 (C4), 24.7 (CH3). 
LRMS (ESI) m/z calcd for C12H14NO3 [M + H]
+ 220, found 220.  
7.2.2 Synthesis of Indole Derivatives  
3-Cyclohexyl-1H-indole (345iii)121 
  Into a 25 mL round bottom flask equipped with a reflux condenser, were 
added toluene (5 mL), triethylsilane (1.49 g, 12.8 mmol, 2.05 mL) and 
trichloroacetic acid (1.05 g, 6.4 mmol, 0.65 mL) under an N2 atmosphere. 
The mixture was heated to 70 ˚C and a solution of cyclohexanone (0.46 g, 
4.68 mmol, 0.49 mL) and indole (0.50 g, 4.3 mmol) in toluene (3 mL) was 
added dropwise. The reaction mixture was stirred for 2 h then cooled to room temperature. 
Saturated Na2CO3 solution (5 mL) was then added and the mixture was extracted with 
Et2O (3 x 5 mL). The combined organic layers were then dried over anhydrous MgSO4, 
filtered, then concentrated in vacuo. Purification by flash column chromatography (1:30 
PS/EtOAc) gave the desired product 345iii as a brown solid (578 mg, 2.90 mmol, 68%). 
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δH 7.88 (1H, bs), 7.66 (1H, d, J = 7.8 Hz), 7.35 (1H, d, J = 7.8 Hz), 7.17 (1H, t, J = 7.5 
Hz), 7.13 – 7.06 (1H, m), 6.95 (1H, s), 2.84 (1H, bs), 2.11 (2H, d, J = 7.8 Hz), 1.85 (3H, 
d, J = 4.2 Hz), 1.78 (1H, d, J = 12.5 Hz), 1.53 – 1.40 (5H, m), 1.36 – 1.20 (1H, m). The 
characterisation data was in agreement with the literature values (note, it matches the 1H 
NMR spectra data in the supplementary information accurately, the NMR resonances in 
the actual paper are described as multiplets).122  
LRMS (ESI) m/z calcd for C14H17NNa [M + Na]
+ 222, found 222. 
1-Methyl-1H-indole (343i)123  
A stirred solution of indole (350 mg, 2.98 mmol) in THF (30 mL) was 
cooled to 0 °C, then sodium hydride in mineral oil dispersion (107.5 mg, 
4.48 mmol, 60% w/w) was added portion-wise. Methyl iodide (636 mg, 
4.48 mmol, 0.28 mL) was then added dropwise and the reaction mixture was allowed to 
warm to room temperature and left stirring for 16 h. Thin layer chromatography showed 
an absence of starting material the next day. Saturated NH4Cl solution (10 mL) then water 
(10 mL) was added slowly, followed by extraction of the aqueous layer with Et2O (3 x 10 
mL). The combined organic layers were then dried over anhydrous MgSO4, filtered, and 
the solvent was removed in vacuo, yielding the product 343i as a slightly brown white 
solid (376 g, 96%). The NMR data were consistent with those reported in the literature.123 
δH 7.62 (1H, d, J = 8.0 Hz), 7.31 (1H, d, J = 8.0 Hz), 7.21 (1H, t, J = 7.6 Hz), 7.10 (1H, 
t, J = 7.6 Hz), 7.02 (1H, d, J = 2.9 Hz), 6.48 (1H, d, J = 2.9 Hz), 3.76 (3H, s).  
LRMS (ESI) m/z calcd for C9H10N [M + H]
+ 132, found 132. 
 5-Fluoro-1-methyl-1H-indole (343ii)124 
 Potassium hydroxide (230 mg, 4 mmol) was dissolved in DMSO 
(3.5 mL) and the solution was cooled to 0° C with an ice bath. 
5-Fluoroindole (135 mg, 1.0 mmol) was added slowly and the 
solution was stirred for 1 h before the dropwise addition of iodomethane (290 mg, 2 
mmol). After 45 min the solution was diluted with water (3.5 mL). The aqueous layer was 
then extracted with Et2O (3 x 3 mL), then the organic layers were combined and washed 
with water (2 x 3 mL) and brine (2 x 3 mL), and the organic layer was dried over 
anhydrous MgSO4. The mixture was filtered, concentrated in vacuo, then purified by flash 
column chromatography (1:10 EtOAc/PS) yielding a yellow solid (135 mg, 90%).  The 
NMR data were consistent with those reported in the literature.124 
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δH 7.33 – 7.17 (2H, m), 7.10 (1H, d, J = 2.9 Hz), 6.98 (1H, td, J = 9.1, 2.3 Hz), 6.44 (1H, 
d, J = 2.3 Hz), 3.80 (3H, s).  
LRMS (ESI) m/z calcd for C9H9FN [M + H]
+ 150, found 150.  
5-Bromo-1-methyl-1H-indole (343iii)125 
 Potassium hydroxide (230 mg, 4 mmol) was dissolved in DMSO 
(3.5 mL) and the solution was cooled to 0° C with an ice bath. 5-
Bromoindole (200 mg, 1.0 mmol) was added slowly and the 
solution was stirred for 1 h before the dropwise addition of iodomethane (290 mg, 2 
mmol). After 45 minutes the solution was diluted with water (3.5 mL). The aqueous layer 
was then extracted with Et2O (3 x 3 mL), then the organic layers were combined and 
further washed with water (2 x 3 mL) and brine (2 x 3 mL), then dried over anhydrous 
MgSO4. The mixture was then filtered, concentrated in vacuo, then purified by flash 
column chromatography (1:10 EtOAc/PS) yielding a yellow solid (197 mg, 92%).  
δH 7.75 (1H, d, J = 1.8 Hz), 7.30 (1H, dd, J = 8.7, 1.6 Hz), 7.18 (1H, d, J = 8.8 Hz), 7.04 
(1H, d, J = 2.9 Hz), 6.42 (1H, d, J = 2.9 Hz), 3.77 (3H, s).  
LRMS (ESI) m/z calcd for C9H9
79BrN [M + H]+ 211, found 211. The NMR data were 
consistent with those reported in the literature.125  
7.2.3 Silver(I) oxide synthesis. 
AgNO3 (30.0 g, 0.177 mol) in a solution of distilled water (200 mL) was heated to 85 °C 
and an 85 °C solution of NaOH (6.90 g, 0.172 mol) in water (200 mL) was then quickly 
added. After the addition, the reaction mixture was hot filtered with a Buckner funnel, 
and the solids were rinsed with hot distilled water (200 mL). The solids were then rinsed 
with absolute ethanol (200 mL), then dried in vacuo and finally dried under high vacuum 
to give a black/brown solid (18.53 g, 87%). 
7.2.4 Synthesis of N-Acyliminium Ion Substrates 
(5R)-1-Benzyl-4-(benzyloxy)-5-cyclopropyl-5-hydroxypyrrolidin-2-one (197) 
 A solution of (S)-1-benzyl-3-(benzyloxy)pyrrolidine-2,5-dione 224 
(2.0 g, 6.7 mmol) in THF (60 mL) was cooled to 0 °C with an ice 
bath, then cyclopropylmagnesium bromide in 2-methylfuran (8.8 
mL, 1.0 M, 8.8 mmol) was added and the solution turned yellow. The 
solution was allowed to warm to room temperature and over 30 min the reaction mixture 
turned a transparent dark orange, which turned to deep purple as the reaction mixture was 
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stirred for another 40 h. The reaction was quenched with saturated NH4Cl solution (30 
mL), and the organic layer was extracted with Et2O (2 X 60 mL), then dried over 
anhydrous MgSO4, filtered, then concentrated in vacuo giving a dark purple oil. The crude 
product was purified by flash column chromatography (1:2 EtOAc/PS), yielding a white 
solid 197 (0.724 g, 2.1 mmol, 63%) as a mixture of diastereomers (dr = 90:10). A small 
amount of each diastereomer could be isolated pure by further separation using column 
chromatography. 
 (4S,5R)-1-Benzyl-4-(benzyloxy)-5-cyclopropyl-5-hydroxypyrrolidin-2-one (197a) 
Major diastereomer (197a) 
[α]25
D
  = 13.4 ˚ ± 0.5 ˚ (c 10.3, CDCl3)  
δH 7.37 – 7.17 (10H, m, ArCH), 4.68 – 4.64 (2H, m, OCH2Ph, 
NCH2Ph), 4.57 (1H, d, J = 12.0 Hz, OCH2Ph), 4.42 (1H, d, J = 15.0 
Hz, NCH2Ph), 4.02 (1H, dd, J = 4.0, 6.5 Hz, H4), 3.55 (1H, d,  J = 
4.0 Hz, OH), 2.73 (1H, dd,  J = 6.5, 17.2 Hz, H3), 2.56 (1H, dd,  J = 4.0, 17.2 Hz, H3),  
0.83 – 0.78 (1H, m, H7), 0.68 – 0.62 (1H, m, H6), 0.34 – 0.28 (3H, m, H7 H7ʹ). 
 δC 171.5 (C2), 139.0 (ipso-OCH2Ph), 136.8 (ipso-NCH2Ph), 128.7 (ArCH), 128.4 
(ArCH), 128.3 (ArCH), 127.9 (ArCH), 127.7 (ArCH), 126.9 (ArCH), 89.5 (C5), 77.9 
(C4), 72.4 (OCH2Ph), 42.7 (NCH2Ph), 36.2 (C3), 17.7 (C6), 1.9 (C7), 0.7 (C7ʹ).  
vmax/cm
-1 3269, 2941, 2859, 2109, 1754, 1672, 1406, 1351, 1221, 1146, 1112, 1023, 982, 
784, 696.  
HRMS (ESI) m/z calcd for C21H24NO3 [M + H]
+ 338.1756, found 338.1752. 




  = -21.1 ˚ ± 0.2 ˚ (c 11.5, CDCl3).   
δH 7.42 – 7.18 (10H, m, ArCH), 4.75 (1H, d, J = 15.4 Hz, NCH2Ph), 
4.66 (d, J = 11.8 Hz, OCH2Ph), 4.62 (d, J = 11.8 Hz, OCH2Ph), 4.45 
(1H, d, J = 15.4 Hz, NCH2Ph), 3.80 (1H, dd, J = 5.5, 1.3 Hz, H4), 
2.85 (1H, dd, J = 17.1, 5.5 Hz, H3), 2.54 (1H, dd, J = 17.1, 1.3 Hz, H3), 1.21 (1H, m, J 
= 7.2, 7.2 Hz, H6), 0.56 – 0.45 (3H, m, H7 H7ʹ), 0.42 – 0.36 (1H, m, H7). 
δC 174.6 (C2), 138.7 (ipso-NCH2Ph (gHMBC correlation to 4.75, 4.45 ppm)), 138.0 
(ipso-OCH2Ph (gHMBC correlation to 4.66, 4.62 ppm)), 128.9 (ArCH), 128.7 (ArCH), 
128.0 (ArCH), 127.8 (ArCH), 127.7 (ArCH), 127.6 (ArCH), 93.3 (C5), 80.4 (C4 (gHSQC 
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correlation to 3.80 ppm)),  72.3 (OCH2Ph (gHSQC correlation to 4.66, 4.62 ppm)), 42.9 
(NCH2Ph (gHSQC correlation to 4.75, 4.45 ppm)), 36.5 (gHSQC correlation to 2.85, 2.54 
ppm)), 13.4 (C6 (gHSQC correlation to 1.21 ppm)), 1.6 (C7ʹ gHSQC correlation to 0.45-
0.56 ppm), 0.9 (C7 gHSQC correlation to 0.45-0.56 ppm and 0.36-0.42 ppm).  
LRMS (ESI) m/z calcd for C21H24NO3 [M + H]
+ 338, found 338. 
(4S,5R)-4-(Benzyloxy)-5-cyclopropyl-5-hydroxy-1-methylpyrrolidin-2-one (199) 
The title compound was prepared using a solution of (S)-3-
(benzyloxy)-1-methylpyrrolidine-2,5-dione 229 (0.75 g, 3.4 mmol) 
in THF (30 mL) which was cooled to 0 °C with an ice bath, then 1.0 
M cyclopropylmagnesium bromide in 2-methylfuran (3.75 mL, 0.1 
M, 3.75 mmol) was added dropwise. The solution was allowed to warm to room 
temperature then was stirred for another 40 h. The reaction was quenched with saturated 
NH4Cl solution (15 mL), and the organic layer was extracted with Et2O (2 x 30 mL), then 
dried over anhydrous MgSO4, filtered, then concentrated in vacuo giving a dark purple 
oil. The crude product was then purified by flash column chromatography using a system 
of 1:1 EtOAc/PS as eluent, yielding a white solid 199 (0.595 g, 67%) as a mixture of 
diastereomers (dr = 71:29). A small amount of the major diastereomer could be isolated 
pure by further separation using column chromatography. 
(4S,5R)-4-(Benzyloxy)-5-cyclopropyl-5-hydroxy-1-methylpyrrolidin-2-one (199a) 
Major diastereomer  
[α]25
D
  = 26.3 ˚ ± 0.3 ˚ (c 9.2, CHCl3). 
 δH 7.45 – 7.28 (5H, m, ArC-), 4.66 (2H, d, J = 11.7 Hz, OCH2Ph), 4.58 (1H, d, J  = 11.7 
Hz, OCH2Ph), 4.00 (1H, dd, J = 6.6, 2.4 Hz, H4), 3.63 (1H, app. d, J = 5.4 Hz, OH), 2.84 
(3H, s, NCH3), 2.64 (1H, dd, J = 17.1, 6.6 Hz, H3), 2.48 (1H, dd,  J = 17.1, 2.4 Hz, H3), 
0.94 – 0.83 (1H, m, H6), 0.82 – 0.74 (1H, m, H7), 0.60 – 0.52 (1H, m, H7), 0.45 – 0.31 
(2H, m, H7ʹ). 
δC 170.8 (C2), 136.8 (ipso-CH2Ph), 128.7 (m-PhC), 128.3 (p-PhC), 128.0 (o-PhC), 89.0 
(C5 (no gHSQC correlation, gHMBC correlation to CH3, H7ʹ and H3)), 77.7 (C4), 72.5 
(OCH2Ph), 36.3 (C3), 24.8 (CH3), 16.7 (C6), 1.3 (C7), -0.3 (C7ʹ). 
vmax/cm
-1 3317, 3009, 2928, 1671, 1434, 1394, 1339, 1207, 1176, 1075, 1024, 877, 807, 
736, 697, 601.  
HRMS (ESI) m/z calcd for C15H20NO3 [M + H]





 A solution of 1-Benzylpyrrolidine-2,5-dione 231 (0.85 g, 4.5 mmol) in 
THF (37 mL) was cooled to 0 °C with an ice bath, then 1.0 M 
cyclopropylmagnesium bromide in 2-methylfuran (8.8 mL, 0.1 M, 8.8 
mmol) was added dropwise over 10 min. The solution was stirred for another 1.5 h. The 
reaction was quenched with saturated NH4Cl solution (3 mL) giving a clear solution, after 
which a white precipitate formed. Water was then added to dissolve the white precipitate, 
and the aqueous layer was extracted with EtOAc (3 x 50 mL), then dried over anhydrous 
MgSO4, filtered, then concentrated in vacuo. The crude product was then purified by flash 
column chromatography using a system of 2:1 EtOAc/PS as eluent, yielding a white solid 
232 (0.35 g, 1.5 mmol, 33%). 
7.34 – 7.26 (2 H, m, ArH), 7.26 – 7.20 (3 H, m, ArH), 6.37 (1 H, bs, NH), 4.38 (2 H, app. 
d, J = 6.0 Hz, CH2Ph), 2.93 (1 H, t, J = 6.5 Hz, H3), 2.45 (2 H, t, J=6.5 Hz, H2), 1.97 – 
1.90 (1 H, m, H5), 1.03 – 0.97 (1 H, m, H6), 0.91 – 0.84 (1 H, m, H6). 
210.0 (C), 172.0 (C1), 135.6 (ipso-Ph), 129.1 (ArCH), 128.8 (ArCH), 128.8 (ArCH), 
128.7 (ArCH), 128.2 (ArCH), 128.0 (ArCH), 127.8 (ArCH), 127.7 (ArCH), 127.5 
(ArCH), 43.8 (CH2Ph), 38.5 (C3), 30.2 (C2), 20.7 (C5), 11.0 (C6, C7). 
LRMS (ESI) m/z calcd for C14H18NO2 [M + H]
+ 232, found 232. 
3-Cyclopropyl-3-hydroxy-2-methylisoindolin-1-one (203) 
  A solution of N-methylphthalimide (1.00 g, 6.21 mmol) in THF (55 
mL) was cooled to 0 °C with an ice bath, then 1.0 M 
cyclopropylmagnesium bromide in 2-methylfuran (7.45 mL, 0.1 M, 
7.45 mmol) was added dropwise over 10 min, where a fine white 
precipitate formed and the solution turned green. The solution was 
stirred for another 1.5 h. The reaction was quenched with saturated NH4Cl solution (5 
mL) giving a clear solution, after which a white precipitate formed. Water was then added 
to dissolve the white precipitate, and the aqueous layer was extracted with Et2O (3 x 60 
mL), then dried over anhydrous MgSO4, filtered, then concentrated in vacuo. The crude 
solid was dissolved in EtOAc and a white precipitate was crystallised from solution with 
hexane, yielding the product as a white solid 203 (1.09 g, 5.36 mmol, 87%). 
Melting point: 179 ˚C. 
δH 7.59 (1H, d, J = 7.3 Hz, H7), 7.52 (1H, app. t, J = 7.3 Hz, H5 (gHMBC correlation to 
C3a)), 7.42 (1H, d, J = 7.3 Hz, H4 (gHMBC correlation to C3a)), 7.37 – 7.31 (1H, m, H6 
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(gCOSY correlation to H5 and H7)), 4.00 (1H, s, OH (no gHSQC correlation, gHMBC 
correlation to C1ʹ, C3 and C3a)), 2.79 (3H, s, CH3), 1.03 – 0.95 (1H, m, H2ʹ), 0.85 – 0.77 
(1H, m, H1ʹ (gHSQC correlation to C1ʹ)), 0.74 – 0.68 (1H, m, H3ʹ), 0.61 – 0.54 (1H, m, 
H2ʹ), 0.51 – 0.44 (1H, m, H3ʹ); δC 167.1 (C2), 148.3 (C3a (quaternary by gHSQC and 
APT)), 132.1 (C5), 130.7 (C7a (quaternary by gHSQC and APT)), 129.4 (C6), 123.0 
(C4), 122.5 (C7), 88.4 (C3), 24.0 (CH3), 16.8 (C1ʹ), 1.0 (C2ʹ), -0.2 (C3ʹ). vmax/cm
-1 3187, 
2972, 2108, 1753, 1678, 1481, 1426, 1262, 1173, 1030, 757, 703, 685. HRMS (ESI) m/z 
calcd for C12H14NO2 [M + H]
+ 204.1025, found 204.1015.  
7.3 Nucleophilic Additions to α-Cyclopropyl N-Acyliminium Ion Precursors 
7.3.1 General Procedure for the Addition of Nucleophiles to the (4S,5R)-4-
(benzyloxy)-5-cyclopropyl-5-hydroxy-pyrrolidin-2-one Substrates  
Method A: A solution of (4S,5R)-4-(benzyloxy)-5-cyclopropyl-5-hydroxy-pyrrolidin-2-
one substrate (1 mol. eq.) and nucleophile (2 mol. eq. or 3 mol. eq.) in anhydrous CH2Cl2 
(0.2 M) was cooled to 0 °C with an ice bath. BF3·Et2O (2 mol. eq.) was then added 
dropwise to the solution with vigorous stirring. The solution was allowed to warm to room 
temperature and stirred for 12 h. Upon completion, the reaction was quenched with a 
saturated aqueous solution of NaHCO3, a minimal amount of acetone was added to 
dissolve any solids, and the aqueous phase was then extracted with CH2Cl2 (3 x initially 
used volume of CH2Cl2). The organic layers were combined then dried over anhydrous 
MgSO4, filtered then concentrated in vacuo. The crude product was then purified by flash 
column chromatography. 
Method B: A solution of (4S,5R)-4-(benzyloxy)-5-cyclopropyl-5-hydroxy-pyrrolidin-2-
one substrate (1 mol. eq.) and the nucleophile (2 mol. eq.) in anhydrous CH2Cl2 (0.2 M) 
was cooled to 0 °C with an ice bath. BF3·Et2O (2 mol. eq., 0.3 mol/L in CH2Cl2) was then 
added via a syringe pump over 1 h to the solution with vigorous stirring. The solution was 
allowed to warm to room temperature and stirred for 12 h. The reaction was then 
quenched with a saturated aqueous solution of NaHCO3, a minimal amount of acetone 
was added to dissolve any solids, and the aqueous phase was then extracted with CH2Cl2 
(3 x initially used volume of CH2Cl2). The organic layers were combined then dried over 
anhydrous MgSO4, filtered then concentrated in vacuo. The crude product was then 
purified by flash column chromatography. 
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7.3.2 General Procedure for the Addition of Nucleophiles to 3-cyclopropyl-3-
hydroxy-2-methylisoindolin-1-one. 
Method C: A solution of 3-cyclopropyl-3-hydroxy-2-methylisoindolin-1-one (1 mol. 
eq.) and the nucleophile (2 mol. eq.) in CH2Cl2 (0.2 M) was cooled to 0 °C with an ice 
bath. BF3·Et2O (2 mol. eq., 0.3 mol/L in CH2Cl2) was then added via syringe pump over 
1 h to the solution with vigorous stirring. The solution was allowed to warm to room 
temperature and stirred for 12 h. The reaction was then quenched with a saturated aqueous 
solution of NaHCO3, and the aqueous phase was then extracted with CH2Cl2 (3 x the 
initially used volume of CH2Cl2). The organic layers were combined then dried over 
anhydrous MgSO4, filtered then concentrated in vacuo. The crude product was then 
purified by flash column chromatography. 
7.3.3 Lewis Acid Induced Ring Openings 
(9S)-6-Benzyl-9-(benzyloxy)-1-oxa-6-azaspiro[4.4]nonan-7-one (242)  
Prepared following general method A, using a 5-hydroxy-5-
cyclopropylpyrrolidin-2-one mixture 197 (0.050 g, 0.15 mmol), 
CH2Cl2 (7.5 mL) and In(OTf)3 (0.169 g, 0.3 mmol) instead of 
BF3·Et2O, which was added portionwise. The crude product was then 
purified by flash column chromatography (3:1 EtOAc/PS) yielding a mixture of 
diastereomers (dr = 76:24 from 1 H NMR analysis of the crude reaction mixture) as a 
slightly brown transparent oil 242 (45 mg, 0.132 mmol, 88%), where a small amount of 
the major diastereomer could be isolated pure by further separation using column 
chromatography. 
 (5S,9S)-6-Benzyl-9-(benzyloxy)-1-oxa-6-azaspiro[4.4]nonan-7-one 
Major diastereomer (242a) 
[α]25
D
  56 ˚ ± 0.2 ˚ (c 8.0, CDCl3).  
δH 7.44 – 7.29 (9H, m, ArCH), 7.28 – 7.24 (1H, m, ArCH), 4.74 – 4.65 
(2H, m, NCH2Ph and OCH2Ph), 4.53 (1H, d, J = 11.8 Hz, OCH2Ph), 
4.31 (1H, d, J = 15.9 Hz, NCH2Ph), 4.00 – 3.95 (1H, m, H9 (gCOSY 
correlation to H8)), 3.92 (1H, app. q, J = 7.0 Hz, H2 (gHSQC correlation to C2)), 3.79 
(1H, dd, J = 14.0, 7.0 Hz, H2 (gHSQC correlation to C2)), 2.81 (1H, dd, J = 16.8, 6.0 Hz, 
H8 (gCOSY correlation to H8 and H9)), 2.52 (1H, dd, J = 16.8, 3.8 Hz, H8 (gCOSY 
correlation to H8 and H9)), 2.45 (1H, dt, J = 13.7, 7.0 Hz, H4 ((gCOSY correlation to H3 
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and H4)), 1.96 – 1.86 (2H, m, H3 (gCOSY correlation to H2 and H4)), 1.83 – 1.75 (1H, 
m, H4 (gCOSY correlation to H3 and H4)). 
 δC 172.8 (C7), 138.2 (ipso-NCH2Ph (gHMBC correlation to NCH2Ph)), 137.7 (ipso-
OCH2Ph (gHMBC correlation to OCH2Ph), 128.6 (ArCH), 128.6 (ArCH), 128.0 (ArCH), 
127.7 (ArCH), 127.1 (ArCH), 103.3 (C5), 79.2 (C9), 71.8 (OCH2Ph), 68.4 (C2), 42.6 
(NCH2Ph), 35.8 (C8), 28.5 (C4), 25.8 (C3). 
vmax/cm
-1 3356, 3063, 22865, 1453, 1333, 1233, 1154, 1071, 1027, 7335, 604, 456. HRMS 
(ESI) m/z calcd for C21H24NO3 [M+H]
+ 338.1756, found 338.1764.  
(4S,9S)-6-Benzyl-9-(benzyloxy)-1-oxa-6-azaspiro[4.4]nonan-7-one (242b) 
Minor diastereomer (242b) 
δH (in part from the mixture) 4.79 (1H, d, J = 16.0 Hz), 4.72 (1H, d, J = 12.3 Hz), 4.54 
(1H, d, J = 12.2 Hz). 
1-Benzyl-4-(benzyloxy)-5-(3-chloropropyl)3-one mixture 197 (0.050 g, 0.15 mmol), 
CH2Cl2 (7.5 mL), 1,2-dimethoxybenzene (0.041 g, 0.04 mL, 0.30 mmol) and 
aluminium(III) chloride (0.040 g, 0.30 mmol) instead of BF3·Et2O. The solution turned 
red when the AlCl3 was added. The solution turned a clear light brown after 1 h at room 
temperature and the starting material was no longer visible by TLC analysis. The reaction 
was quenched with saturated NaHCO3 solution. The crude product was then purified by 




  = 0 (c 8.0, CHCl3). δH 7.43 – 7.22 (10H, m, ArCH), 5.19 (1H, s, H3), 5.05 (1H, d, J 
= 15.5 Hz, NCH2Ph), 4.98 (1H, d, J = 11.5 Hz, OCH2Ph), 4.92 (1H, d, J = 11.5 Hz, 
OCH2Ph), 4.04 (1H, d, J = 15.5 Hz, NCH2Ph), 3.96 (1H, t, J = 3.9 Hz, H5), 3.93 (2H, t, 
J = 6.1 Hz, H8),  1.98 – 1.89 (1H, m, H6), 1.85 (1H, ddt, J = 14.8, 10.0, 5.0, 5.0 Hz, H6), 
1.62 – 1.53 (1H, m, H7), 1.52 – 1.42 (1H, m, H7) ; δC  174.1 (C4), 171.8 (C2),  137.7 
(ipso-CH2Ph),  134.8 (ipso-CH2Ph), 128.9 (ArCH), 128.9 (ArCH), 128.9  (ArCH), 128.8 
(ArCH), 128.2 (ArCH), 127.8 (ArCH), 95.5 (C3), 73.2 (OCH2Ph), 58.8 (C5), 44.7 (C8), 
43.5 (NCH2Ph), 25.4 (C6), 25.4 (C7).  
vmax/cm
-1 3085, 3031, 2920, 1670, 1620, 1403, 1343, 1309, 1227, 973, 935, 908, 718, 695, 
640, 433.  
HRMS (ESI) m/z calcd for C21H23
35ClNO2 [M+H]
+ 356.1417, found 356.1406. 
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7.3.4 Methoxy Substituted Benzene Nucleophiles 
Reaction of 197 and Anisole in the Presence of BF3·Et2O 
 This reaction was performed following general method A, using a 5-hydroxy-
5-cyclopropylpyrrolidin-2-one mixture (0.050 g, 0.15 mmol), anisole (0.032 g, 
0.3 mmol, 0.032 mL), BF3·Et2O (0.046 g, 0.040 mL, 0.32 mmol) and CH2Cl2 
(7.5 mL). The product was purified by flash chromatography using gradient 
elution (5:1 hexane/EtOAc to 2:1 hexane/EtOAc), yielding 242 as a clear oil (0.036 g, 
0.107 mmol, 72%, dr = 76:24) and as a mixture of diastereomers.  
(3ʹS)-1ʹ-Benzyl-3ʹ-(benzyloxy)-6,7-dimethoxy-3,4-dihydro-2H-spiro[naphthalene-
1,2ʹ-pyrrolidin]-5ʹ-one (218) 
Prepared following general method A, using a 5-hydroxy-5-
cyclopropylpyrrolidin-2-one mixture 197 (0.050 g, 0.15 
mmol), 1,2-dimethoxybenzene (0.041 g, 0.040 mL, 0.30 
mmol), BF3·Et2O (0.046 g, 0.040 mL, 0.32 mmol) and CH2Cl2 
(7.5 mL). The product was purified by column 
chromatography (3:1 EtOAc/PS) yielding a clear oil 218 (37 mg, 0.080 mmol, 54%) as a 




δH 7.28 – 7.16 (6H, m, ArCH), 7.11 – 7.09 (2H, m, ArCH), 6.96 
– 6.95 (2H, m, ArCH), 6.62 (1H, s, H5 (gHMBC correlation to 
C4a and C6, NOESY correlation to H4)), 6.59 (1H, s, H8 
(gHMBC correlation to C1, C7 and C8a)), 4.57 (1H, d, J = 15.2 
Hz, NCH2Ph (gHMBC correlation to C1 and C5ʹ)), 4.05 (1H, d, 
J = 11.5 Hz, OCH2Ph (gHMBC correlation to C3ʹ)), 3.96 (1H, d, J = 15.2 Hz, NCH2Ph 
(gHMBC correlation to C1 and C5ʹ)), 3.90 (3H, s, C7-OCH3 (gHMBC correlation to C7 
and C8)), 3.89 – 3.87 (1H, m, H3ʹ (gCOSY correlation to both H4ʹ protons)), 3.85 (1H, 
d, J = 11.5 Hz, OCH2Ph (gHMBC correlation to C3ʹ)), 3.43 (3H, s, C6-OCH3 (gHMBC 
correlation to C6)), 2.96 (1H, dd, J = 17.8, 6.9 Hz, H4ʹ(gCOSY correlation to H3ʹ and 
H4ʹ)), 2.73 – 2.68 (2H, m, H4 (gCOSY correlation to H3, gHMBC correlation to C4a and 
C8a)), 2.65 (1H, d, J = 17.8 Hz, H4ʹ(gCOSY correlation to H3ʹ and H4ʹ)), 1.86 – 1.78 
(1H, m, H3 (gCOSY correlation to H2 and H4)), 1.77 – 1.68 (1H, m, H3 (gCOSY 
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correlation to H2 and H4)), 1.68 – 1.59 (1H, m, H2 (gHMBC correlation to C1 and C3ʹ)), 
1.55 – 1.48 (1H, m, H2 (gHMBC correlation to C1, C3ʹ and C4a)). 
δC 174.1 (C5ʹ), 148.7 (C7 (gHMBC correlation to H8 and C7-OCH3), 146.7 (C6 (gHMBC 
correlation to H5 and C6-OCH3)), 138.7 (ipso-NCH2Ph (gHMBC correlation to 
NCH2Ph)), 137.7 (ipso-OCH2Ph (gHMBC correlation to OCH2Ph)), 131.5 (C8a 
(gHMBC correlation to H8)), 128.5 (ArCH), 128.4 (ArCH), 128.3 (ArCH), 127.7 
(ArCH), 127.6 (ArCH), 127.1 (ArCH), 124.5 (C4a (gHMBC correlation to H5)), 113.3 
(C8 (gHSQC correlation to H8)), 111.0 (C5 (gHSQC correlation to H5)), 79.8 
(C3ʹ(gHSQC correlation to H3ʹ, gHMBC correlation to H2)), 71.9 (OCH2Ph), 70.4 (C1), 
55.9 (C7-OCH3 (gHSQC correlation to C7-OCH3)), 55.7 ((C6-OCH3 (gHSQC correlation 
to C6-OCH3)), 44.4 (NCH2Ph), 37.9 (C4ʹ (gHSQC correlation to both H4ʹ)), 33.5 (C2 
(gHSQC correlation to both H2)), 29.2 (C4 (gHSQC correlation to H4)), 20.6 (C3 
(gHSQC correlation to both H3)).  
vmax/cm
-1 2934, 2848, 1684, 1512, 1452, 1397, 1355, 1267, 1079, 738, 701.  
HRMS (ESI) m/z calcd for C29H31NO4Na [M+Na]
+ 480.2151, found 480.2125. 
 Reaction of 197 and 1,4-Dimethoxybenzene in the Presence of BF3·Et2O 
  This reaction was performed following general method A, using a 5-hydroxy-
5-cyclopropylpyrrolidin-2-one mixture 197 (0.050 g, 0.15 mmol), 1,4-
dimethoxybenzene 197  (0.042 g, 0.3 mmol, 0.041 mL), BF3·Et2O (0.046 g, 
0.040 mL, 0.32 mmol) and CH2Cl2 (7.5 mL). The product was purified by flash 
chromatography using gradient elution (5:1 hexane/EtOAc to 2:1 
hexane/EtOAc), yielding 242 as a clear oil (0.037 g, 0.11 mmol, 74%) as a mixture of 
diastereomers (dr = 76:24, 242a:242b).  
Reaction of 197 and 3,4-Dimethoxyphenylboronic in the Presence of BF3·Et2O 
 This reaction was performed following general method A, using a mixture of α-
cyclopropyl N-acyliminium ion precursor 197 (0.050 g, 0.15 mmol), 3,4-
dimethoxyphenylboronic acid (0.044 g, 0.15 mmol, 0.032 mL), BF3·Et2O 
(0.046 g, 0.040 mL, 0.32 mmol) and CH2Cl2 (7.5 mL). The product was 
purified by flash chromatography using gradient elution (5:1 
hexane/EtOAc to 2:1 hexane/EtOAc), yielding 242 as a clear oil (0.032 g, 0.10 mmol, 





Prepared following general method A, using a 5-hydroxy-
5-cyclopropylpyrrolidin-2-one mixture 197 (0.050 g, 0.15 
mmol), 1,2,3-trimethoxybenzene (0.050 g, 0.30 mmol), 
BF3·Et2O (0.046 g, 0.040 mL, 0.32 mmol) and CH2Cl2 
(7.5 mL). The product was purified by column 
chromatography (1:1 EtOAc/PS) yielding a clear oil 275v 




δH 7.37 – 7.28 (5 H, m, ArCH), 7.25 - 7.16 (6H, m, ArCH), 
7.11 (2H, d, J = 5.9 Hz, ArCH), 6.95 - 6.93 (2H, m, ArCH), 
6.39 (1H, s, H8), 4.61 (1H, d, J = 15.1 Hz, NCH2Ph), 4.16 
(1H, d, J = 11.7 Hz, OCH2Ph), 3.95 (1H, d, J  =  15.1 Hz, 
NCH2Ph), 3.93 – 3.90 (2H, m, OCH2Ph, H3ʹ), 3.91 - 3.88 
(6H, m, C5-OCH3 C6-OCH3), 3.42 (3H, s, C7-OCH3), 2.96 
(1H, dd, J = 17.6, 7.3 Hz, H4ʹ), 2.90 - 2.83 (1H, m, H4), 2.68 – 2.61 (1H, m, H4ʹ), 2.52 - 
2.39 (1H, m, H4), 1.91 - 1.80 (1H, m, H3), 1.74 - 1.66 (2H, m, H2 H3), 1.56 - 1.48 (1H, 
m, H2 (gHMBC to C3ʹ)). 
δC 174.1 (C5ʹ), 150.9 (C5 or C6), 150.8 (C5 or C6), 141.8 (C7 (strong gHMBC to H8)), 
138.6 (ipso-NCH2Ph), 137.8 (ipso-OCH2Ph), 128.5 (ArCH), 128.4 (ArCH), 128.4 
(ArCH), 128.32 (C4a), 128.31 (ArCH), 128.0 (ArCH), 127.9 (ArCH), 127.7 (ArCH), 
127.6 (ArCH), 127.4 (ArCH), 127.2 (ArCH), 125.9 (C8a), 109.1 (C8), 80.0 (C3ʹ), 71.7 
(OCH2Ph), 70.5 (C1), 61.0 (OCH3), 60.6 (OCH3), 55.7 (a-OCH3), 44.6 (NCH2Ph), 37.6 
(C4ʹ), 33.7 (C2), 23.0 (C4), 19.7 (C3).  
vmax/cm
-1 3384, 2934, 1683, 1493, 1453, 1403, 1343, 1327, 1270, 1191, 1108, 1075, 1028, 
935, 699, 620, 497.  
HRMS (ESI) m/z calcd for C30H34NO5 [M+H]








Minor diastereomer indicative peaks from mixture of diastereomers: δH 6.09 (1H, s, H8), 
4.36 (1H, d, J = 11.7 Hz, OCH2Ph), 3.55 (3H, s, OCH3). 
7.3.5 Substituted Furans as Nucleophiles 
(4S)-1-Benzyl-4-(benzyloxy)-5-cyclopropyl-5-(furan-2-yl)pyrrolidin-2-one (277i) 
 Prepared following general method A, using a 5-hydroxy-5-
cyclopropylpyrrolidin-2-one mixture 197 (0.050 g, 0.15 mmol), furan 
(0.033 g, 0.45 mmol), BF3·Et2O (0.046 g, 0.040 mL, 0.32 mmol) and 
CH2Cl2 (7.5 mL). The product was purified by flash chromatography 
using gradient elution from 4:1 PS to EtOAc to 2:1 hexane to EtOAc, 
yielding compound 277i (0.021 g, 0.054 mmol, 37%, dr = 68:32) as a clear oil. A small 
amount of the major diastereomer could be isolated pure by further separation using 
column chromatography. The spirocyclic furan 242 was also isolated (0.006 g, 0.018 
mmol, 12%) as a mixture of diastereomers (dr = 75:25, 242a:242b).  
The reaction was also repeated under all the same conditions; however, it was carried out 







  = 19 ˚ ± 3 ˚ (c 1.05, CDCl3)  
δH 7.36 (1H, d, J = 0.8 Hz, H5ʹ), 7.31 – 7.23 (4H, m, ArCH), 7.22 – 
7.18 (4H, m, ArCH), 7.15 (3H, d, J = 6.6 Hz, ArCH), 6.37 (1H, d, J 
= 2.5 Hz, H3ʹ), 6.33 – 6.30 (1H, m, H4ʹ (gCOSY correlation to H5ʹ)), 
4.86 (1H, d, J = 15.5 Hz, NCH2Ph), 4.47 (1H, d, J = 12.0 Hz, 
OCH2Ph), 4.39 (1H, d, J = 12.0 Hz, OCH2Ph), 4.01 (1H, d, J = 15.5 Hz, NCH2Ph), 3.62 
(1H, t, J = 8.3 Hz, H4 (ROESY correlation to H1ʹʹ, H2ʹʹ H3ʹʹ)), 2.69 (2H, d, J = 8.3 Hz, 
H3), 1.16 – 1.08 (1H, m, H1ʹʹ), 0.65 – 0.57 (1H, m, H2ʹʹ), 0.55 – 0.50 (1H, m, H2ʹʹ), 0.35 
– 0.27 (1H, m, H3ʹʹ), 0.11 – 0.03 (1H, m, H3ʹʹ);  
δC 172.2 (C2), 153.0 (C2ʹ), 142.7 (C5ʹ), 138.6 (ipso-NCH2Ph (gHMBC correlation to  
NCH2Ph)), 137.7 (ipso-OCH2Ph (gHMBC correlation to  OCH2Ph)), 128.6 (ArCH), 
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128.3 (ArCH), 127.5 (ArCH), 127.0 (ArCH), 110.3 (C4ʹ (gHSQC correlation to  H4ʹ)), 
110.0 (C3ʹ (gHSQC correlation to  H3ʹ)), 74.6 (C4), 71.5 (OCH2Ph), 44.4 (NCH2Ph), 36.3 
(C3), 15.8 (C1ʹʹ), 3.8 (C2ʹʹ), 1.8 (C3ʹʹ).  
vmax/cm
-1 2978 (alkane C-H), 1663 (tertiary amide C=O), 1337 (Ar O-C), 1270 (Ar N-C), 
1092 (C-O C-OBn ether) 1051 (C-O ester), 803 (Ar C-H), 699 (Ar C-H).  
HRMS (ESI) m/z calcd for NaC25H25NO3 [M + Na]
+ 410.1732, found 410.1745. 
(4S)-1-Benzyl-4-(benzyloxy)-5-cyclopropyl-5-(5-methylfuran-2-yl)pyrrolidin-2-one 
(277ii). 
Prepared following general method A, using a 5-hydroxy-5-
cyclopropylpyrrolidin-2-one mixture 197 (0.050 g, 0.15 mmol), 2-
methylfuran (0.024 g, 0.3 mmol, 0.027 mL), BF3·Et2O (0.046 g, 
0.040 mL, 0.32 mmol) and CH2Cl2 (7.5 mL). This reaction was 
cooled to -18 °C rather than 0 °C for both the BF3·Et2O addition and 
the duration of the reaction (48 h).  The product was purified by flash chromatography 
using gradient elution (5:1 hexane/EtOAc to 2:1 hexane/EtOAc), yielding the 1,2-
addition product 277ii as a clear oil (0.024 mg, 0.060 mmol, 41%, dr = 88:12). A small 
amount of the major diastereomer could be isolated pure by further separation using 






  = 51.9 ˚ ± 0.6 ˚ (c 10.4, CDCl3).   
δH 7.32 – 7.24 (4H, m, ArCH), 7.21 (4H, m, ArCH), 7.19 – 7.14 (2H, 
m, ArCH), 6.25 (1H, d, J =  3.1 Hz, H3ʹ), 5.89 – 5.85 (1H, m, H4ʹ), 
4.78 (1H, d, J = 15.4 Hz, NCH2Ph), 4.47 (1H, d, J = 12.2 Hz, 
OCH2Ph), 4.40 (1H, d, J = 12.2 Hz, OCH2Ph), 4.10 (1H, d, J = 15.4 
Hz, NCH2Ph), 3.60 (1H, app. t, J = 8.4 Hz, H4), 2.69 (2H, dd, J = 8.3, 3.3 Hz, H3), 2.20 
(3H, s, CH3), 1.13 (1H, ddd, J =  8.5, 5.5 Hz, H1ʹʹ), 0.60 (1H, ddd, J = 8.9, 5.6 Hz, H2ʹʹ), 
0.56 – 0.49 (1H, m, H2ʹʹ), 0.35 – 0.28 (1H, m, H3ʹʹ), 0.10 (1H, ddd, J = 8.8, 6.0 Hz, H3ʹʹ).  
δC 172.7 (C2), 152.2 (C2ʹ), 151.0 (C5ʹ), 138.5 (ipso-NCH2Ph), 137.8 (ipso-OCH2Ph), 
128.4 (ArCH), 128.1 (ArCH), 128.0 (ArCH), 127.8 (ArCH), 127.4 (ArCH), 126.8 
(ArCH), 110.7 (C3ʹ), 106.2 (C4ʹ), 74.6 (C4), 71.4 (OCH2Ph), 44.2 (NCH2Ph), 36.3 (H3), 




-1 2875, 1684, 1453, 1349, 1269, 1049, 922, 739, 699, 670.  
HRMS (ESI) m/z calcd for C26H28NO3 [M + H]
+ 402.2069, found 402.2072. 
Methyl 4-((3S)-1-benzyl-3-(benzyloxy)-2-cyclopropyl-5-oxopyrrolidin-2-yl)-4-
oxobutanoate (279) 
Prepared following general method A, using a 5-hydroxy-5-
cyclopropylpyrrolidin-2-one mixture 197 (0.050 g, 0.15 mmol), 2-
methoxyfuran (0.029 g, 0.3 mmol), BF3·Et2O (0.046 g, 0.040 mL, 
0.32 mmol) and CH2Cl2 (7.5 mL).  Product was purified by flash 
chromatography using gradient elution (5:1 hexane/EtOAc to 2:1 
hexane/EtOAc), yielding compound 279 as a clear oil (0.034 g, 0.078 
mmol, 53%) as a mixture of diastereomers (dr = 89:11).  A small amount of the major 






  = 12.5 ˚ ± 0.4 ˚ (c 2.6, CDCl3).  
δH 7.41 – 7.15 (10H, m, ArCH), 4.91 (1H, d, J = 15.6 Hz, NCH2Ph), 
4.45 (1H, d, J = 11.4 Hz, OCH2Ph), 4.29 (1H, d, J = 11.4 Hz, 
OCH2Ph), 3.89 (1H, d, J = 15.6 Hz, NCH2Ph), 3.67 (3H, s, OCH3), 
3.44 (1H, t, J = 8.2 Hz, H3ʹ), 3.14 – 3.03 (1H, m, H3 (ROESY 
correlation to H1ʹʹ)), 2.85 – 2.75 (1H, m, H3 (gHSQC to C3)), 2.71 – 
2.60 (2H, m, H4ʹ, H2), 2.43 (1H, dd, J = 16.1, 8.7 Hz, H4ʹ), 2.33 (1H, dt, J = 17.1, 5.9 
Hz, H2), 1.28 – 1.17 (1H, m, H1ʹʹ), 0.84 – 0.75 (1H, m, H2ʹʹ), 0.69 – 0.61 (1H, m H2ʹʹ), 
0.14 – 0.06 (1H, m H3ʹʹ), -0.02 – -0.11 (1H, m, H3ʹʹ).  
δC 207.6 (C4 (assigned from gHMBC correlation)), 173.6 (C1), 172.7 (C5ʹ), 138.2 (ipso-
NCH2Ph), 136 .5 (ipso-OCH2Ph), 128.7 (ArCH), 128.5 (ArCH), 128.4 (ArCH), 128.3 
(ArCH), 128.0 (ArCH), 127.1 (ArCH), 76.6 (C2ʹ), 72.7 (C3ʹ), 72.0 (OCH2Ph), 51.9 
(OCH3), 45.0 (NCH2Ph), 35.5 (C3), 35.3 (C4ʹ), 28.3 (C2), 13.4 (C1ʹʹ), 5.0 (C2ʹʹ), 2.6 
(C3ʹʹ).  
vmax/cm
-1 3064, 3030, 2725, 1716, 1690, 1436, 1399, 1350, 1205, 1168, 1091, 1027, 944, 
855, 740, 700, 632, 459.  
HRMS (ESI) m/z calcd for NaC26H29NO5 [M+Na]
+ 458.1943, found 458.1959. 
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Reaction of 197 and Benzofuran in the Presence of BF3·Et2O 
 This reaction was performed following general method A, using a 5-hydroxy-
5-cyclopropylpyrrolidin-2-one mixture 197 (0.050 g, 0.15 mmol), benzofuran 
(0.035 g, 0.3 mmol), BF3·Et2O (0.046 g, 0.040 mL, 0.32 mmol) and CH2Cl2 
(7.5 mL). The product was purified by flash chromatography using gradient 
elution (5:1 hexane/EtOAc to 2:1 hexane/EtOAc), yielding 242 as a clear oil (0.036 g, 
0.107 mmol, 72%) as a mixture of diastereomers (dr = 76:24, 242a:242b).  
Reaction of 197 and 2,5-Dimethylfuran in the Presence of BF3·Et2O 
 This reaction was performed following general method A, using a 5-hydroxy-
5-cyclopropylpyrrolidin-2-one mixture 197 (0.050 g, 0.15 mmol), 2-
methylfuran (0.029 g, 0.3 mmol, 0.033 mL), BF3·Et2O (0.046 g, 0.040 mL, 
0.32 mmol) and CH2Cl2 (7.5 mL). The product was purified by flash chromatography 
using gradient elution (5:1 hexane/EtOAc to 2:1 hexane/EtOAc), yielding 242 as a clear 
oil (0.035 g, 0.104 mmol, 70%) as a mixture of diastereomers (dr = 76:24, 242a:242b). 
7.3.6 Allyltrimethylsilanes as Nucleophiles 
(4S)-5-Allyl-1-benzyl-4-(benzyloxy)-5-cyclopropylpyrrolidin-2-one (291i) 
Prepared following general method A, using a 5-hydroxy-5-cyclopropylpyrrolidin-2-one 
mixture 197 (0.050 g, 0.15 mmol), allyltrimethylsilane (0.020 g, 
0.028 mL, 0.178 mmol), BF3·Et2O (0.046 g, 0.040 mL, 0.32 mmol) 
and CH2Cl2 (7.5 mL) The reaction mixture was stirred for 22 h at 
room temperature rather than 12 h.  The product was purified by flash 
chromatography using gradient elution from 4:1 PS to EtOAc to 1:1 
PS to EtOAc, yielding compound 291i as a clear oil (0.042 g, 0.12 mmol, 78%) in as a 
mixture of diastereomers (dr = 77:23). A small amount of the major diastereomer could 





  = 15 ˚ ± 2 ˚ (c 2.95, CDCl3).  
δH 7.43 – 7.13 (10H, m, ArCH), 5.83 (1H, td, J = 16.8, 7.2 Hz, H2ʹ), 
5.03 (1H, d, J = 10.3 Hz, H3ʹb), 4.95 (1H, d, J = 17.3 Hz, H3ʹa), 4.72 
(1H, d, J = 15.2 Hz, NCH2Ph), 4.59 (1H, d, J = 11.8 Hz, OCH2Ph), 
4.45 (1H, d, J = 11.8 Hz, OCH2Ph), 4.27 (1H, d, J = 15.2 Hz, 
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NCH2Ph), 3.76 (1H, app. t, J = 7.8 Hz, H4), 2.67 (1H, dd, J = 16.0, 7.8 Hz, H3), 2.51 
(1H, dd, J = 16.0, 7.8 Hz, H3), 2.36 (1H, dd, J = 13.8, 7.0 Hz, H1ʹ), 2.24 (1H, dd, J = 
13.8, 7.9 Hz, H1ʹ), 0.80 – 0.73 (1H, m, H1ʹʹ), 0.47 – 0.33 (2H, m, H2ʹʹ), 0.26 – 0.14 (2H, 
m, H3ʹʹ). 
δC 172.5 (C2), 139.0 (ipso-NCH2Ph (gHMBC correlation to NCH2Ph)), 137.8 (ipso- 
OCH2Ph (gHMBC correlation to OCH2Ph)), 133.6 (C2ʹ), 128.7 (ArCH), 128.5 (ArCH), 
128.2 (ArCH), 127.8 (ArCH), 127.4 (ArCH), 126.9 (ArCH), 119.3 (C3ʹ), 77.7 (C4), 71.8 
(OCH2Ph), 68.8 (C5), 43.7 (NCH2Ph), 37.0 (C3), 36.1 (C1ʹ), 19.2 (C1ʹʹ), 2.6 (C2ʹʹ), 1.2 
(C3ʹʹʹ). 
vmax/cm
-1 3310, 2975, 2887, 1672, 1378, 1344, 1088, 1046, 880, 699, 655.  
HRMS (ESI) m/z calcd for NaC24H27NO2 [M + Na]
+ 384.1939, found 384.1931. 
Reaction of 197 and Methylallyltrimethylsilane in the Presence of BF3·Et2O 
Prepared following general method A, using a 5-hydroxy-5-
cyclopropylpyrrolidin-2-one mixture 197 (0.050 g, 0.15 mmol), 
methylallyltrimethylsilane (0.023 g, 0.03 mL, 0.178 mmol), BF3·Et2O 
(0.046 g, 0.040 mL, 0.32 mmol) and CH2Cl2 (7.5 mL) Stirred for 22 h at room temperature 
rather than 12 h.  Product was purified by flash chromatography using gradient elution 
from 4:1 PS to EtOAc to 1:1 PS to EtOAc, yielding gem dimethyl compound 292 (0.007 
g, 0.019 mmol, 13%), 1,2- addition compound 291ii (0.010 g, 0.027 mmol, 18%) as a 
mixture of diastereomers (dr = 84:16 isolated), and spirocyclic furan 242 (0.021 g, 0.062 






  = 0 ˚ (c 4.1, CHCl3).  
δH 7.40 – 7.23 (8H, m, ArCH), 7.18 (2H, d, J = 7.4 Hz, ArCH), 5.38 
(1H, d, J = 15.5 Hz, NCH2Ph), 5.23 (1H, s, H3), 4.92 (1H, d, J = 11.6 
Hz, OCH2Ph), 4.89 (1H, d, J = 11.6 Hz, OCH2Ph), 3.97 (1H, d, J = 
3.2 Hz, H5 (gHMBC correlation to C3, gCOSY correlation to  C1ʹ ppm)), 3.92 (1H, d, J 
= 15.5 Hz, NCH2Ph), 2.17 (1H, m, H1ʹ (gCOSY correlation to H5 and H5ʹ)), 2.03 – 1.96 
(1H, m, H5ʹ), 1.65 (1H, app. td, J = 8.6, 4.2 Hz, H5ʹ), 1.62 – 1.50 (2H, m, H4ʹ (gCOSY 
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correlation to  H5ʹ)), 1.47 – 1.37 (2H, m, H3ʹ (gCOSY correlation to  H4ʹ)), 1.06 (3H, s, 
CH3) 0.89 (3H, s, CH3);  
δC 176.7 (C4 (gHMBC correlation to  OCH2Ph)), 172.2 (C2 (gHMBC correlation to 
NCH2Ph)) 137.7 (ipso-NCH2Ph (gHMBC correlation to NCH2Ph)), 134.9 (ipso-OCH2Ph 
(gHMBC correlation to  OCH2Ph)), 128.9 (ArCH), 128.9 (ArCH), 128.7 (ArCH), 127.9 
(ArCH), 127.9 (ArCH), 127.5 (ArCH), 95.5 (C3 (gHSQC correlation to  H3)), 73.1 
(OCH2Ph), 60.1 (C5), 47.8 (C1ʹ (gHMBC correlation to  CH3)), 43.6 (NCH2Ph), 43.5 
(C3ʹ (gHSQC correlation to  H3ʹ ppm)), 41.4 (C2ʹ), 29.5 (CH3), 27.2 (C5ʹ), 22.8 (CH3), 
20.9 (C4ʹ).  
vmax/cm
-1 3063, 3032, 2950, 2871, 1660, 1632, 1454, 1402, 1313, 1225, 1068, 804, 737, 
697, 466. 
HRMS (ESI) m/z calcd for C25H30NO2 [M+H]
+ 376.2277, found 376.2280. 
 (4S,5R)-1-Benzyl-4-(benzyloxy)-5-cyclopropyl-5-(2-methylallyl)pyrrolidin-2-one 
(291iia) 
  Major Diastereomer  
[α]25
D
  = 11.4 ˚ ± 2 ˚ (c 1.9, CHCl3).  
δH 7.44 – 7.06 (10H, m, ArCH), 4.94 (1H, bs, H3ʹ), 4.89 – 4.81 (2H, 
m, H3ʹ NCH2Ph), 4.59 (1H, d, J = 11.4 Hz, OCH2Ph), 4.43 (1H, d, J 
= 11.4 Hz, OCH2Ph), 4.17 (1H, d, J = 15.5 Hz, OCH2Ph), 3.77 (1H, 
app. t, J = 7.4 Hz, H4), 2.66 – 2.55 (2H, m, H3), 2.43 (1H, d, J = 13.4 
Hz, H3ʹ), 2.30 (1H, d, J = 13.4 Hz, H3ʹ), 1.83 (3H, s, CH3), 0.81 – 0.72 (1H, m, H1ʹʹ), 
0.49 – 0.40 (1H, m, H2ʹʹ), 0.39 – 0.31 (1H, m, H2ʹʹ), 0.23 – 0.16 (1H, m, H3ʹʹ), 0.10 – 
0.02 (1H, m, H3ʹʹ). 
δC 173.0 (C2), 141.3 (C2ʹ), 139.0 (ipso-NCH2Ph), 137.7 (ipso-OCH2Ph), 128.6 (ArCH), 
128.3 (ArCH), 127.9 (ArCH), 127.7 (ArCH), 127.5 (ArCH), 126.9 (ArCH), 117.0 (C3ʹ), 
78.1 (C4), 71.4 (OCH2Ph), 68.8 (C5), 44.1 (NCH2Ph), 37.9 (C1ʹ), 36.3 (C3), 25.2 (CH3), 
19.3 (C1ʹʹ), 2.8 (C2ʹʹ), 2.0 (C3ʹʹ).  
LRMS (ESI) m/z calcd for C25H30NO2 [M+H]
+ 376, found 376. 
7.3.7 Five-Membered Aromatic Heterocycles as Nucleophiles 
Reaction of 197 and Pyrrole in the Presence of BF3·Et2O 
This reaction was performed following general method B, using a 5-hydroxy-5-
cyclopropylpyrrolidin-2-one mixture 197 (0.050 g, 0.15 mmol), pyrrole (0.020 
g, 0.30 mmol, 0.021 mL), BF3·Et2O (0.046 g, 0.040 mL, 0.32 mmol) and CH2Cl2 
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(7.5 mL). After 48 h, the reaction was not proceeding and was quenched. After the 
standard work up, 1H NMR analysis indicated only starting material 197. 
Reaction of 197 and Thiophene in the Presence of BF3·Et2O 
This reaction was performed following general method B, using a 5-hydroxy-5-
cyclopropylpyrrolidin-2-one mixture 197 (0.050 g, 0.15 mmol), thiophene (0.025 
g, 0.30 mmol, 0.024 mL), BF3·Et2O (0.046 g, 0.040 mL, 0.32 mmol) and CH2Cl2 (7.5 
mL). After 48 h, the reaction was not proceeding and was quenched. After the standard 
work up, 1H NMR analysis indicated only starting material 197. 
 Reaction of 197 and Imidazole in the Presence of BF3·Et2O 
This reaction was performed following general method B, using a 5-hydroxy-5-
cyclopropylpyrrolidin-2-one mixture 197 (0.050 g, 0.15 mmol), imidazole (0.020 
g, 0.30 mmol), BF3·Et2O (0.046 g, 0.040 mL, 0.32 mmol) and CH2Cl2 (7.5 mL). 
After 48 h, the reaction was not proceeding and was quenched. After the standard work 
up, 1H NMR analysis indicated only starting material 197. 
7.3.6 Substituted Indoles as Nucleophiles 
(4S)-1-Benzyl-4-(benzyloxy)-5-cyclopropyl-5-(1H-indol-3-yl)pyrrolidin-2-one (296)  
Prepared following general method B, using a 5-hydroxy-5-
cyclopropylpyrrolidin-2-one mixture 197 (0.050 g, 0.15 mmol), 
indole (0.035 g, 0.30 mmol), BF3·Et2O (0.046 g, 0.040 mL, 0.32 
mmol) and CH2Cl2 (7.5 mL). This reaction was cooled to -40 °C, 
rather than 0 °C for both the BF3·Et2O addition, and for the duration 
of the reaction (26 h). The crude product was purified by flash column chromatography 
(1:1 EtOAc/PS) yielding the title compound 296 as a colourless oil (0.048 g, 0.11 mmol, 
74%) as a mixture of diastereomers (dr = 94:6). A small amount of each diastereomer 
could be isolated pure by further separation using column chromatography. 
Alternative synthesis of the title compound: 
When this reaction was carried out initially at 0 °C, rather than -40°C, the title compound 
was obtained as a colourless oil (0.045 g, 70%) as a mixture of diastereomers (dr = 52:48). 
When this reaction was carried out at reflux in CH2Cl2 over 3 h, the title compound was 
obtained as a colourless oil (0.047 g, 73%) as a mixture of diastereomers favouring the 








  = -21.9 ˚ ± 0.3 ˚ (c 12.0, CDCl3).  
δH 8.34 (1H, bs, H1ʹ (No gHSQC correlation)), 7.70 (1H, d, J = 8.1 
Hz, H4ʹ), 7.39 (1H, d, J = 8.1 Hz, H7ʹ), 7.23 – 7.18 (7H, m, ArCH), 
7.17 – 7.13 (4H, m, ArCH), 7.09 (1H, dd, J = 15.3 7.9 Hz, H5ʹ), 
6.84 (1H, d, J = 4.8 Hz, H2ʹ (gCOSY correlation to H1ʹ)), 5.13 (1H, 
d, J = 15.5 Hz, NCH2Ph), 4.21 (1H, d, J = 12.0 Hz, OCH2Ph), 4.12 (1H, dd, J = 12.0 Hz, 
OCH2Ph), 3.83 (1H, d, J = 15.5 Hz, NCH2Ph), 3.49 (1H, app. t, J = 7.3 Hz, H4), 2.83 
(1H, dd, J = 16.7, 7.7 Hz, H3), 2.58 (1H, dd, J = 16.7, 6.8 Hz, H3), 1.29 – 1.18 (1H, m, 
H1ʹʹ), 0.82 – 0.70 (2H, m, H2ʹʹ), 0.15 – 0.06 (1H, m, H3ʹʹ), -0.12— -0.20 (1H, m, H3ʹʹ); 
δC 173.0 (C2), 139.2 (ipso-NCH2Ph), 137.7 (ipso-OCH2Ph)), 137.1 (C7ʹa), 128.2 (ArCH), 
128.2 (ArCH), 128.1 (ArCH), 127.5 (ArCH), 127.3 (ArCH), 127.0 (C3ʹa), 126.9 (ArCH), 
124.1 (ArCH), 122.2 (ArCH), 121.9 (C4ʹ), 120.2 (C5ʹ), 116.7 (C3ʹ), 111.3 (C7ʹ), 73.3 
(C4), 71.3 (OCH2Ph), 70.9 (C5), 44.7 (NCH2Ph), 37.0 (C3), 18.4 (C1ʹʹ), 5.3 (C2ʹʹ), 2.4 
(C3ʹʹ).  
vmax/cm
-1 3265, 3005, 1662, 1434, 1408, 1354, 1094, 1026, 738, 698, 617, 465, 426. 
HRMS (ESI) m/z calcd for C29H28N2O2 [M + H]
+ 437.2229, found 437.2244.  
 (4S,5R)-1-Benzyl-4-(benzyloxy)-5-cyclopropyl-5-(1H-indol-3-yl)pyrrolidin-2-one 
(296b) 
Minor Diastereomer  
[α]25
D
  = 30.5 ˚ ± 1.9 ˚ (c 1.05, CDCl3). 
δH 8.52 (1H, bs, H1ʹ (No gHSQC correlation)), 7.35 (1H, d, J = 8.3 
Hz, H7ʹ), 7.31 – 7.13 (12H, m, ArCH), 7.12 (1H, d, J = 1.8 Hz, 
H2ʹ(gCOSY correlation to H1ʹ), 6.97 (1H, t, J = 7.5 Hz, ArCH), 
4.97 (1H, d, J = 15.7 Hz, NCH2Ph), 4.79 (1H, app. t, J = 5.5 Hz, 
H4), 4.61 (1H, d, J = 12.1 Hz, OCH2Ph), 4.56 (1H, d, J = 12.1 Hz, OCH2Ph), 4.17 (1H, 
d, J = 15.7 Hz, NCH2Ph), 2.67 (1H, dd, J = 16.4, 4.9 Hz, H3), 2.50 (1H, dd, J = 16.4, 6.1 
Hz, H3), 1.58 – 1.50 (1H, m, H1ʹʹ), 0.42 – 0.32 (3H, m, H2ʹʹ H3ʹʹ), 0.31 – 0.25 (1H, m, 
H3ʹʹ). 
δC 174.5 (C2), 139.0 (ipso-OCH2Ph), 138.2 (ipso-NCH2Ph), 137.1 (C7ʹa), 128.5 (ArCH), 
128.2 (ArCH), 127.7 (ArCH), 127.6 (ArCH), 126.9 (ArCH), 125.4 (C3ʹa), 124.5 (ArC), 
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122.3 (ArCH), 120.7 (ArCH), 120.0 (ArCH), 115.8 (C3ʹ), 111.9 (C7ʹ), 79.9 (C4), 72.0 
(OCH2Ph), 45.2 (NCH2Ph), 37.3 (C3), 14.6 (C1ʹʹ), 2.8 (C2ʹʹ), 2.4 (C3ʹʹ).  
LRMS (ESI) m/z calcd for C29H28N2O2 [M + H]
+ 437, found 437. 
(4S)-4-(Benzyloxy)-5-cyclopropyl-5-(1H-indol-3-yl)-1-methylpyrrolidin-2-one (304) 
Prepared following general method B, 5-hydroxy-5-cyclopropyl-1-
methylpyrrolidin-2-one mixture 199 (0.062 g, 0.24 mmol), indole 
(0.056 g, 0.47 mmol), BF3·Et2O (0.046 g, 0.040 mL, 0.32 mmol) 
and CH2Cl2 (7.5 mL). Reaction was run for 3 h. The product was 
purified by column chromatography (3:2 EtOAc/PS), yielding a 
white solid 304 (0.085 g, 0.23 mmol, 98%) as a mixture of diastereomers (dr = 90:10). A 







  = 70 ˚ ± 6 ˚ (c 1.2, CDCl3).  
δH 8.37 (1H, bs, H1ʹ), 7.69 (1H, d, J = 7.8 Hz, H4ʹ), 7.37 (1H, d, J 
= 8.3 Hz, H7ʹ), 7.19 (1H, t, J = 7.6 Hz, H6ʹ), 7.16 - 7.10 (3H, m, 
ArCH), 7.09 - 7.03 (1H, m, ArCH), 6.79 (2H, d, J = 7.3 Hz, ArCH), 
4.15 (1H, d, J = 12.0 Hz, OCH2Ph), 4.04 (1H, d, J = 12.0 Hz, 
OCH2Ph), 3.65 (1H, app. t, J = 6.1 Hz, H4), 2.81 - 2.72 (4H, m, H3 CH3), 2.53 (1H, dd, 
J = 5.4, 16.6 Hz, H3), 1.56 - 1.47 (1H, m, H4), 0.86 (1H, td, J = 4.9, 9.0 Hz, H2ʹʹ), 0.75 - 
0.68 (1H, m, H2ʹʹ), 0.67 - 0.58 (1H, m, H3ʹʹ), 0.37 (1H, app. dq, J = 10.0, 5.3 Hz, H3ʹʹ). 
172.8 (C2), 137.7 (ipso- OCH2Ph), 137.0 (C7ʹa), 128.2 (ArCH), 127.5 (ArCH), 127.4 
(ArCH), 127.2 (C2ʹ), 123.5 (ArCH), 122.4 (ArCH), 122.3 (C4ʹ), 120.1 (C5ʹ), 116.2 
(C3ʹa), 111.1 (C7ʹ), 76.4 (C4), 71.7 (OCH2Ph), 69.4 (C5), 37.3 (C3), 27.0 (NCH3), 17.9 
(C1ʹʹ), 3.6 (C2ʹʹ), 1.7 (C3ʹʹ).  
vmax/cm
-1 3250, 3223, 3185, 3062, 3005, 2926, 2871, 1667, 1456, 1396, 1332, 1246, 1111, 
1074, 1026, 766, 741, 698.  
HRMS (ESI) m/z calcd for C23H25N2O2 [M+H]






 Minor Diastereomer 
δH 8.45 (1H, bs, H1ʹ), 7.44 (1H, d, J = 2.0 Hz, H2ʹ (gCOSY to H1ʹ)), 
7.41 (1H, d, J = 8.2 Hz, ArCH), 7.33 (1H, d, J = 7.8 Hz, ArCH), 
7.23 – 7.16 (4H, m, ArCH), 7.10 – 7.03 (3H, m, ArCH), 4.73 (1H, 
t, J = 8.7 Hz, H4), 4.42 (1H, d, J = 11.9 Hz, OCH2Ph), 4.33 (1H, d, 
J = 11.9 Hz, OCH2Ph), 2.74 – 2.60 (2H, m, H3), 1.90 – 1.81 (1H, 
m, H1ʹʹ), 0.75 (1H, dt, J = 8.9, 4.4 Hz H2ʹʹ), 0.67 (1H, dd, J = 9.2, 4.8 Hz H2ʹʹ), 0.48 – 
0.35 (2H, m H3ʹʹ).  
δC 173.1 (C2), 137.9 (ipso-CH2Ph), 137.2 (C7ʹa), 128.3 (ArCH), 127.7 (ArCH), 127.6 
(ArCH), 125.2 (ArC), 124.8 (ArC), 122.5 (ArC), 120.3 (ArC), 119.9 (ArC), 117.4 (C3ʹ), 
111.8 (C7ʹ), 81.1 (C4), 72.4 (OCH2Ph), 67.6 (C5), 36.8 (CH3), 28.4 (C3), 14.6 (C1ʹʹ), 14.3 
(C1ʹʹ), 1.7 (C2ʹʹ), 1.5 (C3ʹʹ). vmax/cm
-1 3262, 3061, 3010, 2928, 2869, 1673, 1456, 1439, 
1422, 1390, 1264, 1126, 767, 744, 699, 677.  
LRMS (ESI) m/z calcd for C23H25N2O2 [M+H]
+ 361, found 361. 
 (4S)-1-Benzyl-4-(benzyloxy)-5-cyclopropyl-5-(5-methoxy-1H-indol-3-yl)pyrrolidin-
2-one (323i) 
Prepared following general method B, using a 5-hydroxy-5-
cyclopropylpyrrolidin-2-one mixture 197 (0.050 g, 0.15 
mmol), 5-methoxyindole (0.044 g, 0.30 mmol), BF3·Et2O 
(0.046 g, 0.040 mL, 0.32 mmol) and CH2Cl2 (7.5 mL). This 
reaction was cooled to -40 °C rather than 0 °C for the 
BF3·Et2O addition and kept at that temperature for the duration of the reaction. The crude 
product was purified by flash column chromatography (1:1 EtOAc/PS) yielding the title 
compound 323i as a colourless oil (0.059 g, 85%) and as a mixture of diastereomers (dr 
= 88:12). A small amount of each diastereomer could be isolated pure by further 
separation using column chromatography. 
Alternative syntheses of the title compound 323i: 
(a) When this reaction was carried out at 0 °C, for both the BF3·Et2O addition and the 
duration of the reaction, the title compound was obtained as a colourless oil (0.048 
g, 0.10 mmol, 70%) and as a mixture of diastereomers (dr = 80:20). 
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(b)  Using general method A, this reaction gave the title compound as a colourless oil 






  = 5.8 ˚ ± 0.7 ˚ (c 2.95, CDCl3).  
δH 8.42 (1H, bs, H1ʹ (No gHSQC correlation)), 7.25 (1H, d, 
J = 8.5 Hz, H7ʹ), 7.22 – 7.20 (4H, m), 7.18 – 7.14 (5H, m, 
ArCH, H4ʹ (gHSQC correlation to H4ʹ)), 7.09 (1H, d, J = 2.4 
Hz, H2ʹ (gCOSY to H1ʹ)), 6.90 (2H, dd, J = 6.6, 2.9 Hz, 
ArCH), 6.86 (1H, dd, J = 8.9, 2.4 Hz, H6ʹ (gHMBC correlation to H4ʹ and H7ʹ)), 5.12 
(1H, d, J = 15.5 Hz, NCH2Ph), 4.25 (1H, d, J = 11.8 Hz, OCH2Ph), 4.14 (1H, d, J = 11.8 
Hz, OCH2Ph), 3.87 (1H, d, J = 15.5 Hz, NCH2Ph), 3.73 (3H, s, OCH3), 3.50 (1H, app. t, 
J = 7.4 Hz, H4), 2.83 (1H, dd, J = 16.6, 7.4 Hz. H3), 2.57 (1H, dd, J = 16.6, 7.4 Hz, H3), 
1.24 – 1.20 ( 1H, m, H1ʹʹ), 0.81 – 0.73 (2H, m, H2ʹʹ), 0.16 – 0.04 (1H, m, H3ʹʹ), -0.13 – -
0.20 (1H, m, H3ʹʹ). 
δC 173.0 (C2), 154.1 (C5ʹ), 139.1 (ipso-NCH2Ph (gHMBC correlation to NCH2Ph)), 
137.6 (ipso-OCH2Ph (gHMBC correlation to OCH2Ph)), 132.2 (C7ʹa (gHMBC 
correlation to H6ʹ and H2ʹ)), 128.4 (ArCH), 128.2 (ArCH), 128.2 (ArCH), 128.1 (ArCH), 
127.6 (ArCH), 127.34 (ArCH), 127.33 (C3ʹa), 126.9 (ArCH), 124.6 (C2ʹ), 116.1 (C3ʹ 
(gHMBC correlation to H15)), 112.6 (C6ʹ), 112.0 (C7ʹ), 103.6 (C4ʹ), 73.5 (C4), 71.3 
(OCH2Ph), 70.8 (C5), 55.8 (OCH3), 44.6 (NCH2Ph), 36.7 (C3), 18.1 (C1ʹʹ), 5.4 (C2ʹʹ), 2.6 
(C3ʹʹ).  
vmax/cm
-1 2923 (alkane C-H), 1666 (tertiary amide C=O), 1437 (C-H methylene or 
methyl),1295 (Ar N-C), 1213 (C-O OMe), 800 (Ar C-H), 745(Ar C-H), 700 (Ar C-H).  
HRMS (ESI) m/z calcd for C30H31N2O3 [M + H]









 Minor diastereomer 
δH 8.25 (1H, bs, H1ʹ), 7.29 – 7.22 (3H, m, ArCH), 7.22 – 7.19 
(2H, m, ArCH), 7.19 – 7.12 (7H, m, ArCH), 6.82 (1H, dd, J 
= 8.7, 2.0 Hz, H6ʹ), 6.69 (1H, s, H4ʹ), 4.84 – 4.77 (2H, m, 
NCH2Ph, H4), 4.55 (2H, s, OCH2Ph), 4.22 (1H, d, J = 15.5 
Hz, NCH2Ph), 3.62 (3H, s, OCH3), 2.70 (1H, dd, J = 16.3, 
5.7 Hz, H3), 2.53 (1H, dd, J = 16.3, 6.4 Hz, H3), 1.67 – 1.54 
(1H, m, H1ʹʹ), 0.50 – 0.38 (2H, m, H2ʹʹ, H3ʹʹ), 0.37 – 0.32 (1H, d, J = 5.4 Hz, H3ʹʹʹ). 
δC 174.3 (C2), 154.0 (C5ʹ), 138.9 (ipso-NCH2Ph), 138.2 (ipso-OCH2Ph), 132.2 (C7ʹa (no 
gHSQC correlation, gHMBC correlation to H4ʹ)), 128.5 (ArCH), 128.1 (ArCH), 127.9 
(ArCH), 127.8 (ArCH), 127.5 (ArCH), 126.9 (ArCH), 125.8 (C3ʹa), 125.2 (ArCH), 115.8 
(C3ʹ (gHMBC correlation to H4)), 112.5 (C6ʹ (gHSQC correlation to H6ʹ)), 112.4 (C7ʹ 
(process of elimination)), 102.8 (C4ʹ), 79.6 (C4), 71.9 (OCH2Ph), 56.0 (OCH3), 45.2 
(NCH2Ph), 37.2 (C3), 14.7 (C1ʹʹ), 2.7 (C2ʹʹ), 2.3 (C3ʹʹ).  
LRMS (ESI) m/z calcd for C30H31N2O3 [M + H]
+ 467, found 467.  
 (4S)-1-Benzyl-4-(benzyloxy)-5-cyclopropyl-5-(5-fluoro-1H-indol-3-yl)pyrrolidin-2-
one (323ii) 
Prepared following general method A, using a 5-hydroxy-5-
cyclopropylpyrrolidin-2-one mixture 197 (0.050 g, 0.15 mmol), 
5-fluoroindole (0.060 g, 0.44 mmol), BF3·Et2O (0.046 g, 0.040 
mL, 0.32 mmol) and CH2Cl2 (7.5 mL). Stirred for 2 h at room 
temperature rather than 12 h. The crude product was purified by 
flash column chromatography (1:1 EtOAc/PS) yielding the title compound 323ii as a 
yellow solid (0.055 g, 89%) and as a mixture of diastereomers (dr = 89:11). A small 












  = 7.5 ˚ ± 1.3 ˚ (c 5.05, CDCl3). 
δH 8.63 (1H, bs, H1ʹ), 7.40 (1H, dd, J = 10.5, 1.5 Hz, H4ʹ), 7.27 
(2H, dd, J = 8.5, 4.0 Hz H7ʹ, ArCH), 7.23 – 7.16 (8H, m, ArCH), 
7.00 (1H, d, J = 2.5 Hz, ArCH), 6.93 (1H, dd, J = 9.0, 2.0 Hz, 
H6ʹ), 6.89 (1H, s, H2ʹ), 5.10 (1H, d, J = 15.5 Hz, NCH2Ph), 4.23 
(1H, d, J = 12.0 Hz, OCH2Ph), 4.15 (1H, d, J =  12.0 Hz, OCH2Ph), 3.86 (1H, d, J = 15.5 
Hz, NCH2Ph), 3.48 (1H, app. t, J = 7.5 Hz, H4), 2.81 (1H, dd, J =  16.5, 7.5 Hz, H3), 2.54 
(1H, dd, J =  16.5, 7.5 Hz, H3), 1.24 – 1.18 (1H, m, H1ʹʹ), 0.82 – 0.75 (2H, m, H2ʹʹ), 0.12 
– 0.10 (1H, m, H3ʹʹ), -0.12 – -0.15 (1H, m, H3ʹʹ).  
δC 173.0 (C2), 157.9 (d, J = 233.9 Hz, C5ʹ), 138.9 (ipso-NCH2Ph), 137.4 (ipso-OCH2Ph), 
128.5 (C7ʹa), 128.3 (ArCH), 128.2 (ArCH), 128.1 (ArCH), 127.6 (ArCH), 127.3 (ArCH), 
126.9 (ArCH), 126.5 (ArCH), 116.6 (d, J = 4.8 Hz, C3ʹ), 112.0 (d, J = 9.6 Hz, C7ʹ), 110.5 
(d, J = 26.9 Hz, C6ʹ), 107.0 (d, J = 25.0 Hz, C4ʹ), 73.3 (C4), 71.4 (OCH2Ph), 70.7 (C5), 
44.6 (NCH2Ph), 36.7 (C3), 17.9 (C1ʹʹ), 5.5 (C2ʹʹ), 2.6 (C3ʹʹ). vmax/cm
-1 3263, 2921, 2853, 
1662, 1454, 1410, 1352, 1261, 1093, 1026, 930, 798, 737, 633.  
HRMS (ESI) m/z calcd for C29H28FN2O2 [M + H]
+ 455.2135, found 455.2144.  
  (4S)-1-Benzyl-4-(benzyloxy)-5-(5-chloro-1H-indol-3-yl)-5-cyclopropylpyrrolidin-
2-one (323iii)  
Prepared following general method A, using a 5-hydroxy-5-
cyclopropylpyrrolidin-2-one mixture 197 (0.050 g, 0.15 
mmol), 5-chloroindole (0.068 g, 0.45 mmol), BF3·Et2O (0.046 
g, 0.040 mL, 0.32 mmol) and CH2Cl2 (7.5 mL). The reaction 
mixture was stirred for 2 h at room temperature rather than 12 
h. The crude product was purified by flash column chromatography (1:1 EtOAc/PS) 
yielding the title compound 323iii as a yellow solid (0.059 g, 76%) and as a mixture of 
diastereomers (dr > 95:5). A small amount of the major diastereomer could be isolated 










  = 90 ˚ ± 6 ˚ (c 14.4, CDCl3).  
δH 8.42 (1H, bs, H1ʹ), 7.77 (1H, d, J = 1.7 Hz, H4ʹ), 7.27 (1H, 
d, J = 8.7 Hz, H7ʹ), 7.24 – 7.20 (5H, m. ArCH), 7.20 – 7.17 
(3H, m, ArCH), 7.14 (1H, dd, J = 8.6, 1.7 Hz, H6ʹ), 7.04 (1H, 
d, J = 1.7 Hz, H2ʹ), 6.95 – 6.91 (2H, m, ArCH), 5.10 (1H, d, J 
= 15.4 Hz, NCH2Ph), 4.26 (1H, d, J = 12.1 Hz, , OCH2Ph), 4.17 (1H, d, J = 12.1 Hz, 
OCH2Ph), 3.91 (1H, d, J = 15.4 Hz, NCH2Ph), 3.49 (1H, app. t, J = 7.4 Hz, H4), 2.79 
(1H, dd, J = 16.6, 7.4 Hz, H3), 2.52 (1H, dd, J = 16.6, 7.4 Hz, H3), 1.24 – 1.17 (1H, m, 
H1ʹʹ), 0.87 – 0.47 (2H, m, H2ʹʹ), 0.11 (1H, m, J = 9.2, 5.9 Hz, H3ʹʹ), -0.09 – -0.17 (1H, 
m, H3ʹʹ). 
δC 172.8 (C2), 138.9 (ipso-NCH2Ph), 137.4 (ipso-OCH2Ph), 135.6 (C7ʹa), 128.4 (ArCH), 
128.3 (ArCH), 128.2 (ArCH), 128.1 (C5ʹa), 127.6 (ArCH), 127.2 (ArCH), 127.0 
(ArCH), 125.7 (C3ʹa), 124.7 (C2ʹ), 122.6 (C6ʹ), 122.0 (C4ʹ), 116.7 (C3ʹ), 112.3 (C7ʹ), 
73.4 (C4), 71.4 (OCH2Ph), 70.5 (C5), 44.6 (NCH2Ph), 36.3 (C3), 17.7 (C1ʹʹ), 5.8 (C2ʹʹ), 
2.9 (C3ʹʹ).  
vmax/cm
-1 2926 (alkane C-H), 1666 (tertiary amide C=O), 1402 (C-H methylene or 
methyl), 1270 (Ar N-C), 1069 (C-O C-OBn ether), 744 (Ar C-H), 697 (Ar C-H).  
HRMS (ESI) m/z calcd for NaC29H27
35ClN2O2 [M + Na]




Minor diastereomer indicative peaks from mixture of 
diastereomers δH 8.31 (1H, bs, H1ʹ), 7.39 – 7.34 (1H, m, H7ʹ), 
7.32 – 7.13 (11H, m, ArCH), 6.98 (2H, app. t, J = 7.6 Hz, 
ArCH), 4.97 (1H, d, J = 15.5 Hz, NCH2Ph), 4.80 (1H, app. t, J 
= 5.5 Hz, H4), 4.61 (1H, d, J = 12.2 Hz, OCH2Ph), 4.56 (1H, 
d, J = 12.2 Hz, OCH2Ph), 4.16 (1H, d, J = 15.5 Hz, NCH2Ph), 
2.68 (1H, dd, J = 16.5, 4.9 Hz, H3), 2.52 (1H, dd, J = 16.5, 6.1 Hz, H3), 1.58 – 1.51 (1H, 





Prepared following general method A, using a 5-hydroxy-5-
cyclopropylpyrrolidin-2-one mixture 197 (0.050 g, 0.15 
mmol), 5-bromoindole (0.068 g, 0.45 mmol), BF3·Et2O (0.046 
g, 0.040 mL, 0.32 mmol) and CH2Cl2 (7.5 mL). The reaction 
mixture was stirred for 2 h at room temperature rather than 12 
h. The crude product was purified by flash column chromatography (1:1 EtOAc/PS) 
yielding the title compound 323iv as a yellow solid (0.070 g, 0.136 mmol, 92%) and as a 
mixture of diastereomers (dr > 95:5). A small amount of the major diastereomer could be 






  = 30.1 ˚ ± 2.0 ˚ (c 2.25, CDCl3).  
δH 8.27 (1H, bs, H1ʹ), 7.96 (1H, s, H4ʹ), 7.27 (1H, dd, J = 8.5, 
1.5 Hz, H6ʹ), 7.24 – 7.16 (10H, m), 7.02 (1H, d, J = 2.6 Hz, 
H2ʹ), 6.95 (1H, d, J = 6.6 Hz, H7ʹ), 5.10 (1H, d, J = 15.2 Hz, 
NCH2Ph), 4.28 (1H, d, J = 12.1 Hz, OCH2Ph), 4.19 (1H, d, J = 
12.1 Hz, OCH2Ph), 3.93 (1H, d, J = 15.2 Hz, NCH2Ph), 3.49 (1H, t, J = 7.4 Hz, H4), 2.79 
(1H, dd, 16.6, 7.4 Hz, H3), 2.52 (1H, dd, J = 16.6, 7.4 Hz, H3), 1.24 – 1.18 (1H, m, H1ʹʹ), 
0.91 – 0.75 (2H, m, H2ʹʹ), 0.13 – 0.08 (1H, d, J = 3.7 Hz, H3ʹʹ), -0.09 – -0.15 (1H, m, 
H3ʹʹ). 
δC 172.8 (C2), 139.0 (ipso-NCH2Ph (gHMBC correlation to NCH2Ph)), 137.4 (ipso-
OCH2Ph (gHMBC correlation to OCH2Ph)), 135.8 (C7ʹa), 128.8 (C3ʹa), 128.3 (ArCH), 
128.3 (ArCH), 127.6 (ArCH), 127.2 (C6ʹ, C7ʹ (gHSQC)), 127.0 (ArCH), 125.2 (C4ʹ), 
124.4 (C2ʹ), 112.7 (C3ʹ), 73.4 (C4), 71.4 (OCH2Ph), 70.4 (C5), 44.6 (NCH2Ph), 36.1 (C3), 
17.7 (C1ʹʹ), 5.9 (C2ʹʹ), 3.0 (C3ʹʹ).  
vmax/cm
-1 3409, 2968, 2921, 2860, 2106, 1753, 1686, 1502, 1414, 1380, 1346, 1258, 1224, 
1007, 980, 797, 735, 695.  
HRMS (ESI) m/z calcd for NaC29H27
79BrN2O2 [M + Na]




indole-5-carboxylate (323v)  
Prepared following general method B, using a 5-hydroxy-
5-cyclopropylpyrrolidin-2-one mixture 197 (0.050 g, 0.15 
mmol), methyl indole-5-carboxylate (0.078 g, 0.45 
mmol), BF3·Et2O (0.046 g, 0.040 mL, 0.32 mmol) and 
CH2Cl2 (7.5 mL). The crude product was purified by flash 
column chromatography (2:1 EtOAc/PS), yielding 323v 
as a white foam (0.045 g, 0.090 mmol, 61%) as a mixture of diastereomers (dr = 84:16). 




Major Diastereomer  
[α]25
D
  = 35.2 ˚ ± 0.5 ˚ (c 17.0, CDCl3).  
δH 8.92 (1H, bs, H1ʹ), 8.64 (1H, s, H4ʹ), 7.89 (1H, d, J = 
8.6 Hz, H6ʹ), 7.35 (1H, d, J = 8.6 Hz, H7ʹ), 7.28 – 7.16 
(6H, m, ArCH), 7.13 (2H, d, J = 6.7 Hz, ArCH), 7.03 
(1H, d, J = 2.0 Hz, ArCH), 6.95 – 6.91 (2H, m, ArCH), 
5.10 (1H, d, J = 15.3 Hz, NCH2Ph), 4.26 (1H, d, J = 11.8 Hz, OCH2Ph), 4.18 (1H, d, J 
= 11.8 Hz, OCH2Ph), 3.95 (1H, d, J = 15.3 Hz, NCH2Ph), 3.90 (3H, s, COOCH3), 3.53 
(1H, t, J = 7.6 Hz, H3), 2.80 (1H, dd, J = 16.5, 7.6 Hz, H4), 2.53 (1H, dd, J = 16.5, 7.6 
Hz, H4), 1.32 – 1.18 (1H, m, H1ʹʹ), 0.94 – 0.82 (2H, m, H2ʹʹ), 0.14 – 0.10 (1H, m, H3ʹʹ), 
-0.10 – -0.16 (1H, m, H3ʹʹ). 
δC 172.9 (C5), 168.4 (ArCOOMe), 140.0 (C7ʹa), 138.9 (ipso-NCH2Ph), 137.4 (ipso-
OCH2Ph), 128.3 (ArCH), 128.2 (ArCH), 128.2 (ArCH), 127.6 (ArCH), 127.4 (ArCH), 
127.0 (ArCH), 126.7 (ArCH), 125.7 (ArCH), 124.5 (ArCH), 123.5 (ArCH), 121.8 
(ArCH), 118.1 (C6ʹ), 111.1 (C7ʹ), 73.3 (C4), 71.4 (OCH2Ph), 70.6 (C2), 52.0 (OCH3), 
44.7 (NCH2Ph), 36.0 (C4), 17.7 (C1ʹʹ), 5.9 (C2ʹʹ), 3.1 (C3ʹʹ).  
vmax/cm
-1 3310, 2935, 2109, 1754, 1665, 1617, 1433, 1351, 1317, 1242, 1105, 907, 730, 
703.  
HRMS (ESI) m/z calcd for NaC31H30N2O4 [M + Na]




carbonitrile (323vi)  
Prepared following general method B, using a 5-hydroxy-5-
cyclopropylpyrrolidin-2-one mixture 197 (0.050 g, 0.148 
mmol), 5-cyanoindole (0.042 g, 0.3 mmol), BF3·Et2O (0.046 
g, 0.040 mL, 0.32 mmol) and CH2Cl2 (10.0 mL). The product 
was purified by column chromatography (1:1 EtOAc/PS), 
yielding the title compound 323vi as a yellow solid (0.048 g, 
0.104 mmol, 70%) as a mixture of diastereomers (93:7). A small amount of the major 






  = 23.5 ˚ ± 0.2 ˚ (c 14.2, CDCl3).  
δH  8.66 (1H, bs, H1ʹ), 8.17 (1H, s, H4ʹ), 7.43 – 7.38 (2H, m, 
ArCH), 7.25 – 7.16 (8H, m, ArCH), 7.08 (1H, d, J = 1.7 Hz, 
ArCH), 6.96 – 6.89 (2H, m, ArCH), 5.07 (1H, d, J = 15.1 Hz, 
NCH2Ph), 4.28 (1H, d, J = 11.7 Hz, OCH2Ph ), 4.18 (1H, d, J 
= 11.7 Hz, OCH2Ph), 3.99 (1H, d, J = 15.1 Hz, NCH2Ph), 3.51 
(1H, app. t, J = 7.4 Hz, H3), 2.78 (1H, dd, J = 16.4, 7.4 Hz, H4), 2.48 (1H, dd, J = 16.4, 
7.7 Hz, H4), 1.24 – 1.17 (1H, m, H1ʹʹ), 0.95 – 0.77 (2H, m, H2ʹʹ), 0.13 (1H, m, H3ʹʹ), -
0.03 – -0.11 (1H, m, H3ʹʹ).  
δC 172.7 (C5), 139.0 (ipso-NCH2Ph), 138.8 (C7ʹa), 137.1 (ipso-OCH2Ph), 128.8 (ArCH), 
128.5 (ArCH), 128.4 (ArCH), 128.3 (ArCH), 127.9 (ArCH), 127.4 (ArCH), 127.2 
(ArCH), 127.1 (C3ʹa), 125.1 (ArCH), 125.0 (C3ʹa), 120.8 (NC), 118.4 (C3ʹ (gHMBC 
correlation to  H4), 112.2 (C7ʹ), 103.1 (C5ʹ), 73.4 (C3), 71.6 (OCH2Ph), 70.3 (C2 
(gHMBC correlation to  H4 and H1ʹʹ)), 44.6 (NCH2Ph), 35.9 (C4), 17.5 (C1ʹʹ), 6.0 (C2ʹʹ), 
3.2 (C3ʹʹ).  
vmax/cm
-1 3241, 2922, 2218, 1664, 1434, 1406, 1348, 1096, 1073, 1026, 808, 735, 700, 
640, 421.  
HRMS (ESI) m/z calcd for NaC30H27N3O2 [M+Na]





 Prepared following general method B, using a 5-hydroxy-5-
cyclopropylpyrrolidin-2-one mixture 197 (0.050 g, 0.15 
mmol), 5-nitroindole (0.068 g, 0.45 mmol), BF3·Et2O (0.046 
g, 0.040 mL, 0.32 mmol) and CH2Cl2 (7.5 mL). The product 
was purified by column chromatography (3:2 PS/EtOAc), 
yielding the title compound 325 as a yellow oil (0.040 g, 0.083 mmol, 56%) and as a 
mixture of diastereomers (dr > 95:5). A small amount of the major diastereomer could be 
isolated pure by further separation using column chromatography. The spirocycle 326a 
was also isolated as a yellow oil (0.011 g, 0.023 mmol, 15%) and as a mixture of 
diastereomers (dr > 95:5). A small amount of the major diastereomer could be isolated 
pure by further separation using column chromatography. 
Alternative synthesis of the title compound: 
The title compound was also prepared following general method A, using a 5-hydroxy-
5-cyclopropylpyrrolidin-2-one mixture 197 (0.050 g, 0.15 mmol), 5-nitroindole (0.068 g, 
0.45 mmol), BF3·Et2O (0.046 g, 0.040 mL, 0.32 mmol) and CH2Cl2 (7.5 mL). After a 
similar work-up and purification procedure the title compound 325 was obtained as a 
yellow oil (0.029 g, 0.060 mmol, 41%) and as a mixture of diastereomers (dr = 88:12). 
The 326a was also isolated as a yellow oil (0.009 g, 0.019 mmol, 13%) and as a mixture 
of diastereomers (dr > 95:5). 
 (4S,5S)-1-Benzyl-4-(benzyloxy)-5-cyclopropyl-5-(5-nitro-1H-indol-3-yl)pyrrolidin-




  = 113 ˚ ± 12 ˚ (c 12.5, CDCl3).  
δH  9.01 (1H, bs, H1ʹ), 8.85 (1H, d, J = 2.1 Hz, H4ʹ), 8.05 (1H, 
dd, J = 8.8, 2.1 Hz, H6ʹ), 7.36 (1H, d, J = 8.8 Hz, H7ʹ), 7.25 
– 7.18 (5H, m, ArCH), 7.17 – 7.14 (3H, m, ArCH), 7.06 (1H, 
d, J = 2.3 Hz, H2ʹ (gCOSY correlation to H1ʹ)), 6.98 –  6.96 
(2H, m,  ArCH), 5.07 (1H, d, J = 15.1 Hz, NCH2Ph), 4.29 (1H, d, J = 11.7 Hz, OCH2Ph), 
4.21 (1H, d, J = 11.7 Hz, OCH2Ph), 4.06 (1H, d, J = 15.1 Hz, NH2Ph), 3.56 (1H, t, J = 
7.7 Hz, H4), 2.79 (1H, dd, J = 16.4, 7.7 Hz, H3), 2.48 (1H, dd, J = 16.4, 7.7 Hz, H3), 
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1.30 – 1.18 (1H, m, H1ʹʹ), 1.02 – 0.88 (2H, m, H2ʹʹ), 0.16 (1H, dd, J = 9.4, 5.7 Hz, H3ʹʹ), 
-0.01 – -0.10 (1H, m, H3ʹʹ). 
δC 172.7 (C2), 141.7 (C7ʹa), 140.4 (C5ʹ), 138.6 (ipso-NCH2Ph), 137.0 (ipso-OCH2Ph), 
128.4 (ArCH), 128.3 (ArCH), 127.9 (ArCH), 127.5 (ArCH), 127.2 (ArCH), 126.6 (C3ʹa), 
125.7 (ArCH), 120.5 (C2ʹ), 119.7 (C3ʹ), 117.7 (C6ʹ), 111.3 (C7ʹ), 73.2 (C4), 71.6 
(OCH2Ph), 70.3 (C5), 44.7 (NCH2Ph), 35.7 (C3), 17.3 (C1ʹʹ), 6.1 (C2ʹʹ), 3.3 (C3ʹʹ).  
vmax/cm
-1 3330, 2975, 2887, 1672, 1519, 1380, 1330, 1088, 1047, 881, 648.  
HRMS (ESI) m/z calcd for NaC29H27N3O4 [M + Na]






  = 61.0 ± 5 (c 2.1, CHCl3).  
δH 8.74 (1H, bs, H9), 8.54 (1H, d, J = 1.5 Hz, H5), 8.08 (1H, d, J = 
9.0, 1.5 Hz, H7), 7.22 – 7.18 (1H, m, ArCH), 7.16 – 7.12 (4H, m, 
ArCH), 7.06 (1H, d, J = 9.0 Hz, H8 (gCOSY correlation to H7)), 
6.97 (2H, d, J = 7.3 Hz, ArCH), 6.82 (2H, d, J = 7.3 Hz, ArCH), 
4.41 (1H, d, J = 15.2 Hz, NCH2Ph), 4.23 (1H, d, J = 11.2 Hz, 
OCH2Ph), 4.16 (1H, d, J = 15.2 Hz, NCH2Ph), 3.98 (1H, d, J = 6.4 
Hz, H3ʹ (ROESY correlation to H2), 3.93 (1H, d, J = 11.2 Hz, OCH2Ph), 2.91 – 2.84 
(2H, m, H4, H4ʹ), 2.72 – 2.65 (2H, m, H4, H4ʹ), 2.01 – 1.99 (1H, m, H3), 1.77 – 1.69 
(2H, m, H2, H3 (ROESY correlation to H3ʹ), 1.68 – 1.62 (1H, m, H2 (gHMBC 
correlation to C2)).  
δC 173.7 (C5ʹ), 141.5 (C8a (gHMBC correlation to H8)), 139.4 (C6 (gHMBC correlation 
to H5 and H7)), 138.2 (ipso-NCH2Ph (gHMBC correlation to NCH2Ph)), 136.9 (ipso-
OCH2Ph (gHMBC correlation to OCH2Ph)), 133.6 (C9a (gHMBC correlation to 
NCH2Ph)), 128.6 (ArCH), 128.5 (ArCH), 128.3 (ArCH), 128.2 (ArCH), 127.9 (ArCH), 
127.6 (ArCH), 125.7 (C4b (gHMBC correlation to H9 and H8, no gHSQC correlation)), 
118.3 (C7), 118.1 (C4a (gHMBC correlation to H4)), 116.4 (C5 (gHSQC correlation to 
H5), 111.2 (C8), 79.5 (C3ʹ), 72.2 (OCH2Ph), 68.0 (C1 (gHMBC correlation to 
NCH2Ph)), 44.6 (NCH2Ph), 37.1 (C4ʹ), 32.5 (C2 (gHSQC correlation to H2, gHMBC 
correlation to H3ʹ), 21.5 (C3), 20.8 (C4).  
vmax/cm
-1 3330, 2975, 2887, 1654, 1522, 1360, 1088, 1044, 870, 740, 648.  
HRMS (ESI) m/z calcd for C29H28N3O4 [M + H]
+ 482.2080, found 482.2074. 
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Reaction of 197 and 5-Aminolindole in the Presence of BF3·Et2O  
This reaction was performed following general method A, using a 5-
hydroxy-5-cyclopropylpyrrolidin-2-one mixture 197 (0.073 g, 0.216 
mmol), 5-aminoindole (0.086 g, 0.65 mmol), BF3·Et2O (0.061 g, 
0.055 mL, 0.432 mmol) and CH2Cl2 (7.5 mL). After the standard 
work up, 1H NMR analysis indicated only starting material 197. 
Reaction of 197 and 7-Fluoroindole in the Presence of BF3·Et2O  
Prepared following general method B, using a 5-hydroxy-5-cyclopropylpyrrolidin-2-one 
mixture 197 (0.050 g, 0.15 mmol), 7-fluoroindole (0.040 g, 0.30 
mmol), BF3·Et2O (0.046 g, 0.040 mL, 0.32 mmol) and CH2Cl2 (7.5 
mL).  The product was purified by column chromatography (1:2 
EtOAc/PS), yielding yellow solid 340i (0.049 g, 0.11 mmol, 73%) 
as a mixture of diastereomers (84:16). A small amount of the major 
diastereomer could be isolated pure by further separation using 
column chromatography. Compound 341i was also isolated as a yellow oil (0.003 g, 0.007 






  = -2.3 ˚ ± 0.2 ˚ (c 14.0, CDCl3). 
δH 8.85 (1H, bs, H1ʹ (no gHSQC correlation)), 7.44 (1H, d, J = 8.1 
Hz, H4ʹ), 7.24 – 7.11 (10H, m, ArCH), 7.01 – 6.97 (1H, m, H5ʹ 
(gCOSY correlation to  H4ʹ and H6ʹ)), 6.90 (1H, dd, J = 10.8, 8.1 
Hz, H6ʹ (gCOSY correlation to H5ʹ, and 10.8 Hz coupling is H-F 
ortho coupling 3J)), 6.87 – 6.82 (1H, m, ArCH), 5.12 (1H, d, J = 
15.5 Hz, NCH2Ph), 4.22 (1H, d, J = 12.0 Hz, OCH2Ph), 4.11 (1H, d, J = 12.0 Hz 
OCH2Ph), 3.81 (1H, d, J = 15.5 Hz, NCH2Ph), 3.49 (1H, app. t, J = 7.2 Hz, H4 (gCOSY 
correlation to  H3)), 2.85 (1H, dd, J = 16.7, 7.4 Hz, H3 (gCOSY correlation to  H4)), 2.58 
(1H, dd, J = 16.7, 6.6 Hz H3 (gCOSY correlation to  H4)), 1.25 – 1.17 (1H, m, H1ʹʹ), 0.82 
– 0.68 (2H, m, H2ʹʹ), 0.16 – 0.07 (1H, m, H3ʹʹ), -0.11 – -0.21 (1H, m, H3ʹʹ). 
δC 173.1 (C2), 149.8 (d, J = 243.8 Hz, C7ʹ (
1J C-F coupling)), 139.1 (ipso-NCH2Ph 
(gHMBC correlation to  NCH2Ph)), 137.6 (ipso-OCH2Ph (gHMBC correlation to  
OCH2Ph)), 130.6 (d, J = 4.7 Hz, C7ʹa (gHMBC correlation to H6ʹ)), 128.3 (ArCH), 128.3 
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(ArCH), 128.2 (ArCH), 127.7 (ArCH), 127.4 (ArCH), 127.0 (ArCH), 125.7 (d, J = 13.0 
Hz, C3ʹa), 125.0 (ArCH), 120.3 (d, J = 6.5 Hz, C5ʹ), 117.7 (d, J = 3.7 Hz, C4ʹ), 117.6 (C3ʹ 
(gHMBC correlation to H4ʹ and H4)), 106.8 (d, J = 15.8 Hz, C6ʹ), 73.3 (C4), 71.5 
(OCH2Ph), 70.8 (C5 (gHSQC no correlation, quaternary in APT, gHMBC correlation to 
H1ʹʹ, H4 and NCH2Ph)), 44.8 (NCH2Ph), 37.0 (C3), 18.5 (C1ʹʹ), 5.4 (C2ʹʹ), 2.5 (C3ʹʹ).  
vmax/cm
-1 2875, 1666, 1353, 1234, 1091, 1025, 934, 847, 749, 701.  
HRMS (ESI) m/z calcd for NaC29H27FN2O2 [M+Na]
+ 477.1954, found 477.1968. 
 (1S,3ʹS)-1ʹ-Benzyl-3ʹ-(benzyloxy)-8-fluoro-2,3,4,9-tetrahydrospiro[carbazole-1,2ʹ-




  = 71 ˚ ± 4 ˚ (c 1.5, CDCl3).  
δH 7.56 (1H, bs, H9), 7.29 – 7.25 (4H, m, CHCl3 and H5 (gHSQC 
correlation to  C4)), 7.17 – 7.07 (4H, m, ArCH), 7.02 (1H, td, J = 
7.6, 4.9 Hz, H6), 6.96 (2H, d, J = 7.4 Hz, ArCH), 6.87 (1H, dd, J 
= 10.9, 7.9 Hz, H7 (gCOSY correlation to  H6, and 10.9 Hz 
coupling is H-F ortho coupling 3J)), 4.42 (1H, d, J = 12.1 Hz, 
OCH2Ph), 4.38 (1H, d, J = 12.1 Hz, OCH2Ph), 4.34 – 4.28 (2H, m, NCH2Ph, H3ʹ (gCOSY 
correlation to H4ʹ, gHSQC correlation to  C3ʹ)), 4.24 (1H, d, J = 15.1 Hz, NCH2Ph), 2.83 
(1H, dd, J = 16.8, 7.4 Hz, H4ʹ (gCOSY correlation to  H4ʹ and H3ʹ)), 2.80 – 2.74 (1H, m, 
H4 (gCOSY correlation to  H3, gHMBC correlation to  C3)), 2.71 (1H, dd, J = 16.8, 7.1 
Hz, H4ʹ (gCOSY correlation to  H3ʹ)), 2.68 – 2.63 (1H, m, H4 (gHMBC correlation to  
C3)), 2.48 – 2.42 (1H, m, H2), 2.04 – 1.98 (1H, m, H3 (gCOSY correlation to  H4)), 1.97 
– 1.90 (1H, m, H3 (gCOSY correlation to  H3 and H4 weakly)), 1.76 (1H, td, J = 12.7, 
3.2 Hz, H2, (gCOSY correlation to  H3)). 
δC 172.3 (C5ʹ), 149.7 (C8 (determined by gHMBC correlations as peak intensity was just 
above the base line)), 138.1 (ipso-NCH2Ph), 137.4 (ipso-OCH2Ph), 133.1 (d, J = 3.7 Hz, 
C8ʹa (gHMBC correlation to H4), 128.5 (ArCH), 128.0 (ArCH), 127.6 (ArCH), 127.4 
(ArCH), 120.1 (d, J = 6.5 Hz, C6, (gHSQC correlation to H6)), 114.7 (d, J = 3.7 Hz, C5), 
107.8 (d, J = 15.8 Hz, C7 (gHSQC correlation to H7)), 79.8 (C3ʹ), 72.4 (OCH2Ph), 65.7 
(C1), 44.1 (NCH2Ph), 36.0 (C4ʹ), 28.6 (C2), 21.6 (C3), 20.9 (C4).  
vmax/cm
-1 3248 (O-H), 2921 (Methylene C-H), 2866 (Methylene C-H), 2218, 2108, 1757, 
1672 (C=O amide), 1447 (methylene C-H), 1412 (methylene C-H), 1351, 1310, 1221 
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(C-N or C-O alcohol), 1146 (C-N or C-O alcohol), 1105 (C-N or C-O alcohol), 1023 (C-
N), 730 (Ar C-H), 696 (Ar C-H).  
LRMS (ESI) m/z calcd for NaC29H27FN2O2 [M+Na]
+ 477, found 477. 
(3ʹS)-1ʹ-Benzyl-3ʹ-(benzyloxy)-8-nitro-2,3,4,9-tetrahydrospiro[carbazole-1,2ʹ-
pyrrolidin]-5ʹ-one (341ii) 
 Prepared following general method B, using a 5-hydroxy-5-
cyclopropylpyrrolidin-2-one mixture 197 (0.057 g, 0.169 
mmol), 7-nitroindole (0.055 g, 0.33 mmol), BF3·Et2O (0.053 g, 
0.045 mL, 0.37 mmol) and CH2Cl2 (8.5 mL). The product was 
purified by column chromatography (1:2 EtOAc/PS), yielding 
compound 341ii as a yellow oil (0.010 g, 0.021 mmol, 12%) as 
pure separated diastereomers (dr = 62:38). The spirofuran 242 
was also isolated as a clear oil (0.028 g, 0.084 mmol, 49%) as a mixture of diastereomers 
(dr = 75:25, 242a:242b). 
 (1S,3ʹS)-1ʹ-Benzyl-3ʹ-(benzyloxy)-8-nitro-2,3,4,9-tetrahydrospiro[carbazole-1,2ʹ-
pyrrolidin]-5ʹ-one (341iia)  
[α]25
D
  = 90 ˚ ± 2 ˚ (c 12.0, CDCl3). δH 9.28 (1H, bs, H9 (No 
gHSQC correlation, no gCOSY correlation)), 8.10 (1H, d, J = 
8.1 Hz, H7), 7.85 (1H, d, J = 7.4 Hz, H5 (gHMBC correlation to 
C4b, gCOSY correlation to H6)), 7.21 – 7.14 (2H, m, ArCH and 
H6 (gHMBC correlation to C4b, gCOSY correlation to H7 and 
H5)), 7.13 – 7.07 (3H, m, ArCH), 7.07 – 7.01 (2H, m, ArCH 
(gHSQC correlation to 128.6 and 128.5 ppm which is 
inconclusive)), 6.92 (2H, d, J = 7.4 Hz, orthoH of-PhCH2N (gHMBC correlation to 
NCH2Ph)), 6.86 (2H, d, J = 7.4 Hz orthoH of-PhCH2O (gHMBC correlation to C2ʹ, 
gHSQC correlation to orthoCH-PhCH2O)), 4.38 (1H, d, J = 15.1 Hz, NCH2Ph (gHMBC 
correlation to C5ʹ)),  4.29 (1H, d, J = 11.8 Hz, OCH2Ph (gHMBC correlation to OCH2Ph 
and C4)), 4.21 (2H, d, J = 15.1 Hz, NCH2Ph (gHMBC correlation to C5ʹ)), 4.03 (1H, d, 
J = 11.8 Hz, OCH2Ph (gHMBC correlation to OCH2Ph and C4)), 3.99 (1H, d, J = 5.9 Hz, 
H3ʹ (gCOSY correlation H4ʹ, ROESY correlation to H2ʹ)), 2.92 (1H, dd, J = 17.6, 5.9 Hz, 
H4ʹ), 2.83 (1H, bd, J = 15.8 Hz, H4), 2.76 (1H, d, J = 17.5 Hz, H4ʹ (gCOSY correlation 
to H4ʹ)), 2.72 – 2.64 (1H, m, H4 (HMBC correlation to C4a)), 2.04 – 1.98 (1H, m, H3 
(gCOSY correlation to H2, H3)), 1.86 – 1.79 (1H, m, H2 (gCOSY correlation to H3)), 
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1.77 – 1.69 (2H, m, H2 and H3 (gHSQC correlation to C2 and C3, gCOSY correlation to 
H2, H3 and H4, ROESY correlation to H3ʹ)). 
δC 173.5 (C5ʹ (gHMBC correlation to NCH2Ph, NCH2Ph, H3ʹ, H4ʹ)), 138.0 (ipso-
NCH2Ph (gHMBC correlation to NCH2Ph)), 137.0 (ipso-OCH2Ph (gHMBC correlation 
to OCH2Ph)), 130.2 (C9a), 129.5 (C4b (gHMBC correlation to  H7)), 128.6 (ArCH), 
128.5 (ArCH), 128.2 (ArCH), 128.0 (ArCH), 127.6 (orthoC-PhCH2O (gHSQC 
correlation to  6.86 ppm)), 127.3 (ArCH), 126.7 (C5), 119.8 (C7), 118.6 (C6), 117.1 (C4a 
(gHMBC correlation to  H5, Quaternary on APT)), 79.1 (C3ʹ (gHSQC correlation to  
H3ʹ)), 72.1 (OCH2Ph (gHSQC correlation to OCH2Ph, gHMBC correlation to orthoCH-
PhCH2O and H4)), 67.7 (C1 (gHSQC no correlation, Quaternary on APT, gHMBC 
correlation to NCH2Ph, H6 and H7)), 44.5 (NCH2Ph (gHSQC correlation to NCH2Ph)), 
37.1 (C4ʹ), 32.4 (C2 (gHSQC correlation to H2)), 21.7 (C3 (gHSQC correlation to H3)), 
21.0 (C4 (gHSQC correlation to H4)).  
vmax/cm
-1 2926, 1696, 1517, 1395, 1295, 1072, 733, 697.  
HRMS (ESI) m/z calcd for C29H28N3O4 [M + H]
+ 482.2080, found 482.2084. 
(1R,3ʹS)-1ʹ-Benzyl-3ʹ-(benzyloxy)-8-nitro-2,3,4,9-tetrahydrospiro[carbazole-1,2ʹ-
pyrrolidin]-5ʹ-one (341iib) 
Minor Diastereomer  
δH 8.59 (1H, s, H9 (No gHSQC correlation)), 8.09 (1H, dd, J = 
8.1, 0.9 Hz, H7 (gHMBC correlation to C8 and C8a, gCOSY 
correlation to H6)), 7.83 (1H, d, J = 7.6 Hz, H5), 7.19 (1H, t, J 
= 7.9 Hz, H6), 7.14 – 7.11 (2H, m, ArH), 7.08 – 7.04 (2H, m), 
7.01 (1H, d, J = 7.3 Hz), 6.94 (2H, t, J = 7.5 Hz), 6.86 – 6.81 
(2H, d, J = 7.2 Hz, o-NCH2ArH (gHMBC correlation to 
NCH2Ph)), 4.64 (1H, d, J = 15.0 Hz, NCH2Ph (gHMBC 
correlation to C5ʹ)), 4.43 (1H, d, J = 12.1 Hz, OCH2Ph), 4.40 – 4.33 (2H, m, OCH2Ph 
H3ʹ), 3.93 (1H, d, J = 15.0 Hz, NCH2Ph), 2.88 (1H, dd, J = 16.6, 7.5 Hz, H4ʹ), 2.82 (1H, 
dt, J = 15.7, 4.7 Hz, H4 (gHMBC correlation to C4a)), 2.75 – 2.66 (2H, m, H4 H4ʹ), 2.51 
(1H, ddd, J = 13.7, 3.2, 2.1 Hz, H2 (gHMBC correlation to C3ʹ and C9a)), 2.19 – 2.10 
(1H, m, H3), 2.06 – 1.97 (1H, m, H3), 1.85 (1H, ddd, J = 13.7, 11.9, 3.4 Hz, H2).  
δC 171.7 (C5ʹ), 137.9 (ipso-NCH2Ph), 137.2 (ipso-OCH2Ph), 134.7 (C9a (gHMBC 
correlation to H2)), 132.9 (C8a (gHMBC correlation to H7)), 130.7 (C8 (gHMBC 
correlation to H9 and H6)), 129.9 (C4b (gHMBC correlation to H5 and H9)), 128.5 
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(ArCH), 128.4 (ArCH), 128.01 (ArCH), 127.96 (s), 127.6 (s), 127.1 (s), 126.8 (C5), 119.7 
(C7), 119.0 (C6), 118.1 (C4a (gHMBC correlation to H4)), 79.7 (C3ʹ), 72.6 (OCH2Ph), 
64.5 (C1 (gHMBC correlation to H4ʹ and NCH2Ph)), 44.0 (NCH2Ph), 35.7 (C4ʹ), 28.3 
(C2), 21.7 (C3), 20.5 (C4).  
vmax/cm
-1 3064, 3032, 2957, 2919, 2850, 1706, 1669, 1454, 1402, 1356, 1314, 1271, 1125, 
1112, 1071, 1028, 753, 699.  
LRMS (ESI) m/z calcd for C29H28N3O4 [M + H]
+ 482, found 482. 
(4S)-1-Benzyl-4-(benzyloxy)-5-cyclopropyl-5-(1-methyl-1H-indol-3-yl)pyrrolidin-2-
one (344i)  
Prepared following general method A, using a 5-hydroxy-5-
cyclopropylpyrrolidin-2-one mixture 197 (0.050 g, 0.15 mmol), 1-
methylindole (0.059 g, 0.45 mmol), BF3·Et2O (0.046 g, 0.040 mL, 
0.32 mmol) and CH2Cl2 (7.5 mL). The product was purified by 
column chromatography (1:2 EtOAc/PS), yielding the title 
compound 344i as a brown white solid (0.046 g, 0.010 mmol, 69%) and as a mixture of 
diastereomers (dr = 53:47). A small amount of each diastereomer could be isolated pure 







  = 8.3 ˚ ± 1.6 ˚ (c 2.95, CDCl3). 
  
δH 7.71 (1H, d, J = 8.2 Hz, H4ʹ), 7.35 – 7.31 (1H, m, H7), 7.27 – 
7.24 (2H, m, ArCH), 7.22 (3H, d, J = 3.7 Hz), 7.16 (4H, d, J = 4.9 
Hz, ), 7.13 – 7.08 (1H, d, J = 8.2 Hz, H5), 6.96 (1H, s, H2ʹ (no 
gCOSY correlation)), 6.89 (2H, d, J = 4.9 Hz, ArCH), 5.11 (1H, d, 
J = 15.3 Hz, NCH2Ph), 4.25 (1H, d, J = 11.9 Hz, OCH2Ph), 4.15 (1H, d, J = 11.9 Hz, 
OCH2Ph), 3.88 (1H, d, J = 15.3 Hz, NCH2Ph), 3.77 (3H, s, NCH3), 3.47 (1H, app. t, J = 
7.2 Hz, H4), 2.79 (1H, dd, J = 16.6, 7.5 Hz, H3), 2.56 (1H, dd, J = 16.6, 7.2 Hz, H3), 
1.27 – 1.19 (1H, m, H1ʹʹ), 0.84 – 0.72 (2H, m, H2ʹʹ), 0.14 – 0.05 (1H, m, H3ʹʹ), -0.15 – -
0.21 (1H, m, H3ʹʹ);  
δC 172.9 (C2), 139.2 (ipso-NCH2Ph), 137.9 (C7ʹa) ,137.7 (ipso-OCH2Ph), 128.7 (ArCH), 
128.2 (ArCH), 128.2 (ArCH), 127.5 (ArCH), 127.4 (ArCH), 126.9 (ArCH), 122.1 
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(ArCH), 121.7(ArCH), 119.6 (ArCH), 114.9 (C3ʹ (gHMBC correlation to  H3 and H4)), 
109.4 (C5ʹ), 73.2 (C4), 71.3 (OCH2Ph), 70.8 (C5), 44.6 (NCH2Ph), 36.6 (C3), 33.0 
(NCH3), 18.3 (C1ʹʹ), 5.5 (C2ʹʹ), 2.6 (C3ʹʹ).  
vmax/cm
-1 3242, 3078, 2900,2109, 1754, 1706, 1501, 1453, 1378, 1262, 1221, 1010, 976, 
784, 743, 709, 696.  
HRMS (ESI) m/z calcd for NaC30H30N2O2 [M + Na]
+ 451.2386, found 451.2370.  
(4S,5R)-1-Benzyl-4-benzyloxy)-5-cyclopropyl-5-1-methyl-1H-indol-3-yl)pyrrolidin-
2-one (344ib) 
Minor Diastereomer  
[α]25
D
  = 23 ˚ ± 2 ˚ (c 3.0, CDCl3).  
δH 7.33 – 7.27 (5H, m, ArCH), 7.24 – 7.15 (8H, m, ArCH), 6.98 
(1H, app. t, J = 7.5 Hz, ArCH), 6.95 (1H, s, H2ʹ), 4.98 (1H, d, J = 
15.6 Hz, NCH2Ph), 4.77 (1H, app. t, J = 5.2 Hz, H4), 4.63 (1H, d, J 
= 12.0 Hz, OCH2Ph), 4.56 (1H, d, J = 12.0 Hz, OCH2Ph), 4.19 (1H, 
d, J = 15.6 Hz, NCH2Ph), 3.75 (3H, s, NCH3), 2.66 (1H, dd, J = 
16.4, 4.7 Hz, H3), 2.50 (1H, dd, J = 16.4, 5.9 Hz, H3), 1.54 – 1.50 (1H, m, H1ʹʹ), 0.38 
(3H, m, J = 8.10 Hz, H2ʹʹ H3ʹʹ), 0.31 – 0.25 (1H, m, H3ʹʹ). 
δC 174.6 (C2 assigned from gHMBC), 139.2 (ipso-NCH2Ph (assigned from gHMBC)), 
138.6 (ipso-OCH2Ph), 137.7 (C7ʹa), 129.1 (ArC), 128.5 (ArCH), 128.2 (ArCH), 127.8 
(ArCH), 127.7 (ArCH), 127.6 (ArCH), 126.9 (ArCH), 121.9 (ArCH), 120.9 (ArCH), 
119.5 (ArCH), 109.9 (C7ʹa), 80.0 (C5), 71.9 (OCH2Ph) 45.1 (NCH2Ph) 37.3 (C3), 31.1 
(NCH3), 14.6 (C1ʹʹ), 3.4 (C3ʹʹ), 2.8 (C2ʹʹ).  
LRMS (ESI) m/z calcd for NaC30H30N2O2 [M + Na]
+ 451, found 451. Melting point: 162 
˚C. 
(4S)-1-Benzyl-4-(benzyloxy)-5-cyclopropyl-5-(5-fluoro-1-methyl-1H-indol-3-
yl)pyrrolidin-2-one (344ii)  
Prepared following general method A, using a 5-hydroxy-5-
cyclopropylpyrrolidin-2-one mixture 197 (0.050 g, 0.15 mmol), 
5-fluoro-1-methylindole (0.044 g, 0.3 mmol), BF3·Et2O (0.046 
g, 0.040 mL, 0.32 mmol) and CH2Cl2 (7.5 mL). The product was 
purified by column chromatography (1:2 EtOAc/PS), yielding 
the title compound 344ii as a yellow oil (0.031 g, 0.066 mmol, 45%, 68:32). The 






 δH 7.43 (1H, dd, J = 10.53 
2J coupling, 2.44 Hz meta coupling, 
H4ʹ), 7.26 - 7.32 (2H, m, ArH), 7.16 - 7.25 (7H, m, ArH), 6.98 
(2H, td, J = 8.93, 2.59 Hz, ArH), 6.92 - 6.96 (2H, m, ArH), 6.89 
(1H, s, H2ʹ), 5.09 (1H, d, J = 15.26 Hz, NCH2Ph), 4.29 (1H, d, J 
= 12.05 Hz, OCH2Ph), 4.18 (1H, d, J = 12.05 Hz, OCH2Ph), 3.93 
(1H, d, J=15.26 Hz, NCH2Ph), 3.74 (3H, s, NCH3), 3.46 (1H, t, 
J = 7.63 Hz, H4), 2.76 (1H, dd, J=16.63, 7.78 Hz, H3), 2.51 (1H, dd, J=16.48, 7.78 Hz, 
H3), 1.23 – 1.17 (1H, m, H1ʹʹ), 0.84 – 0.76 (2H, m, H2ʹʹ), 0.08 – 0.07 (1H, m, H3ʹʹ), -0.12 
– -0.18 (1H, m, H3ʹʹ).  
δC 172.8 (C2), 157.8 (d, J = 233.5 Hz, C5ʹ), 139.1 (ipso-NCH2Ph), 137.5 (ipso-OCH2Ph), 
134.6 (C7ʹa), 129.6 (H2ʹ), 129.3 (ArCH), 128.3 (ArCH), 128.2 (ArCH), 127.7 (ArCH), 
127.3 (ArCH), 126.9 (ArCH), 115.0 (d, J = 4.6 Hz 3J coupling, C3ʹa), 107.4 (d, J = 24.8 
Hz, H4ʹ), 73.2 (C4), 71.3 (OCH2Ph), 70.5 (C5), 44.5 (NCH2Ph), 36.1 (C3), 33.3 (NCH3), 
17.7 (C1ʹʹ), 5.8 (C2ʹʹ), 2.8 (C3ʹʹ).  
vmax/cm
-1 3228, 3057, 2928, 2853, 2109, 1754, 1692, 1501, 1460, 1385, 1262, 1228, 1010, 
976, 737, 696.  
HRMS (ESI) m/z calcd for C30H30N2O2F [M + H]
+ 469.2291, found 469.2303. 
(4S,5S)-1-Benzyl-4-(benzyloxy)-5-cyclopropyl-5-(5-fluoro-1-methyl-1H-indol-3-
yl)pyrrolidin-2-one (344iib) 
Minor Diastereomer  
Minor diastereomer indicative peaks. δH 4.87 (1H, d, J = 15.62 
Hz, NCH2Ph), 4.71 (1H, t, J = 5.37 Hz, H4), 4.64 (1H, d, J = 
12.21 Hz, OCH2Ph), 4.57 (1H, d, J = 12.21 Hz, OCH2Ph), 1.54 
- 1.61 (1H, m, H1ʹʹ), 0.53 – 0.44 (2H, m, H2ʹʹ), 0.44 – 0.37 (1H, 








 Prepared following general method A, using a 5-hydroxy-5-
cyclopropylpyrrolidin-2-one mixture 197 (0.050 g, 0.15 
mmol), 3-bromo-1-methylindole (0.063 g, 0.30 mmol), 
BF3·Et2O (0.046 g, 0.040 mL, 0.32 mmol) and CH2Cl2 (7.5 
mL). The product was purified by column chromatography (2:3 
EtOAc/PS), yielding title compound 344iii as a yellow solid (0.054 g, 0.10 mmol, 69%) 




 δH 7.97 (1H, d, J = 1.5 Hz, H4ʹ), 7.30 (1H, dd, J = 8.5, 1.8 Hz, 
H6ʹ), 7.25 – 7.20 (5H, m, ArCH), 7.20 – 7.17 (2H, m, ArCH), 
7.15 (2H, d, J = 1.5 Hz, H7ʹ ArCH), 6.97 (2H, d, J = 7.3 Hz, 
ArCH), 6.79 (1H, s, H2ʹ), 5.08 (1H, d, J = 15.3 Hz, NCH2Ph), 
4.30 (1H, d, J = 12.0 Hz, OCH2Ph), 4.20 (1H, d, J = 12.0 Hz, 
OCH2Ph), 3.98 (1H, d, J = 15.3 Hz, NCH2Ph), 3.70 (3H, s, 
NCH3), 3.47 (1H, app. t, J = 7.6 Hz, H4), 2.77 (1H, dd, J = 16.5, 7.3 Hz, H3), 2.50 (1H, 
dd, J = 16.5, 7.9 Hz, H3), 1.23 – 1.17 (1H, m, H1ʹʹ), 0.89 – 0.76 (2H, m, H2ʹʹ), 0.14 – 
0.05 (1H, m, H3ʹʹ), -0.08 – -0.17 (1H, m, H3ʹʹ).  
δC 172.7 (C2), 139.0 (ipso-NCH2Ph), 137.4 (ipso-OCH2Ph), 136.7 (C7ʹa), 129.2 (C3ʹa), 
129.0 (C2ʹ), 128.5 (ArCH), 128.4 (ArCH), 128.2 (ArCH), 127.6 (ArCH), 127.1 (ArCH, 
gHSQC with 6.97 ppm inconclusive), 127.0 (ArCH, gHSQC with 6.97 ppm 
inconclusive), 125.2 (C4ʹ), 124.6 (C6ʹ), 114.8 (C3ʹ), 112.9 (C5ʹ), 110.8 (C7ʹ), 73.4 (C4), 
71.3 (OCH2Ph), 44.5 (NCH2Ph), 33.1 (ArNCH3), 17.6 (C1ʹʹ), 6.0 (C2ʹʹ), 3.0 (C3ʹʹ).  
vmax/cm
-1 2924, 1664, 1454, 1354, 1094, 884, 736, 700.  
HRMS (ESI) m/z calcd for NaC30H30
35BrN2O2 [M+H]









Minor diastereomer indicative peaks. δH 4.74 (1H, d, J = 15.3 
Hz, NCH2Ph), 4.67 (1H, t, J = 5.8 Hz, H4), 4.59 (1H, d, J = 
12.2 Hz, OCH2Ph), 4.52 (1H, d, J = 12.2 Hz, OCH2Ph), 2.66 
(1H, dd, J=16.5, 5.5 Hz, H3), 1.61 – 1.50 (1H, m, H1ʹʹ), 0.39 – 
0.36 (1H, m, H3ʹʹ), 0.30 (1H, m, H3ʹʹ) 
Reaction of 197 and N-Acetylindole in the Presence of BF3·Et2O  
This reaction was performed following general method A, using a 5-
hydroxy-5-cyclopropylpyrrolidin-2-one mixture 197 (0.050 g, 0.15 mmol), 
N-acetylindole (0.065 g, 0.4 mmol), BF3·Et2O (0.046 g, 0.040 mL, 0.32 
mmol) and CH2Cl2 (7.5 mL). The product was purified by flash 
chromatography using gradient elution (5:1 hexane/EtOAc to 2:1 
hexane/EtOAc), yielding 242 as a clear oil (0.030 g, 0.088 mmol, 60%) as a mixture of 
diastereomers (dr = 75:25, 242a:242b). 
Reaction of 197 and N-Carboxybenzylindole in the Presence of BF3·Et2O  
This reaction was performed following general method A, using a 5-
hydroxy-5-cyclopropylpyrrolidin-2-one mixture 197 (0.050 g, 0.15 
mmol), benzyl 1H-indole-1-carboxylate (0.065 g, 0.4 mmol), BF3·Et2O 
(0.046 g, 0.040 mL, 0.32 mmol) and CH2Cl2 (7.5 mL). The product was 
purified by flash chromatography using gradient elution (5:1 hexane/EtOAc to 2:1 
hexane/EtOAc), yielding 242 as a clear oil (0.0325 g, 0.096 mmol, 65%) as a mixture of 
diastereomers (dr = 76:24, 242a:242b). 
Reaction of 197 and 3-Methylindole in the Presence of BF3·Et2O   
Prepared following general method A, using a 5-hydroxy-5-
cyclopropylpyrrolidin-2-one mixture 197 (0.050 g, 0.15 mmol), 3-
methylindole (0.059 g, 0.45 mmol), BF3·Et2O (0.046 g, 0.040 mL, 0.32 
mmol) and CH2Cl2 (7.5 mL). The product was purified by flash chromatography using 
gradient elution from 4:1 PS/EtOAc to 1:1 PS/EtOAc, yielding compound 346i as a clear 
oil (0.018 g, 0.040 mmol, 27%) as a mixture diastereomers (dr >95:5). A small amount 
of the major diastereomer could be isolated pure by separation using column 
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chromatography. Compound 348i was also isolated as a clear oil (0.016 g, 0.036 mmol, 
24%) as a mixture of diastereomers (dr = 79:21). A small amount of the major 




 δH 7.54 (1H, d, J = 7.7 Hz, H1), 7.24 – 7.17 (6H, m, ArCH), 7.15 
(1H, app. t, J = 7.3 Hz, H2), 7.10 (2H, d, J = 7.3 Hz, ArCH), 7.06 
(1H, app. t, J = 7.3 Hz, H3), 7.01 (2H, d, J = 3.6 Hz, ArCH), 6.94 
(1H, d, J = 8.0 Hz, H4), 4.89 (1H, d, J = 15.6 Hz, NCH2Ph), 4.70 
(1H, app. t, J = 8.2 Hz, H3ʹ (no NOESY correlation to H7), 4.27 
(1H, d, J = 11.6 Hz, OCH2Ph), 4.23 (1H, d, J = 11.6 Hz, OCH2Ph), 
3.50 (1H, d, J = 15.6 Hz, NCH2Ph), 2.97 – 2.91 (1H, m, H9), 2.90 – 2.85 (1H, m, H4ʹ), 
2.70 (1H, dd, J = 16.9, 8.3 Hz, H4ʹ), 2.53 – 2.47 (1H, m, H9), 2.41 (1H, d, J = 13.6 Hz, 
H7), 2.25 (3H, s, ArCH3), 2.06 – 1.96 (1H, m, H8), 1.73 (1H, dd, J = 9.3, 4.0 Hz, H8), 
1.66 (1H, td, J = 13.6, 3.0 Hz, H7). 
δC 171.1 (C2), 137.9 (ipso-NCH2Ph), 137.3 (ipso-OCH2Ph), 134.9 (C9a), 134.1 (C4a), 
130.6 (C10a), 128.6 (ArCH), 128.5 (ArCH), 128.3 (ArCH), 128.0 (ArCH), 127.6 (ArCH), 
127.4 (ArCH), 121.7 (C2), 120.2 (C3), 118.6 (C4), 111.7 (C1), 107.2 (C10), 82.2 (C6), 
79.0 (C3ʹ), 72.6 (OCH2Ph), 43.4 (NCH2Ph), 36.7 (C4ʹ), 30.9 (C7), 22.4 (C9), 19.7 (C8), 
8.5 (ArCH3).  
vmax/cm
-1 2923, 2851, 1634, 1454, 1396, 1319, 1107, 1027, 739, 692.  
HRMS (ESI) m/z calcd for C30H31N2O2 [M + H]




δH 7.40 – 7.32 (4H, m, ArCH), 7.32 – 7.27 (4H, m, ArCH), 7.18 
(2H, d, J = 7.5 Hz, ArCH), 6.96 (1H, d, J = 7.5 Hz, H8), 6.92 
(1H, app. t, J = 7.5 Hz, H6), 6.65 (1H, app. t, J = 7.3 Hz, H7), 
6.24 (1H, d, J = 7.5 Hz, H5), 5.48 (1H, d, J = 16.2 Hz, NCH2Ph), 
5.27 (1H, s, H3ʹ), 4.99 (1H, d, J = 11.7 Hz, OCH2Ph), 4.93 (1H, 
d, J = 11.7 Hz, OCH2Ph), 4.19 (1H, d, J = 6.5 Hz, H5ʹ), 4.15 
(1H, d, J = 16.2 Hz, NCH2Ph), 3.87 (1H, d, J = 4.7 Hz, H3a 
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(NOE correlation to H3 and CH3 in NOESY)), 2.16 (1H, dt, J = 11.9, 5.7 Hz, H3), 1.86 
(1H, dd, J = 12.2, 6.5 Hz, H1), 1.80 – 1.72 (1H, m, H2), 1.68 (1H, dt, J = 12.5, 6.3 Hz, 
H2), 1.52 (1H, dt, J = 12.4, 6.1Hz, H1), 1.38 (3H, s, CH3).  
δC 175.9 (C4ʹ (gHMBC correlation to OCH2PH)), 172.2 (C2ʹ(gHMBC correlation to 
NCH2PH)), 150.8 (C4a), 137.8 (ipso- NCH2Ph), 137.2 (C8a), 134.7 (ipso-OCH2Ph), 
129.1 (ArCH), 128.9 (ArCH), 128.8 (ArCH), 128.0 (ArCH), 127.7 (ArCH), 127.5 
(ArCH), 127.4 (ArCH), 122.7 (C8), 118.5 (C7), 108.6 (C5), 94.7 (C3ʹ), 73.3 (OCH2Ph), 
71.9 (C3a), 59.4 (C5ʹ), 53.5 (C8b gHSQC No correlation), 49.0 (C3), 44.5 (NCH2Ph), 
42.3 (C1), 28.5 (C2), 28.4 (CH3).  
vmax/cm
-1 2937, 1662, 1619, 1454, 1210, 806, 741, 697.  
HRMS (ESI) m/z calcd for C30H31N2O2 [M + Na]
+ 451.2386, found 451.2394. 
Reaction of 197 and 3-Cyclohexylindole in the Presence of BF3·Et2O 
Prepared following general method B, using a 5-hydroxy-5-
cyclopropylpyrrolidin-2-one mixture 197 (0.100 g, 0.296 mmol), 3-
cyclohexylindole (0.08 g, 0.6 mmol), BF3·Et2O (0.09 g, 0.08 mL, 0.6 mmol) 
and CH2Cl2 (15.0 mL). The products were purified by column 
chromatography (1:6 EtOAc/PS to 2:1 EtOAc/PS), yielding several 
compounds. Compounds 346iii (0.069 g, 0.133 mmol, 45%) were isolated as a mixture 
of diastereomers (73:27) and small amount of both diastereomers could be isolated pure 
by separation using column chromatography which gave two a colourless oils. Compound 
347iiia was isolated as a colourless oil (0.008 g, 0.016 mmol, 5.3%) as a single isomer 
(dr > 95:5). Compounds 348iii were isolated as a brown oil (0.036 g, 0.069, 24%) as a 




 δH 7.87 (1H, d, J = 7.9 Hz, H1 (ROESY correlation to H1ʹʹ, 
H2ʹʹa and H2ʹʹb)), 7.32 (1H, d, J = 7.9 Hz, H4)), 7.25 – 7.21 
(8H, m, ArH), 7.17 – 7.13 (3H, m, ArH), 7.13 – 7.09 (2H, m, 
ArH), 5.06 (1H, d, J = 15.6 Hz, NCH2Ph), 4.47 (1H, d, J = 11.8 
Hz, OCH2Ph), 4.40 (1H, app. t, J = 7.5 Hz, H3ʹ (gHMBC 
correlation to C8, C9a. ROESY correlation to H1ʹʹ)), 4.33 (1H, 
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d, J = 11.8 Hz, OCH2Ph), 4.17 – 4.12 (1H, m, H6), 3.68 (1H, d, J = 15.6 Hz, NCH2Ph), 
3.60 (1H, td, J = 11.6, 4.5 Hz, H6 (gHMBC correlation to C7)), 2.82 (1H, dd, J=16.7, 7.5 
Hz, H4ʹ), 2.73 (1H, dd, J = 16.7, 7.3 Hz, H4ʹ), 2.51 (1H, tt, J = 12.07, 3.19 Hz, H1ʹʹ 
(ROESY correlation to H3ʹ)), 2.34 (1H, dt, J=13.69, 3.30 Hz, H8 (gHMBC correlation to 
C3ʹ and C7)), 2.21 – 2.11 (2H, m, H7 H2ʹʹb), 2.03 – 1.93 (1H, m, H2ʹʹa (ROESY 
correlation to H1)), 1.88 – 1.74 (4H, m, H7 H2ʹʹb CH2), 1.54 (1H, m, H2ʹʹa), 1.52 – 1.46 
(1H, m, H8), 1.29 – 1.14 (4H, m, CH2).  
δC 172.0 (C5ʹ), 138.5 (ipso-NCH2Ph), 137.4 (ipso-OCH2Ph), 136.7 (C4a), 130.3 (C9a 
(gHMBC correlation to H3ʹ)), 128.6 (ArCH), 128.6 (ArCH), 128.1 (ArCH), 128.0 
(ArCH), 127.6 (ArCH), 127.3 (ArCH), 126.6 (C10a), 121.8 (C1), 121.7 (ArCH), 119.2 
(ArCH), 118.6 (C10), 109.6 (C4), 82.3 (C3ʹ (gHMBC correlation to H8)), 72.5 
(OCH2Ph), 44.3 (NCH2Ph), 42.0 (C6), 37.0 (C1ʹʹ), 36.1 (C4ʹ), 33.4 (C2ʹʹa), 33.2 (C2ʹʹb), 
29.0 (C8), 27.6 (CH2), 27.3 (CH2), 26.4 (CH2), 21.0 (C7).  
vmax/cm
-1 2927, 2851, 1694, 1457, 1402, 1349, 1328, 1206, 927, 742, 704.  
LRMS (ESI) m/z calcd for C35H39N2O2 [M+H]
+ 519, found 519. 
(3ʹS,6S)-1ʹ-Benzyl-3ʹ-(benzyloxy)-10-cyclohexyl-8,9-dihydro-7H-spiro[pyrido[1,2-
a]indole-6,2ʹ-pyrrolidin]-5ʹ-one (346iiib) 
Minor Diastereomer  
[α]25
D
  = 72.7 ˚ ± 4.6 ˚ (c 1.35, CDCl3).  
δH 7.76 (1H, d, J = 7.8 Hz, H1 (ROESY correlation to H1ʹʹ, 
gHMBC correlation to C9a)), 7.25 – 7.16 (8H, m, ArCH), 
7.10 (1H, app. td, J = 7.5 0.9 Hz, H2 (gHMBC correlation to 
C10a)), 7.08 – 7.06 (1H, m, ArCH), 7.03 – 7.00 (1H, m, H3 
(gHMBC correlation to C4a)), 6.99 – 6.97 (1H, m, ArCH), 
6.94 (1H, d, J = 8.2 Hz, H4 (ROESY correlation to H3ʹ, 
gHMBC correlation to C4a)), 4.88 (1H, d, J = 15.4 Hz, NCH2Ph), 4.77 (1H, app. t, J = 
8.4 Hz, H3ʹ (ROESY correlation to H4)), 4.28 (1H, d, J = 11.8 Hz, OCH2Ph), 4.22 (1H, 
d, J = 11.8 Hz, OCH2Ph), 3.47 (1H, d, J = 15.4 Hz, NCH2Ph), 3.06 – 2.98 (1H, m, H9 
(ROESY correlation to H1ʹʹ, gCOSY correlation to H8)), 2.89 (1H, dd, J = 16.8, 8.1 Hz, 
H4ʹ), 2.82 – 2.75 (1H, m, H1ʹʹ (ROESY correlation to H1 and H9)), 2.71 (1H, dd, J = 
16.8, 8.7 Hz, H4ʹ), 2.54 – 2.46 (1H, m, H9), 2.43 – 2.37 (1H, m, H7 (ROESY correlation 
to NCH2Ph)), 2.03 – 1.94 (2H, m, H8, CH2), 1.92 – 1.89 (2H, m, CH2), 1.84 – 1.80 (3H, 
m, CH2), 1.74 – 1.67 (1H, m, H8), 1.66 – 1.60 (1H, m, H7), 1.50 – 1.33 (3H, m, CH2). δC 
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170.9 (C5ʹ), 137.8 (ipso-NCH2Ph), 137.2 (ipso-OCH2Ph), 134.4 (C9a), 134.0 (C4a), 
128.9 (C10a), 128.6 (ArCH), 128.5 (ArCH), 128.4 (ArCH), 127.9 (ArCH), 127.5 (ArCH), 
121.2 (C3), 120.3 (C1), 119.8 (C2), 117.4 (C10), 112.0 (C4), 78.6 (C6), 72.4 (OCH2Ph), 
43.4 (NCH2Ph), 36.55 (C4ʹ), 36.53 (C1ʹʹ), 33.14 (CH2), 33.06 (CH2), 30.8 (C7), 27.6 
(CH2), 27.5 (CH2), 26.5 (CH2), 22.9 (C9), 19.7 (C8).  
LRMS (ESI) m/z calcd for C35H39N2O2 [M+H]




  δH 7.73 (1H, d, J = 7.8 Hz, H1 (ROESY correlation to H1ʹʹ, 
gHMBC correlation to C4a)), 7.31 – 7.18 (6H, m, ArCH), 
7.17 – 7.07 (5H, m, ArCH), 6.55 (2H, d, J = 7.3 Hz, ArCH 
from ortho-OBn (gHMBC correlation to OCH2Ph)), 5.10 
(1H, d, J = 16.1 Hz, NCH2Ph), 4.16 (1H, dd, J = 8.1, 2.7 Hz, 
H3ʹ), 3.86 (1H, d, J = 11.2 Hz, OCH2Ph), 3.67 (1H, d, J = 
15.6 Hz, NCH2Ph), 3.61 (1H, d, J = 11.7 Hz, OCH2Ph), 3.13 – 3.08 (1H, m, H9), 3.05 
(1H, dd, J = 18.1, 7.8 Hz, H4ʹ), 2.82 – 2.69 (2H, m, H4ʹ H1ʹʹ (gHMBC correlation to 
C8)), 2.65 – 2.55 (1H, m, H9), 2.06 – 1.67 (10H, m, H7 H8 CH2), 1.64 – 1.60 (1H, m, H7 
(ROESY correlation to H3ʹ)), 1.49 – 1.32 (3H, m, CH2).  
δC 172.7 (C5ʹ), 138.3 (ipso-NCH2Ph), 137.2 (C4a (gHMBC correlation to H1)), 137.1 
(ipso-OCH2Ph), 132.6 (C9a), 128.7 (ArCH), 128.2 (ArCH), 128.0 (ArCH), 127.5 
(ArCH), 127.4 (ArCH), 121.3 (C2), 119.4 (C1), 117.7 (C10), 113.8 (C4), 82.5 (C6), 79.5 
(C3ʹ), 71.8 (OCH2Ph), 44.1 (NCH2Ph), 38.3 (C4ʹ), 36.6 (C1ʹʹ), 36.4 (C7), 33.0 (CH2), 
32.8 (CH2), 27.6 (CH2), 27.5 (CH2), 26.5 (CH2), 22.9 (C9), 18.6 (C8).  
vmax/cm
-1 2926, 2850, 1708, 1530, 1454, 1399, 1358, 1332, 1313, 1262, 1116, 974, 928, 
906, 839, 771, 746, 701.  
HRMS (ESI) m/z calcd for C35H39N2O2 [M+H]











  = -37.5 ˚ ± -4.0 ˚ (c 1.35, CDCl3).  
δH 7.39 – 7.14 (13H, m, ArH), 6.99 – 6.88 (2H, m, H8 H6 
(ROESY correlation to H1ʹʹ)), 6.65 – 6.54 (1H, m, H7), 
6.22 (1H, d, J = 7.7 Hz, H5), 5.28 – 5.22 (2H, m, H3ʹ 
NCH2Ph), 5.06 – 4.89 (2H, m, OCH2Ph), 4.28 (1H, d, J = 
16.3 Hz, NCH2Ph), 4.23 (1H, d, J = 6.7 Hz, H5ʹ), 3.86 
(1H, d, J = 5.6 Hz, H3a (ROESY correlation to H3 and 
H1ʹʹ)), 1.96 – 1.87 (1H, m, H3), 1.76 – 1.67 (6H, m, CH2 H2 H2ʹʹa), 1.66 – 1.58 (3H, m, 
CH2), 1.54 – 1.49 (2H, m, CH2 H2), 1.44 – 1.37 (1H, m, H1ʹʹ), 1.22 – 1.02 (3H, m, CH2), 
1.01 – 0.94 (1H, m, CH2), 0.66 – 0.55 (1H, m, H2ʹʹa (ROESY correlation to 3a, COSY 
correlation to H1ʹʹ)).  
δC 176.1 (C4ʹ), 172.3 (C2ʹ), 151.9 (C4a), 138.0 (ipso-NCH2Ph), 134.7 (ipso-OCH2Ph), 
134.6 (C8a), 128.9 (ArCH), 128.7 (ArCH), 128.7 (ArCH), 128.0 (ArCH), 127.5 (ArCH), 
127.3 (C6), 127.1 (ArCH), 123.7 (C8), 118.1 (C7), 108.5 (C5), 94.7 (C3ʹ), 73.2 
(OCH2Ph), 66.4 (C3a), 62.2 (C8b), 59.7 (C5ʹ), 49.7 (C3), 46.6 (C1ʹʹ), 44.7 (NCH2Ph), 
37.7 (CH2), 28.8 (CH2), 28.5 (C2ʹʹa), 27.5 (C2), 26.9 (CH2), 26.7 (CH2), 26.5 (CH2).  
vmax/cm
-1 3390, 3031, 2927, 2851, 1665, 1621, 1484, 1452, 1403, 1337, 1262,  1227, 
1198, 987, 977, 804, 741, 702.  
HRMS (ESI) m/z calcd for C35H39N2O2 [M+H]
+ 519.3012, found 519.3010. 
(4S)-1-Benzyl-4-(benzyloxy)-5-cyclopropyl-5-(2-methyl-1H-indol-3-yl)pyrrolidin-2-
one (366i)   
Prepared following general method B, using a 5-hydroxy-5-
cyclopropylpyrrolidin-2-one mixture 197 (0.050 g, 0.15 mmol), 2-
methyl indole (0.059 g, 0.45 mmol), BF3·Et2O (0.046 g, 0.040 mL, 
0.32 mmol) and CH2Cl2 (7.5 mL). This reaction was cooled to -40 
°C rather than 0 °C for both the BF3·Et2O addition and the duration 
of the reaction (24 h). The crude product was purified by flash 
column chromatography (3:4 EtOAc/PS) yielding the title compound 366i as a colourless 
oil (0.051 g, 0.11 mmol, 75%) as a mixture of diastereomers (dr = 86:14). A small amount 
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of the major diastereomer could be isolated pure by further separation using column 
chromatography.  
(4S,5S)-1-Benzyl-4-(benzyloxy)-5-cyclopropyl-5-(2-methyl-1H-indol-3-yl)pyrrolidin
-2-one (366ia)  
Major Diastereomer 
 δH 8.10 (1H, bs, H1ʹ), 7.02 –  7.45 (10H, m, ArCH), 6.84 –  7.02 
(1H, m, ArCH), 5.11 –  5.28 (1H, m, NCH2Ph), 4.21 –  4.32 (1H, 
m, OCH2Ph), 4.15 (1H, bs, OCH2Ph), 3.68 –  3.86 (1H, m, 
NCH2Ph), 3.43 (1H, bs, H4), 2.82 (1H, dd, J = 16.5, 7.7 Hz, H3), 
2.49 (4H, dd, J =  16.5, 8.1 Hz, H3), 1.15 –  1.39 (1H, m, H1ʹʹ), 
0.64 –  0.92 (2H, m, H2ʹʹ), -0.09 –  -0.02 (1H, m, H3ʹʹ), -0.39 (1H, 
bs, H3ʹʹ). δC 172.8 (C2), 137.7 (s), 128.6 (ArCH), 128.3 (ArCH), 128.2 (ArCH), 127.7 
(ArCH), 127.5 (ArCH), 126.8 (ArCH), 120.9 (s), 110.4 (C7ʹa), 73.4 (C4), 71.3 (OCH2Ph), 
45.5 (NCH2Ph), 37.5 (CH3), 29.8 (C1ʹʹ), 8.8 (C2ʹʹ), 4.5 (C3ʹʹ).  
HRMS (ESI) m/z calcd for NaC30H30N2O2 [M+Na]
+ 473.2205, found 473.2228. 
 (4S)-1-Benzyl-4-(benzyloxy)-5-(2-methyl-5-nitro-1H-indol-3-yl)-5-(3-(2-methyl-5-
nitro-1H-indol-3-yl)propyl)pyrrolidin-2-one (367ii)  
Prepared following general method B, using a 5-
hydroxy-5-cyclopropylpyrrolidin-2-one mixture 
197 (0.040 g, 0.119 mmol), 2-methyl-5-
nitroindole (0.042 g, 0.24 mmol), BF3·Et2O 
(0.034 g, 0.032 mL, 0.26 mmol) and CH2Cl2 (6.0 
mL). The product was purified by column 
chromatography (1:2 EtOAc/hexanes), yielding the bis-adduct 367iia as a yellow solid 
(0.021 g, 0.07 mmol, 27%, dr > 95:5) and its minor diastereomer 367iib as a yellow oil 
(0.009 g, 0.013 mmol, 10%, dr > 95:5). A mixture of the two diastereomers 367iia and 
367iib was also isolated (0.011 g, 0.016 mmol, 9%, dr = 67:33) for a total combined yield 
of 367ii (0.041, 0.061 mmol, 51%, dr = 69:31). The spirocyclic furan 242 was also 
isolated as a colourless oil (0.006 g, 0.018 mmol, 15%) and as a a mix of diastereomers 









  = 85.4 ˚ ± 0.8 ˚ (c 7.6, CDCl3). 
δH 9.16 (1H, s, NH a (ROESY correlation to  
CH3a, no gHSQC correlation, gHMBC to C3ʹ)), 
8.50 (1H, s, NH b (ROESY correlation to  CH3b, 
no gHSQC correlation, gHMBC to C3ʹʹʹ)), 8.16 
(1H, s, H4ʹʹʹ), 8.04 (1H, s, H4ʹ (ROESY 
correlation to  NCH2Ph), 7.93 (2H, app. t, J = 8.2 Hz, H6ʹ and H6ʹʹʹ), 7.29 – 7.24 (2H, m, 
ArCH), 7.24 – 7.17 (6H, m, ArCH), 7.16 – 7.10 (2H, m, ArCH), 6.95 (2H, d, J = 6.7 Hz, 
ArCH), 4.91 (1H, d, J = 15.1 Hz, NCH2Ph), 4.38 (2H, d, J = 11.4 Hz, OCH2Ph, H4 
(gHSQC correlation to  72.6, 81.7 ppm, ROESY correlation to  2.226 –2.30 ppm)), 4.25 
(1H, d, J = 11.4 Hz, OCH2Ph), 3.81 (1H, d, J = 15.1 Hz, NCH2Ph), 2.80 (1H, dd, J = 
17.1, 7.7 Hz, H3), 2.64 (1H, dd, J = 17.5, 6.4 Hz, H3), 2.38 – 2.34 (1H, m, H3ʹʹ), 2.30 – 
2.27 (1H, m, H2ʹʹ, (ROESY correlation to  4.38 ppm, gHSQC correlation to  C2ʹʹ), 2.24 
(3H, s, H3ʹʹ a-ArCH3 (gHSQC correlation to  14.4 ppm, ROESY correlation to NCH2Ph)), 
2.19 (4H, s, b-ArCH3 H3ʹʹ (gHSQC correlation to  11.8 ppm)), 2.00 (1H, t, J = 12.8 Hz, 
H2ʹʹ (ROESY correlation to NCH2Ph)), 1.90–1.82 (1H, m, H1ʹʹ (ROESY correlation to 
NCH2Ph and H3)), 1.33 –1.29 (1H, m, H1ʹʹ (ROESY correlation to NCH2Ph weak)).  
δC 173.5 (C2), 141.6 (C7ʹʹʹa (gHMBC correlation to H4ʹʹʹ)), 141.3 (C7ʹa), 138.7 (Either 
C7ʹa or C7ʹʹʹa (gHMBC correlation inconclusive due to similarity of carbon signals)), 
138.6 (Either C7ʹa or C7ʹʹʹa (gHMBC correlation inconclusive due to similarity of carbon 
signals)),), 137.8 (ipso-NCH2Ph (gHMBC correlation to NCH2Ph)), 137.6 (ipso-OCH2Ph 
(gHMBC correlation to OCH2Ph)), 136.3 (C2ʹ(gHMBC correlation to a-ArCH3)), 135.1 
(C2ʹʹ (gHMBC correlation to b-ArCH3, gHMBC correlation to C3ʹʹ)), 129.0 (ArCH), 
128.9 (ArCH), 128.6 (ArCH), 128.5 (ArCH), 128.3 (ArCH), 128.0 (ArCH), 127.9 
(ArCH), 127.7 (ArCH), 127.6 (ArCH), 126.4 (ArCH), 117.3 (C6ʹ or C6ʹʹʹ), 116.9 (C6ʹ or 
C6ʹʹʹ), 116.5 (s), 115.3 (s), 115.2 (C3ʹ (gHMBC correlation to H4 and H1ʹ)), 113.7 (C3ʹʹʹ), 
110.8 (s), 110.3 (s), 81.7 (C4 (gHSQC correlation to  4.38)), 72.6 (OCH2Ph (gHSQC 
correlation to  4.38, 4.25 ppm)), 71.6 (C5), 45.0 (NCH2Ph (gHSQC correlation to  4.91, 
3.81 ppm)), 37.8 (s), 34.3 (C2ʹʹ), 25.0 (C1ʹʹ (gHSQC correlation to  1.82-1.90, 1.29-1.33 
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ppm))), 23.7 (C3ʹʹ (gHSQC correlation to  2.35, 2.26-2.30 ppm), 14.4 (a-ArCH3 (gHSQC 
correlation to  2.24 ppm)), 11.8 (b-ArCH3 (gHSQC correlation to  2.19 ppm)).  
vmax/cm
-1 2973, 1663, 1514, 1320, 1052, 738, 699.  
HRMS (ESI) m/z calcd for NaC39H38N5O6 [M+Na]
+ 672.2822, found 672.2844. 
 (4S,5R)-1-Benzyl-4-(benzyloxy)-5-(2-methyl-5-nitro-1H-indol-3-yl)-5-(3-(2-methyl-
5-nitro-1H-indol-3-yl)propyl)pyrrolidin-2-one (367iib) 
Minor Diastereomer  
.δH 8.80 (1H, bs, NHa), 8.51 (1H, bs NH b), 8.33 
(1H, bs), 8.22 (1H, bs), 8.01 (2H, d, J = 8.7 Hz, ), 
7.17 –  7.39 (11H, m), 7.12 –  6.99 (3H, m), 6.68 
(2H, d, J = 7.1 Hz), 5.02 (1H, d, J = 13.8 Hz, 
NCH2Ph), 4.04 (1H, d, J = 10.7 Hz, OCH2Ph), 
3.95 (1H, bs, H4), 3.70 (2H, m, NCH2Ph 
OCH2Ph), 2.97 (1H, dd, J=17.8, 7.7 Hz, H3), 2.62 –  2.51 (1H, m), 2.45 (2H, bs), 1.94 
(1H, bs), 1.70 (1H, bs), 1.52 (1H, bs). 
δC 173.5 (C2), 142.8 (C7ʹa), 141.4 (C7ʹʹʹa), 137.8 (Either C7ʹa or C7ʹʹʹa (gHMBC 
correlation inconclusive due to similarity of carbon signals)), 137.1 (Either C7ʹa or C7ʹʹʹa 
(gHMBC correlation inconclusive due to similarity of carbon signals)), 129.1 (ArCH), 
128.6 (ArCH), 128.2 (ArCH), 127.7 (ArCH), 127.4 (ArCH), 117.0 (C6ʹ or C6ʹʹʹ), 116.8 
(C6ʹ or C6ʹʹʹ), 115.0, 110.8, 110.3, 84.1 (C4), 79.6, 72.5 (OCH2Ph, 44.9 (NCH2Ph), 38.8, 
38.7, 23.7 (C3ʹʹ), 23.2, 15.2 (a-OCH3), 11.9 (b-OCH3). 
7.3.8 Reactions with the Phthalimide α-Cyclopropyl N-Acyliminium ion Precursor 
203 
3-Cyclopropyl-3-(1H-indol-3-yl)-2-methylisoindolin-1-one (308) 
Prepared following general method C, using a mixture of 3-
cyclopropyl-3-hydroxy-2-methylisoindolin-1-one 203 (0.050 
g, 0.25 mmol), indole (0.035, 0.3 mmol), BF3·Et2O (0.07 g, 
0.06 mL, 0.49 mmol) in CH2Cl2 (10 mL). The reaction mixture 
was quenched after 2 h. The product was dissolved in acetone 
then precipitated with hexane to yield the title compound 308 
as a white foam (0.064 g, 0.21 mmol, 86%). 
Melting point: Decomposed before melting, discolouration observed. 
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δH 8.34 (1H, bs, H1ʹ (no gHSQC correlation)), 7.93 (1H, d, J = 7.7 Hz, H7), 7.65 (1H, d, 
J = 2.3 Hz, H2ʹ (gCOSY correlation to H1ʹ)), 7.45 – 7.38 (1H, m, H6), 7.37 – 7.30 (2H, 
m, H5, H7ʹ (gCOSY correlation to H5)), 7.10 (1H, app. t, J = 7.5 Hz, H6ʹ), 7.03 (1H, d, 
J = 7.4 Hz, H4 (gCOSY correlation to H5)), 6.84 (1H, app. t, J = 7.7 Hz, H5ʹ), 6.71 (1H, 
d, J = 8.1 Hz, H4ʹ (gHMBC correlation to C3ʹ and C7ʹa)), 2.94 (3H, s, CH3), 1.95 – 1.87 
(1H, m, H1ʹʹ), 0.83 (1H, s, H2ʹʹ (gHSQC correlation to C2ʹʹ)), 0.77 – 0.69 (1H, m, H2ʹʹ 
(gHSQC correlation to C2ʹʹ)), 0.42 (1H, bs, H3ʹʹʹ (gHSQC correlation to C3ʹʹ)), -0.27 – -
0.34 (1H, m, H3ʹʹ (gHSQC correlation to C3ʹʹ)). 
δC 168.2 (C1), 146.3 (C3a (gHMBC correlation to H1ʹʹ)), 137.0 (C7ʹa), 132.9 (C7a), 131.0 
(C5), 128.4 (C6), 125.0 (C3ʹa), 124.4 (C2ʹ (gHSQC correlation to H2ʹ)), 123.5 (C4), 123.4 
(C7), 122.6 (C6ʹ), 120.3 (C5ʹ), 119.7 (C4ʹ), 115.8 (C3ʹ), 111.3 (C7ʹ), 68.0 (C3), 25.6 (CH3 
(gHSQC correlation to CH3)), 17.2 (C1ʹʹ), 3.9 (C2ʹʹ), 0.1 (C3ʹʹ).  
vmax/cm
-1 3177, 2928, 2218, 1664, 1434, 1406, 1349, 1096, 1073, 1026, 808, 735, 700, 
640, 421.  
HRMS (ESI) m/z calcd for C20H19NO2 [M+H]
+ 303.1497, found 304.1491.  
3-Cyclopropyl-2-methyl-3-(5-nitro-1H-indol-3-yl)isoindolin-1-one (342) 
 Prepared following general method C, using a mixture of 
3-cyclopropyl-3-hydroxy-2-methylisoindolin-1-one 203 
(0.050 g, 0.25 mmol), indole (0.081, 0.3 mmol), BF3·Et2O 
(0.07 g, 0.06 mL, 0.49 mmol) in CH2Cl2 (10 mL). The 
product was dissolved in acetone then precipitated with 
hexane to yield the title compound 342 as a yellow foam 
(0.081 g, 0.23 mmol, 93%). 
Melting point: Decomposes at 246 ˚C before melting. 
δH 9.37 (1H, bs, H1ʹ), 8.03 (1H, dd, J = 7.4, 1.3 Hz, H6ʹ), 7.98 (1H, d, J = 7.4 Hz, H7), 
7.79 (1H, d, J = 2.4 Hz, H2ʹ (gCOSY to H8)), 7.73 (1H, d, J = 1.3 Hz, H4ʹ), 7.50 – 7.46 
(1H, m, H6), 7.44 (1H, d, J = 9.1 Hz, H7ʹ), 7.39 (1H, t, J = 7.4 Hz, H5), 7.06 (1H, d, J = 
7.4 Hz, H4), 2.99 (3H, s, CH3), 1.97 – 1.89 (1H, m, H1ʹʹ), 0.96 – 0.89 (1H, m, H2ʹʹ), 0.79 
(1H, dq, J = 10.0, 5.2 Hz, H2ʹʹ), 0.52 – 0.46 (1H, m, H3ʹʹ), -0.27 (1H, dd, J = 9.7, 5.4 Hz, 
H3ʹʹ). δC 168.1 (C1), 145.7 (C3a), 142.2 (C7ʹa), 140.1 (C5ʹ), 132.6 (C7a), 131.3 (C5), 
129.0 (C6), 127.4 (C2ʹ), 124.5 (C3ʹa), 123.9 (C7), 123.4 (C4), 118.5 (C3ʹ), 118.3 (C6ʹ), 
116.8 (C4ʹ), 111.7 (C7ʹ), 67.6 (C3), 25.6 (CH3), 17.1 (C1ʹʹ), 4.3 (C2ʹʹ), 0.3 (C3ʹʹ).  
vmax/cm
-1 2977, 1661, 1520, 1474, 1334, 1052, 814, 743, 696. 
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HRMS (ESI) m/z calcd for C20H18N3O3 [M+H]
+ 348.1348 found 348.1365.  
3-Cyclopropyl-2-methyl-3-(3-methyl-1H-indol-2-yl)isoindolin-1-one (364)  
Prepared following general method C, using a mixture of 3-
cyclopropyl-3-hydroxy-2-methylisoindolin-1-one 203 (0.050 
g, 0.25 mmol), 3-methylindole (0.066, 0.5 mmol), BF3·Et2O 
(0.14 g, 0.12 mL, 0.97 mmol) in CH2Cl2 (10 mL). The product 
was purified by column chromatography (1:1 EtOAc/PS), to 
yield the title compound 364 as a white foam (0.41 g, 0.13 
mmol, 52%). 
δH (DMSO-d6) 10.73 (1H, bs, H1ʹ), 7.81 – 7.68 (1H, m), 7.52 – 7.45 (1H, m), 7.42 (1H, 
d, J = 7.9 Hz, H7ʹ (gHMBC correlation to H1ʹ)), 7.36 (1H, d, J = 8.1 Hz, H4ʹ), 7.23 – 7.16 
(1H, m, ), 7.07 (1H, t, J = 7.6 Hz, H5ʹ), 7.00 – 6.93 (1H, m, H6ʹ), 2.89 (3H, s, NCH3), 
2.08 – 2.00 (1H, m, H1ʹʹ), 1.93 (3H, bs, ArCH3), 1.03 – 0.92 (1H, m, H2ʹʹ), 0.79 – 0.68 
(1H, m, H2ʹʹ), 0.57 – 0.46 (1H, m, H3ʹʹ), -0.48 – -0.60 (1H, m, H3ʹʹ).  
δC (DMSO-d6) 166.6 (C1), 145.0 (C7a), 135.2 (s), 132.0 (s), 131.9 (s), 131.3 (s), 129.2 
(s), 128.6 (s), 122.6 (s), 121.3 (s), 118.4 (C4ʹ), 117.9 (C7ʹ), 111.4 (s), 107.1 (C3ʹ), 67.9 
(C3), 25.4 (NCH3), 15.9 (C1ʹʹ), 8.4 (ArCH3), 5.2 (C2ʹʹ), 0.3 (C3ʹʹ).  
vmax/cm
-1 2974, 1676, 1456, 1389, 1332, 1022, 885, 744, 690.  
HRMS (ESI) m/z calcd for C21H21N2O [M + H]
+ 317.1654, found 317.1649. 
3-Cyclopropyl-2-methyl-3-(2-methyl-1H-indol-3-yl)isoindolin-1-one (368)  
Prepared following general method C, using a mixture of 3-
cyclopropyl-3-hydroxy-2-methylisoindolin-1-one 203 (0.050 
g, 0.25 mmol), 2-methylindole (0.066, 0.5 mmol), BF3·Et2O 
(0.14 g, 0.12 mL, 0.97 mmol) in CH2Cl2 (10 mL). The product 
was purified by column chromatography (2:1 EtOAc/PS), to 
yield the title compound 368 as a white foam (0.41 g, 0.13 
mmol, 52%). 
δH (DMSO-d6) 10.91 (1H, bs, H1ʹ), 7.72 – 7.71 (1H, m, H7 (gHMBC correlation to C1 
and C7a), 7.45 – 7.39 (2H, m, H6 H5), 7.23 (1H, d, J = 8.1 Hz, H7ʹ), 7.15 – 7.12 (1H, m, 
H4), 6.93 (1H, t, J = 7.3 Hz, H6ʹ), 6.73 (1H, bs, H5ʹ), 3.17 (3H, s, ArCH3), 2.80 (3H, s, 
NCH3), 2.08 – 2.06 (1H, m, H1ʹʹ), 0.87 (1H, bs, H2ʹʹ), 0.67 – 0.62 (1H, m, H2ʹʹ), 0.54 – 
0.49 (1H, m, H3ʹʹ), -0.42 – -0.47 (1H, m, H3ʹʹ).  
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δC (DMSO-d6) 166.4 (C1), 146.9 (C7a), 134.8 (C7ʹa), 131.9 (C3a (gHMBC correlation 
to H4), 130.6 (C6), 127.7 (C5), 123.3 (C4), 121.9 (C7), 119.8 (C6ʹ), 118.5 (C5ʹ), 110.3 
(C7ʹ), 107.6 (C3ʹ), 68.3 (C3), 24.9 (NCH3), 17.6 (C1ʹʹ), 5.8 (C2ʹʹ), 1.2 (C3ʹʹ).  
vmax/cm
-1 2974, 1676, 1456, 1389, 1332, 1022, 885, 744, 690. 
2-Methyl-3-(3-(1,2,3,4-tetrahydro-4aH-carbazol-4a-yl)propylidene)isoindolin-1-one 
(369)  
Prepared following general method C, using a mixture of 
3-cyclopropyl-3-hydroxy-2-methylisoindolin-1-one 203 
(0.100 g, 0.492 mmol), tetrahydrocarbazole (0.094, 0.55 
mmol), BF3·Et2O (0.14 g, 0.12 mL, 0.97 mmol) in 
CH2Cl2 (25 mL). The product was purified by column 
chromatography (3:2 EtOAc/PS), yielding title 
compound 369 as a yellow foam (0.032 g, 0.090 mmol, 18%) as a mixture of 
diastereomers (E/Z = 86:14 from 1H of the NMR crude reaction product). A small amount 




Major Diastereomer (369a) 
 δH 7.79 (1H, dd, J = 5.1, 3.0 Hz, ArCH), 7.62 (1H, d, J 
= 7.8 Hz, H5ʹʹ (gHMBC correlation to C4ʹʹa)), 7.44 – 
7.39 (2H, m, ArCH), 7.38 – 7.36 (1H, m, ArCH), 7.33 
(1H, d, J = 7.1 Hz, H8ʹʹ(gHMBC correlation to C4ʹʹa and 
C9ʹʹb)), 7.27 (1H, d, J = 7.4 Hz, ArCH), 7.22 – 7.17 (1H, 
m, ArCH), 5.14 (1H, t, J = 7.6 Hz, H1ʹ (ROESY 
correlation to CH3 indicating E stereochemistry)), 3.13 
(3H, s, CH3), 2.94 (1H, d, J = 13.3 Hz, H1ʹʹ), 2.56 (1H, td, J = 13.3, 5.6 Hz, H1ʹʹ), 2.45 – 
2.40 (1H, m, H3ʹ), 2.37 (1H, d, J = 12.8 Hz, H4ʹʹ), 2.22 (1H, app. d, J = 12.2 Hz, H2ʹʹ), 
2.11 – 2.03 (1H, m, H3ʹ), 2.02 – 1.98 (1H, m, H2ʹ), 1.97 – 1.91 (1H, m, H2ʹ), 1.90 – 1.79 
(1H, m, H3ʹʹ), 1.72 (1H, d, J = 13.5 Hz, H3ʹʹ), 1.52 – 1.39 (1H, m, H2ʹʹ), 1.30 – 1.18 (1H, 
m, H4ʹʹ).  
δC 189.0 (C9ʹʹb), 166.3 (C1), 155.2 (C8ʹʹa (gHMBC correlation to C5ʹʹ)), 144.4 (C4ʹʹb 
(gHMBC correlation to C3ʹ and C5ʹʹ)), 136.4 (C3), 134.8 (C3a), 131.8 (ArCH), 130.7 
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(C7a), 128.7 (ArCH), 128.1 (ArCH), 125.1 (ArCH), 123.3 (ArCH), 123.0 (ArCH), 121.7 
(C8ʹʹ), 120.5 (C5ʹʹ), 110.5 (C1ʹ), 58.1 (C4ʹʹa), 38.4 (C4ʹʹ), 34.5 (C3ʹ), 30.4 (C1ʹʹ), 29.1 
(C2ʹʹ), 25.8 (CH3), 21.8 (C2ʹ), 21.4 (C3ʹʹ).  
LRMS (ESI) m/z calcd for C36H38N3O [M+H]
+ 528, found 528. 
(Z)-2-Methyl-3-(3-(1,2,3,4-tetrahydro-4aH-carbazol-4a-yl)propylidene)isoindolin-
1-one (369b) 
Minor Diastereomer  
δH (DMSO-d6) 7.72 (1H, d, J = 7.3 Hz, H5ʹʹ (gHMBC 
correlation to C4ʹʹa)), 7.68 (1H, d, J = 7.3 Hz, H7 (gHMBC 
correlation to C1)), 7.47 (2H, app. t, J = 7.3 Hz, ArCH), 
7.45 – 7.38 (3H, m, ArCH), 7.07 (1H, d, J = 7.6 Hz, H4 
(gHMBC correlation to C1ʹ)), 5.30 (1H, t, J = 8.1 Hz, H1ʹ), 
3.11 (1H, d, J = 5.8 Hz, H1ʹʹ), 3.03 (3H, s, CH3), 2.97 (1H, 
d, J = 12.5 Hz, H1ʹʹ (gCOSY correlation to H2ʹʹ)), 2.68 – 
2.56 (2H, m, H4ʹʹ and H3ʹ(gCOSY correlation to H3ʹʹ, gHMBC correlation to C3ʹ)), 2.41 
(1H, d, J = 6.1 Hz, H3ʹ (gCOSY correlation to H2ʹ)), 2.27 (1H, bs, H4ʹʹ (gCOSY 
correlation to H3ʹʹ)), 2.21 – 2.10 (1H, m, H2ʹ (gCOSY correlation to H1ʹʹ and H3ʹʹ)), 2.10 
– 2.02 (1H, m, H2ʹ (gCOSY correlation to H1ʹʹ and H3ʹʹ)), 1.96 – 1.86 (1H, m, H3ʹʹ 
(gCOSY correlation to H2ʹʹ and H4ʹʹ)), 1.64 (1H, d, J = 13.4 Hz, H3ʹʹ (gCOSY correlation 
to H2ʹʹ and H4ʹʹ)), 1.56 – 1.44 (1H, m, H2ʹʹ (gCOSY correlation to H3ʹʹ and H1ʹʹ), 1.24 
(1H, m, J = 2.7 Hz, H4ʹʹ(gCOSY correlation to H3ʹʹ, gHMBC correlation to C3ʹ)). 
δC (DMSO-d6) 195.7 (C9ʹʹb), 164.8 (C1), 146.4 (C4ʹʹa (signal assigned by gHMBC)), 
142.5 (C8ʹʹa (signal assigned by gHMBC)), 135.28 (C3 (gHMBC correlation to H7, H1ʹ 
and H2ʹ)), 134.07 (ArC), 131.89 (ArCH), 129.82 (ArC), 128.87 (ArCH), 128.49 (ArCH), 
127.09 (ArCH), 123.3 (C5ʹʹ), 122.7 (C4), 122.6 (C7), 117.66 (C6ʹʹ(gHMBC correlation 
to H5ʹʹ)), 110.70 (C1ʹ), 58.4 (C4ʹʹa), 33.53 (C4ʹʹ), 29.79 (C2ʹʹ), 29.09 (C1ʹʹ), 25.45 (CH3), 
22.06 (C2ʹ), 20.20 (C3ʹʹ).  
vmax/cm
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LRMS (ESI) m/z calcd for C36H38N3O [M+H]
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